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Introduction
Chapter 1
Introduction
BURDEN OF COLORECTAL CANCER
Colon and rectal cancer are the fourth most common types of cancer in the world (1). In
both men and women, incidence of colon cancer occurs at a similar rate However, cancer
of the rectum has a 20-50% higher incidence in men than in women In The Netherlands,
colon and rectal cancer rank fourth (world stanCard annual incidence rate (WSR) 23 per
100.000 persons) and sixth (WSR 15 per 100,000 persons) on the list of most frequent
cancers among men and second (WSR 19 per 100.000 persons) and eighth (WSR 9 per
100,000 persons) among women, respectively (Cancer Incidence in Five Continents, vol.
VIII, 2002).
High-risk areas include North America, Western Europe. New Zealand and Australia.
Central and South America. Asia and Africa are areas of low nsk. but the incidence in these
areas nses consistently with migration and westernisation of diet (2-4) Migrant and temporal
trend studies suggest that colon and rectal cancer are determined largely by environmental
exposures, such as diet. The cancer risk rates of migrants who move from low-to-high-risk
countries tend to increase to the rates of the host countries within one or two generations, or
even as early as within the migrating generation itself Lichtenstein et al (5) suggested that
environmental factors may contribute a proportion of approximately 65% to the susceptibility
to colorectal cancer (CRC).
DIETARY FACTORS AND AETIOLOGY OF SPORADIC COLORECTAL CANCER
In a multitude of prospective cohort and case-control studies, the importance of dietary
factors for CRC incidence has been investigated The most common hypotheses from
epidemiological studies suggest that an increased risk of CRC is the result of a typical
western diet, rich in fat and low in Fibre (6,7). However, most of the associations between
dietary factors and CRC are still prone to debate.
Regarding dietary fat, it has been difficult to determine whether it is the fal content of
diet or the associated consumption of meat, which is related to the increased risk of CRC.
Epidemiological evidence, supported by identification of biological mechanisms through
experimental evidence, suggests that a diet high in total fat and saturated fat possibly
increases the risk of CRC (8-10). The evidence with respect to diets high in
monounsaturated fat or polyunsaturated fat and the risk of CRC is inconsistent (11-13).
Energy intake was suggested to be increased associated with colon cancer risk in some
studies, after adjustment for physical activity (10,14). Regarding meat, associations have
been found with red meat consumption (15), with the preparation of meat, like high
temperature cooking, and with processed meal (4.9,16). Fish consumption is inversely
associated with CRC (12,17).
A diet rich in dietary fibre, vegetables and fruit has been suggested to be protective of
CRC (6,18,19). For a potential protective effect of dietary calcium on CRC, overall results
from case-control and cohort studies indicate no effect (19-21). High intake of both folate
and methionine are inversely associated with CRC risk (22,23), whereas deficient intakes of
folate or methionine, in combination with high alcohol consumption, may be positively
associated with CRC (24.25). For high intake of alcohol, a majority of epidemiological
studies have reported either an increased risk of colon cancer (26,27) or of rectal cancer
(28,29) or no association at all (30,31).
Although part of the inconsistent findings may be due to methodological issues related
to the assessment of dietary intake, study design or chance, these are unlikely to be the only
causes. These findings may also result from the oversimplified approach of CRC as a
suddenly arising disease entity and which does not account for the different genes involved.
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Therefore, a better aetiological understanding of CRC requires careful molecular analysis of
the genetic changes involved in carcinogenesis in relation to exogenous factors
DEVELOPMENT OF SPORADIC COLORECTAL CANCER
Approximately 5% of all CRCs are directly caused by inherited genetic abnormalities
The hereditary forms include familial adenomatous polyposis (FAP) and hereditary non-
polyposis colon cancer (HNPCC) FAP arises because of a mutation in the adenomatous
polyposis coli (/JPC) gene, a tumour suppressor gene, whereas HNPCC results from
mutations in DNA mismatch repair genes (32,33) Studies of these hereditary forms of CRC
have given us many clues for understanding the molecular basis of sporadic CRC. In this
thesis the focus will be on the sporadic, i.e. non-hereditary, form of CRC
The adenoma-carcinoma sequence
The adenoma-carcinoma sequence (34), the model for pathogenesis of CRC proposed
in 1989, is now widely accepted. According to this model, the initial colorectal lesion arises
as a benign adenomatous polyp that later undergoes further disorganisation which leads to
Morphological appaerance (EpDqenatlc change*
Normal epithelium
Early adenoma
K-fBS
ONA mismatch
repair genes
Carcinoma
Figure 1 The adenoma-carcinoma sequence and genetic alterations, adapted from Fearon and
Vogelstem (35) The tumour suppressor genes /*PC and P53 are indicated in green, the
oncogenes K-ras and fl<aterwn In yellow and other genes in pink
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changes in phenotype Some earlier stages in the process have also been proposed:
hyperprolrferation of the upper crypt cells, aberrant crypt foci, and mtcroadenomas Both
adenomatous polyps and microadenomas may progress to a malignant carcinoma, and
finally metastasis may occur.
A genetic model for the adenoma-carcinoma t
A molecular basis for the adenoma-carcinoma progression has been presented (35)
and this model describes the accumulation of alterations in various genes that control cell
growth and differentiation, a complex multistep process which results in a neoplastic
phenotype (figure 1) This process involves cumulative rather than sequential somatic
genetic and epigenetic changes Some tumour suppressor genes, in particular the APC
gene, are known to prevent CRC through direct control of cell growth Inactivation of these
genes contributes directly to the neoplastic growth of the tumour, thus, the normal gene
products function as "gatekeepers" and prevent uncontrolled growth (33,36,37) These
traditional tumour suppressor genes may be joined by a number of genes responsible for
repair of the genome, like human MutL homologue 1 (hMLH1) and human MutH homologue
2 (hMSH2), that indirectly suppress neoplasia These genes encode ONA repair proteins
that act as "caretakers" of the genome (33.36.37) Inactivation of these genes may result in
greatly increased mutation rates and can be considered a t equivalent to a constant
exposure of mutagens (33.36) However, it is not clear whether such defects lead directly to
cancer, as restoration of these functions in cancer cells has not been found to affect their
growth (36)
One of the first events in the adenoma-carcinoma sequence is presumably an alteration
in the 4PC gene that leads to a functional loss of the APC protein and occurs in 70-80% of
sporadic colorectal adenomas and carcinomas (35,38) Evidence that APC mutations are
involved in the development of an adenoma from normal colonic epithelium, was found in
studies performed with FAP patients (32.33) A mutation in the K-ras oncogene Is another
early event in the adenoma-carcinoma sequence K-ras mutations affect the progression
from a small to a large adenoma The gene has been found mutated in 10% of the screened
adenomas smaller than 1 cm, and in 30-60% of adenomas larger than 1 cm and in
adenocarcinomas (35,38) In addition to mutations in the APC and/or K-ras genes,
mutations in other oncogenes and tumour suppressor genes may occur, such as In
/3-caten/n and p53 Some events occur relatively early, including functional loss of the APC
gene and mutation of the K-ras oncogene, whereas functional loss of other genes, such at
p53, are usually late events (35,37).
The tf-ras oncogene
In a significant proportion (30-60%) of the cancers in colon and rectum, the K-ras gene
is found to be mutated The K-ras gene product, a 21 kDa protein located at the inner
plasma membrane, is activated transiently as a response to extracellular signals such as
growth factors, cytokines and hormones that stimulate cell surface receptors The Ras
protein is involved in the transduction of mitogenic signals, and multiple downstream
effectors of Ras have been revealed, including Raf-1. phosphatidylinositol-3 kinase, and
RalGEF, which are involved in cell growth and proliferation The hallmark of Ras protein
function is the switch between its inactive state, in which the protein is bound to guanosine-
diphosphate (GDP), and an active state in which conversion to guanosine-triphosphate
(GTP) occurs This transit is governed by two types of regulatory proteins GDP-GTP
exchange factors that catalyse the GDP-GTP exchange and GTPase-activating proteins that
enhance the intrinsic capacity of Ras proteins to hydrolyse GTP into GDP, thereby returning
the Ras protein into its inactive state.
11
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Table 1 Overview of case-control and case-case studies of associations between dietary factors and
K-ras mutation status in colorectal adenomas and carcinomas
Study
population
678 colorectal
ad«noma
patients
Marf/ne; el a/,
»999 C4^ J
43 left-sided
colorectal
cancer
patients
O'finen ef a/,
2000(43;
108 colorectal
cancer
patient* and
295 controls
Sauf/sfa ef a/.
1997 (46)
185 colon
canotr
patients
Kampman ef
a/. 2000 (45J
General findings
Dietary factors Wild type K-r»* vs. Mutated K-ns vs.
investigated control control
Cross-Mctfon«7 study
Huh enerav intake
Dietary fat
high total (at, saturated
fat
Dietary fibers
high dietary calcium,
tool calcium
Folate
high dietary folate
high total folate
(dietary * total)
rod most
Alcohol
high red meat
Case-contro/ sludy
Energy intake
high calories, proteins
(total, animal or
vegetable)
Dietary fat
high total fats,
polyunsaturated fat.
saturated fat.
cholesterol
High monounsaturatedi Inverse association" N.S*iershigh carbohydrates,
fiber (total, vegetable.
cereal, fruit or legume)
Minerals
high phosphorous,
sodium, potassium,iron,
magnesium, zinc
Vitamins
high vitamin Bi. vitamin
8.. vitamin B«, vitamin
Bi.<.niadn. folk: acid.
vitamin C. vitamin A.
retinal, carotene,
vitamin E, vitamin D
Calcium N.S' Inverse association*
M M !
high total red meat,
processed meat.
poultry, fish
Dairy wpducts. calcium
toMatsaturated fat,
cholesterol
Mutated K-ras vs. wild
type K-ras
N.S.*
MS.*
MS.*
MS.*
MS*
Inverse association'
MS.*
MS.'
N.S.*
N.S.*
N.S*
Increased association'
N.S.*
MS.*
N.S.*
Inverse association'
MS.*
MS.*
N.S.*
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Table 1 continued
Study
population
185 colon
cancer
_^a^a*^at
patera
Karrpmanef
al. ?O»(<5)
1428 colon
cancer
pater* and
2406 controls
Stoflwytfa/.
2000 (44j
Dietary factors
investigated
Enerov rtafce
proton (total or animal)
Dietary tat
high fat. saturated tot
monounsaturatod tot
polyunsaturated tot.
cholesterol
Insufcn-reiated factors
Ngh carbohydrate.
gtycetmc index
high refined grans
DNA methylabon
low vitamin B«
lowvrtamin B . or
methnnine. high
mlrinhnl
auonoiCarcincoen
detoxificatwn
low cruciferous
vegetables
General findings
Wild type X-yas vs.
control
N.S.*
N.S*
NS*
k 1 • fti r
inert > wo Msootoofr
N.S.*
Increased association'
Mutated K-ias vs.
control
US.*
R8.' ^
sweated •ejodaton'
N S *
N.S>
N.S.*
NS*
Mutated K-raj vs.
wild type K-fas
NS*
NS*
N.S.'
NS*
N S *
ri.ij-
Inwrti Mtocittton*
NS*
Inverse tttociation*
• N S not ngntcaK. • tMrtcaly tignHcant
Most mutations (90-95%) have been found in codons 12 (wild type GGT) and 13 (wild
type GGC) of exon 1 and approximately 5% in codon 61 (wild type CAA) which is located in
exon 2 (38-40) A mutation in one of these codons of K-ras causes the gene to remain
longer in its active state, thereby stimulating cell growth and tissue proliferation (41). The
most frequently observed types of mutation in codons 12 and 13 are G>A transitions and
G>T transversions, whereas relatively few G>C transversions are found.
DIETARY RISK FACTORS, /C-AM5GENE MUTATIONS AND COLORECTAL CANCER
MoJeculair epidemiological studies
To our knowledge, only two cross-sectional case-case studies (42,43) and three
longitudinal case-control studies (44-46) on diet and K-ras mutations in sporadic colon and
rectal cancer have been published and the findings were not consistent (see table 1). The
most prominent results with respect to the K-ras mutation status will be discussed briefly, as
of yet without distinguishing between the specific point mutations or affected codons
Martinez er a/ (42) observed a significant increased association between low total folate
intake (dietary and supplemental, but not dietary alone) and the risk of mutated K-ras
colorectal adenomas as compared to wild type K-ras colorectal adenomas No associations
were observed for energy intake, total or saturated fat, dietary fibre, dietary and total
calcium, dietary folate, red meat and alcohol. In a cross-sectional case-case study by
O'Bnen ef a/ (43), no association was observed between current red meat consumption and
rectal cancer risk with respect to the K-ras mutation status Slattery ef a/ (44) observed a
significant increased association between prior intake of refined grains and the risk of
mutated K-ras colon tumours versus controls. In addition, increased associations were
observed between low intake of dietary folate and vitamin Be for associations with wild type
13
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K-ras colon tumours versus controls. Low consumption of cruciferous vegetables was
associated with an increased risk of wild type K-ras colon tumours as compared to controls.
No associations were observed for saturated fat, monounsaturated fat (MUFA) and
polyunsaturated fat (PUFA), cholesterol, carbohydrate, glycemic index, vitamin B12,
methionine and alcohol with both mutated and wild type K-ras tumours versus controls. In a
case-control study by Kampman ef a/ (45), no associations were observed in the case-case
comparisons between the consumption of total red meat, beef, processed meat, poultry,
fish, dairy products, total or saturated fat, cholesterol, total protein, animal protein and
calcium, and the K-ras mutation status in colon cancer cases Bautista ef a/ (46) observed a
significant inverse association between high intake of MUFA and wild type K-ras colorectal
tumours as compared to controls In addition, a significant inverse association was also
observed for high intake of calcium with mutated K-ras colorectal tumours as compared to
controls. No associations were observed for calories, proteins, animal proteins, vegetable
protein, total fats, PUFA, saturated fat, cholesterol, carbohydrates, fibre, vegetable fibre,
cereal fibre, fruit fibre, legume fibre, phosphorous, sodium, potassium, iron, magnesium,
zinc, vitamin Bi, vitamin B2 vitamin B6, vitamin B12, niacin, folic acid, vitamin C, vitamin A,
retinal, carotene, vitamin E, vitamin D and colorectal cancer risk with respect to K-ras
mutation status.
Experimental studies and proposed hypotheses on biological mechanismen
Results from experimental studies suggest that specific compounds in the diet are
relevant for colon and rectal cancer risk with respect to activating mutations in the K-ras
oncogene. To date, animal and /n wfro studies have yielded information on specific
mutagenic factors present in our environment. The relevant results will be considered and
several mutagenic factors will be discussed with respect to their role in DNA damage that
may lead to oncogenic activity of the K-ras protein, i.e. heterocyclic aromatic amines (HAA),
polycyclic aromatic hydrocarbons (PAH), and nitrosamines from meat proteins, u>-6 PUFA
and folate
Regarding meat intake, animal and /n wfro studies have shown that HAA-DNA-adducts
can cause transitions and transversions in DNA bases, as observed in the K-ras oncogene
(47). On the other hand, studies in rodents have suggested that the HAA-adduct formation
with DNA is associated with the wild type K-ras gene (48). Results from animal experiments
are not entirely consistent. PAHs are suggested to be associated with a high prevalence of
G>T transversions in the K-ras gene (49). High temperature cooking of meat is known to
generate HAAs from meat proteins, whereas the process of grilling and smoking of meat
forms PAHs as a result of fat dropping on open-flames. Another hypothesis linked to meat
consumption involves the possible action of alkylating agents such as nitrosamines, formed
from food preservatives in processed meat, on K-ras oncogene mutations (50). These
agents are thought to induce G>A transitions at codon 12 in the K-ras gene, as was
observed in rodents (51) and proposed for humans (52).
Experimental studies linking fat intake to DNA damage is confined to studies on MUFA
and derivatives of PUFA (11,12). Several of these studies suggest that MUFAs and 10-6
PUFAs have opposite effects on the risk for colon cancer (12). Protective effects of a high
MUFA intake, derived mainly from olive oil and a low intake of w-6 PUFAs, were observed in
experimental studies. Takeshita ef a/ (53) found that the incidence of adenocarcinomas of
the colon in 1,2-dimethylhydrazine-treated mice was significantly higher in animals fed a diet
rich in linoleic acid (main source of w-6 PUFA) than in animals fed a diet enriched with oleic
acid (source of MUFA) or a low-fat diet. To date, no mechanism has been presented that
can explain the effect of MUFAs. Peroxidation of u>-6 PUFAs. however, could lead to the
accumulation of by-products like malondialdehyde (MDA) and 4-hydroxynonenal (4-HNE).
These compounds can react with DNA to form adducts, mainly the pyrimidopurinone adduct
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of deoxyguanosine (M,G) (54-56) The presence of the M,G-adducts may result
predominantly in G>A and G>T with very few G>C transversions in bactena (54,57,58) In
humans, colorectal biopsies from normal mucosa of participants in the United Kingdom
Flexible Sigmoidoscopy Tnal and the European Prospective Investigation on Cancer (EPIC)
(n=162) were analysed for the presence of M,G-adducts (56) Adduct levels were higher in
individuals with adenomas than individuals without adenomas.
For folate. two plausible carcinogenic mechanisms to explain how sub-optimal folate
status could pre-dispose to colon cancer have been proposed Firstly, if the intracellular form
of folate. 5, 10-methylenetetrahydrofolate (5. 10-methyleneTHF) is deficient, less methyl
groups will be donated to uracil which may result in less available thymine (59) Eventually,
the increased uracil incorporation in DNA may lead to DNA strand breaks and chromosome
instability Secondly, a sub-optimal folate status may result in global DNA hypomethylation
and possibly in regional hypermethylation of gene promoters, which interferes with gene
expression and can impair the expression of tumour suppressor genes, oncogenes and
DNA repair genes (48.59.60) DNA strand breaks, global DNA hypomethylation and regional
promoter hypermethylation are common events in colon cancer.
AIMS AND SCOPE OF THIS THESIS
The results from the reports that were described in the previous paragraph
inconsistent, which could be due to the study design, i.e. cross-sectional versus longitudinal
studies, selection bias, recall bias or chance due to small sample sizes In addition, three
case-control studies used case-case comparisons to evaluate the aetiological heterogeneity
of the risk factors for colon tumours with a wild type or mutated K-ras gene, but did not
consistently report the case-control comparisons (44.45.46) It should be emphasized that
case-case comparisons are useful to detect whether the associations between diet and end
points used for cancer cases differ significantly between cases without and cases with the
genetic alterations under study. A definite conclusion on how a dietary factor is related to the
absence or presence of genetic alterations can be obtained with case-control comparisons,
but never with case-case comparisons alone Therefore, a prospective cohort study design,
as used in this thesis, is appropriate to investigate associations between dietary factors and
CRC risk with respect to K-ras mutations.
The studies described in this thesis (chapters 2 through 5) are embedded in the
ongoing Netherlands Cohort Study (NLCS) on diet and cancer The NLCS was initiated in
1986 and includes 58,279 men and 62,573 women, at baseline aged between 55 and 69
years old, who completed a self-administered questionnaire on diet, family history of cancer
and other risk factors for cancer. The entire cohort is being monitored for cancer occurrence
by annual record linkage to the Netherlands Cancer Registry (NCR) and to PALGA. a
nationwide database of pathology reports From 1989 until 1994, with exclusion of the first
2.3 years of follow-up, 819 incident cases of colon and rectal cancer have been identified,
and all pathology laboratories in The Netherlands agreed to make these tissue blocks
available for this study.
Previous studies on frequencies and specific types of point mutations in the K-ras
oncogene in CRC in various countries have been reported (39,41,45.49,50,52,61-65).
However, these results were often based on small numbers of selected patients, obtained
from other populations that may differ from the genetic make-up and the environmental
conditions in The Netherlands Therefore, the first aim of this thesis was to evaluate the
frequencies and specific types of mutations in the K-ras gene in a large number of
unselected. incident colorectal cancer patients, identified in the NLCS This study is
described in chapter 2.
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Chapter 1
As described in the previous paragraph the link between consumption of meat and fish
and the pattern of K-ras mutations in human colon and rectal cancer is not clear. It is
hypothesized that high consumption of meat could contribute to the occurrence of point
mutations in the K-ras gene, leading to oncogenic activation. In this respect it is expected
that N-nitroso compounds, which may be endogenously formed or present in processed
meat, induce G>A transitions in codons 12 and 13 of the K-ras gene. PACs originating from
grilling and smoking of meat may cause G>T transversions. whereas HAAs, which are
generated by high temperature cooking of meat proteins, may lead to transitions and
transversions of DNA bases in the K-ras gene These hypotheses form the basis of the
associations between different types of fresh meat, meat products and fish, and the risk of
CRC with or without specific point mutations in the K-ras gene, which were studied and
described in chapter 3.
For the intake of fats and fatty acids and the risk for K-ras mutations, associations are
inconsistent (unclear, not well-defined) Based on experimental studies it is hypothesized
that peroxidation of iu-6 polyunsaturated fatty acids may lead to accumulation of
malondialdehyde and 4-hydroxynonenal. that could form DNA adducts. The adducts could
result in G>A transitions and G>T transversions. The associations of total, saturated, and
MUFA and PUFA intake with the risk of CRC with or without specific point mutations in the
K-ras gene were studied and described in chapter 4
Folate plays an important role in one-carbon metabolism, in DNA synthesis and in
methylation of DNA and proteins. Since a deficiency in intermediate folate metabolites leads
to a reduced availability of thymine for DNA synthesis, and an increased incorporation of
uracil results in more DNA strand breaks, genomic instability may be generated. In addition,
folate deficiency may also result in global genome hypomethylation and regional
hypermethylation in gene promoters The latter mechanism inhibits gene expression, and
has been demonstrated to evoke DNA repair deficiency. Based on these hypotheses, the
association between dietary folate intake and the risk of CRC with or without K-ras
mutations is studied and described in chapter 5
Finally, the results and their implications are discussed in chapter 6.
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mutations in colorectal cancer
ABSTRACT
Activation of K-ras oncogene has been implicated in colorectal carcinogenesls, being
mutated in 30-60% of the adenocarcinomas In this study. 737 incident colorectal cancer
(CRC) patients, originating from 120,852 men and women (55-69 years at baseline)
participating in The Netherlands Cohort Study (NLCS), were studied in order to evaluate
subgroups with respect to K-ras mutation status.
Mutation analysis of the exon 1 fragment of the K-ras oncogene, spanning codons 8 to
29, was performed on archival colorectal adenocarcinoma samples of all patients using
macrodissection, nested PCR and direct sequencing of purified fragments. The method of
mutation detection was validated by the confirmation of reported K-ras status in CRC cell
lines, a good correlation between fresh-frozen and routinely-fixed, paraffin-embedded tissue,
a detection limit of 5% mutated DNA and a good reproducibility. Various types of K-ras
mutations were evaluated with respect to family history of CRC, tumour sublocalisation,
Dukes' stage and tumour differentiation.
In 37% (271/737) of the patients, the exon 1 fragment of K-ras gene was found to be
mutated The predominant mutations are G>A transitions and G>T transversions, and
codons 12 and 13 are the most frequently affected codons Patients with a rectal tumour
were found to have the highest frequency of G>T transversions as compared to patients with
a colon or rectosigmoid tumour. This difference appeared to be confined to women with a
rectal tumour harbouring G>T transversions. No significant differences were observed for
Dukes' stage with respect to types of K-ras mutation, which does not support direct
involvement of the K-ras oncogene in adenocarcinoma progression
The equal distribution of K-ras mutations among cases with or without a family history of
CRC argues against an important role for this mutation in familial colorectal cancer, and
could imply that K-ras mutations are more likely involved in environmental mechanisms of
colorectal carcinogenesis.
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INTRODUCTION
The development of colorectal cancer (CRC) is a multistep process characterised by
the accumulation of genetic alterations (1.2) The Fearon and Vogelstem model assumes
the involvement of the /APC (Adenomatous Polyposis Coli) gene in adenoma formation and
the K-ras oncogene in the transition from intermediate adenomas to carcinomas in sporadic
CRC(1)
The K-ras oncogene has been found mutated in 10-15% of the screened adenomas
smaller than 1 cm and in 30-60% of adenomas larger than 1 cm Also. 30-60% of the
adenocarcinomas has a K-ras mutation (3,5). It was suggested, therefore, that a mutated
K-ras gene contnbutes to the transition of an intermediate adenoma to a late adenoma or
carcinoma (2) The K-ras gene product, a 21 kD protein located at the inner plasma
membrane, is involved in the transduction of mitogenic signals The Ras protein is activated
transiently as a response to extracellular signals such as growth factors, cytokines and
hormones that stimulate cell surface receptors (6) The hallmark of Ras function is a switch
between an inactive state, in which the proteins are bound to guanosine-diphosphates
(GDP) and an active state in which conversion to guanosine-tnphosphales (GTP) has
occurred This transit is governed by two types of regulatory proteins: GDP-GTP exchange
factors that catalyse the GDP/GTP exchange and GTPase-activating proteins that enhance
the intnnsic capacity of Ras proteins to hydrolyse GTP into GDP, thereby returning Ras to
the inactive state (7)
Mutant, activated forms of Ras proteins have an impaired intrinsic GTPase activity,
which renders the protein resistant to inactivation by regulatory GTPase-activating proteins
(4) Approximately 90% of the activating mutations is found in codons 12 (wild type GGT)
and 13 (wild type GGC) of exon 1 and around 5% in codon 61 (wild type CAA) located in
exon 2 (8,10). Previous studies from various countries have revealed specific point
mutations in codons 12 and 13. The most frequently observed types of mutations are G>A
transitions (11) and G>T transversions (12) and these alterations were found associated
with sex and sublocalisation of the tumour (9).
To date, frequencies and specific types of point mutations in the K-ras oncogene in
CRC have been investigated in several studies (4,5,10,13). These reports were generally
based on small numbers of selected patients In the current study, however, the frequency
of K-ras mutations is studied in a large series of unselected, incident CRC patients from The
Netherlands identified in a prospective cohort study Potential differences in family history of
CRC, tumour sublocalisation, Dukes' stage and tumour differentiation with respect to
presence and type of the K-ras mutations are studied.
MATERIALS AND METHODS
Study Population
The participants in this study are incident CRC cases from The Netherlands Cohort
Study on diet and cancer (NLCS). The NLCS has been described in detail elsewhere (14)
Briefly, the prospective study was initiated in 1986 and includes 58,279 men and 62,573
women, aged between 55 and 69 years old, who completed a self-administered
questionnaire on diet, family history of cancer and other risk factors for cancer at baseline
The entire cohort is being monitored for cancer occurrence by annual record linkage to The
Netherlands Cancer Registry (NCR) and to PALGA, a nationwide database of pathology
reports (15) From 1989 until 1994, with exclusion of the first 2 3 years of follow-up due to
incomplete nationwide coverage of PALGA, 819 incident cases with histological confirmed
CRC have been identified The PALGA database was also used to identify the location of
25
Chapter 2
tumour tissue storage in the Dutch pathology laboratories. CRC was classified according to
site as follows: proximal colon, i.e cecum through transverse colon (ICD-0 codes: 153.0,
153.1, 153.4, 153.5, 153.6); distal colon: splenic flexure through sigmoid colon (ICD-O
codes: 153.2, 153.3, 153.7); rectosigmoid (ICD-0 code 154 0) and rectum (ICD-0 code
154 1) Information about age at diagnosis, sex and family history of CRC (at baseline) was
retrieved from the NLCS database. Information about tumour sublocalisation, Dukes' stage
and differentiation of the tumour was retrieved from the NCR database
Table 1 Characteristics of CRC cases (N=737) subdivided into cases without a K-ras (N=466)
mutation and cases with at least one K-ras mutation (N=271)
TotaJ (N»737) WjW typt K-fM (N»466) K-nw mutrton (N-271)
Ageatdiagno*(n»an±SD) 67.95 ±4.26 67.75 ± 4 21
S«(%Men) 410(56%) 257(55%)
Family history of CRC (%Ya») 76(10%) 53(11%)
68.29 ±4 32
153(57%)
23(9%)
O.fO
0.73
0.2f
• comparing c a n «Mi at toast on* K-nji muMon to case* w*oul < K-os mutton
Tlaaue Samples
Tumour material was collected after approval by the Medical Ethical Committees (MEC)
of the Maastricht University. PALGA and the NCR Subsequently, all pathology laboratories
in The Netherlands agreed to make relevant tissue samples available for this study Tumour
tissue sample collection started in August. 1999 and was completed in December, 2001.
The 819 tissue samples were distributed among 54 pathology laboratories throughout The
Netherlands, and only 44 (5%) tumour tissue samples could not be traced. Finally, 775
(95%) of the eligible tissue samples have been retrieved and 737 (90%) of the tissue
samples contained sufficient tumour material as confirmed by a pathologist (AdB) and hence
were available for molecular analyses Archival tissue sample blocks were registered and
coded using a consecutive, unique identification number
Five CRC cell lines, i.e. HT29, Colo205, CaCo2, SW480 and HCT116 (American Type
Culture Collection (ATCC). Rockville. Md. USA) were used to check the specificity of K-ras
mutation detection. In order to validate mutation analysis on paraffin-embedded tissue, 10
Table 2 Number and type of mutations, affected codons. and corresponding altered amino acids in
exon 1 of the K-ras gene
Codon* Type of point Number of point Wild type codon*
i t t i ( i id')
Mutated codon* (amino
add")
Putative altered
amino acidmutat on*
3(1%) GTA(vaf) GTG (val) 3
9 Insertion' 1 (04%) GTT (val) GTG (val)-GAG (glz)-CTT (leu) 1
10 G>A 1(0 4%) GGA(gly) AGA(arg) 1
12 G>A 91(33%) GGT(gly) GAT (asp) 75(37%)
AGT (ser) 16 (8%)
G>T 87(31%) GTT (val) 70(35%)
TGT(cys) 17(8%)
G>C 23(8%) GCT(ala) 16(8%)
CGT (arg) 7 (3%)
13 G>A 58(21%) GGC(gty) GAC(asp) 58(94%)
G>T 3(1%) TGC(arg) 3 5%)
G>C 1(0 4%) CGC(cys) 1(2%)
15 G>A 1(0.4%) GGC(gly) AGC(ser) 1
16 G>A 10.4%) AAG(lys) AAA(lys) 1
19 G>A 1(0.4%) TTG(leu) TTA(leu) 1
20 C>T 8(3%) ACG(thr) ATG(met) 8
25 G>A 2(0.8%) CAG (glu) CAA(glu) 2
• For 10 paten*. 2 muttons ware found and ties* are included m this table
•glyglycine. a*p*atpartc add. MfMnnt , vat^vatne. cys=cystsm*.
9>i*«iulamin*,lu«l*udn*. JU»JM«T»C acid
' Th* Insertion is 6 nudeoMes (TGGAGC). located after the first position of codon 9. msufcng in 3 allared codons
trg=arginin*. tn-lneoniw. met=methiorane
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fresh CRC specimens were divided into two adjacent tissue blocks, one of which was fresh-
frozen, and one routinely-fixed and embedded in paraffin These specimens were obtained
from patients who did not participate in the NLCS.
DMA Isolation
Sections (5 urn) were cut from paraffin-embedded tumour tissue blocks and stained with
haematoxilin & eosin (H&E) for histopathological examination For DNA isolation, five 20 urn
sections of tumour tissue were used Deparaffination of the sections was performed and.
using the H&E section as a reference, tumour tissue was macrodissected from the normal
colonic epithelium and scraped off
Genomic DNA was extracted from macrodissected tumour tissue using the Puregene*
DNA isolation kit (Gentra Systems) Briefly, 475 pi cell lysis solution and 25 pi proteinase K
stock solution (20 mg/ml. obtained from Qiagen. St Louis. MO. USA) were added to the
tissue samples and incubated overnight at 55°C Subsequently. DNA was extracted for 72
hours at 37°C. protein was removed and DNA was precipitated using 100% 2-propanol and
dissolved in hydration buffer. The DNA concentration and punty was measured at 260 and
280 nm
DNA from fresh, unfixed CRC cell lines and the fresh-frozen tissue samples was
extracted as described for paraffin-embedded sections.
Mutation Analysis
An exon 1 fragment of the K-ras gene was amplified from isolated, genomic DNA using
a nested PCR approach In the first reaction, a fragment of 179 base pairs (bp) was
generated, using the sense primer 5-AGG CCT GCT GAA AAT GAC TGA ATA-3' and
antisense primer 5-CTG TAT CAA AGA ATG GTC CTG CAC-3' The annealing
temperature was 58°C The resulting fragment was used as a template to amplify a 114 bp
fragment spanning codons 8 to 29 This PCR is performed using the biotinylated, sense
primer 5-AAA ATG ACT GAA TAT AAA CTT GTG G-3' and the antisense primer 5'-CTC
TAT TGT TGG ATC ATA TTC GTC-3' at an annealing temperature of 50°C The Inside
products were checked for purity and size by electrophoresis on a 2% agarose gel and
subsequently used for direct sequencing.
Mutations in the exon 1 fragment of the K-ras gene were detected by direct sequencing
with a solid phase sequencing kit (Amersham Pharmacia) using the ALFexpress II DNA
sequencer (Pharmacia Biotech) In brief, the biotinylated PCR product is captured on a
sequencing comb coated with streptavidin. After removal of the non-biotinylated strands by
alkaline denaturation, the remaining immobilized strand was used as a template for dideoxy
sequencing reactions with a Cy5 labeled primer 5-CTC TAT TGT TGG ATC ATA TTC GTC
CAC-3' and T7 DNA polymerase. The sequence profile is analysed on the ALFexpress II
DNA Analysis System. Evaluation was independently performed using ALFwin software
(Amersham Pharmacia Biotech) by two observers, based on the criterium that at an
increase of least a 5% is observed for the mutant peak as well as an a decrease of at least a
5% in the wild type peak, relative to the wild type pattern in the same sequence run Data-
entry was performed blindly by two independent observers
The mutation detection limit was determined by mixing wild type DNA from the cell line
CaCo2 and the homozygously mutated cell line SW480 in amounts varying from 0-100%.
Statistical Analysis
The overall frequency of K-ras mutations as well as the type of mutation and affected
codon was computed for all 737 cases with respect to age at diagnosis, sex, family history of
CRC. tumour sublocalisation. Dukes' stage and tumour differentiation Differences in mean
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Table 3 Characterisation of K-ras mutations at gene and codon level according to tumour subtocalisa-
tton. Dukes' stage and differentiation of the tumour
Totol CRC c o w (N-737)' W»d typt K-/n (WM66) K-/»» mutation (N=271 )«
"iubloctlftiBor^
Proximal cotoo 240 149(62%) 91(38%)
Distal colon 224 156(70%) 68(30%)
Rackwgmoid 85 51(60%) 34(40%)
Redum 176 102(58%) 74(42%)
p-va**» 0.09
OukM' •tag*'
A 179 114(64%) 65(36%)
B 238 154(65%) 84(35%)
C 183 120(66%) 63(34%)
0 86 47(55%) 38(45%)
t " 040
coitf not to datonnlnad (colon, MOS)
'oampartng palanh wNhoul • K-/M fliuMton to paean* «ttiat tat ont K-«s mutaoon. patents with at least on* G>A transiton (N=153) or
( ) (
' For 21 paten* wMwut • K - / M mutafcm and 31 paten* mtti al lead one K-ras mutaton, information on Dukes stage was
ool available
'For 10 patanto, hue muMtont war* bund Theta paten* wan indudad m tie analyta* and tMtad as patents win at least
ont K-fM mutation, etc
' The frtquandM o( 0>A kmtttJon. G>T or G>C tantvtnion par tube* were calculated by dividing the number ol patients
wNh 0>A frantWoni (tar example) Bvough the total numtor of CRC c a m
values of age at diagnosis as a continuous variable was evaluated using the Student t-test.
Differences in the categorical variables sex, family history of CRC, tumour sublocalisation,
Dukes' stage and tumour differentiation between patients without and with K-ras mutations
were evaluated for significance with the x^-test In addition, differences in tumour
sublocalisation. Dukes' stage and tumour differentiation between patients without a K-ras
at least one codon 12 or codon 13 mutation were evaluated with the x^-test A p-value of
0.05 or less was considered statistically significant. Statistical analyses were performed
using the SPSS software (version 9.0).
RESULTS
Validation of Techniques
In the colorectal cancer cell lines HT29, Colo205 and CaCo2, wild type K-ras was
found, whereas homozygously mutated alleles in SW480 and heterozygously mutated
alleles in HCT116 cells were revealed with direct sequence analysis. For the SW480, line, a
GGT to GTT mutation in codon 12 was observed and for the HCT116 line, a GGC to GAC
mutation in codon 13.
The effect of tissue processing was assessed by comparing an adjacent fresh-frozen
and a paraffin-embedded tissue block in a series of 10 fresh colon tumour specimens. In
nine specimens, the K-ras status in the paraffin-embedded tissue was identical to fresh,
unfixed tissue, i.e. six specimens with wild type K-ras, one with a G>T transversion at the
second position of codon 12, one with a G>C transversion at the second position of codon
12 and one with a G>C transversion at the second position of codon 13 In one specimen, a
G>C transversion at the third position of codon 19 was observed in the routinely-fixed,
paraffin-embedded tissue, but not in DNA extracted from the fresh tissue.
Table 3 continued
Point fnutraon
G>T fruwvwtton G>CtraMM
<!»•»)*•
/was oncogene mutations
mton Codon 11 (N-1K)**
codon
Codon 1J ( I K Z P *
22(23%)
38(17%)
20(24%)
37(21%)
039
27(11%)
20(9%)
12(14%)
26(16%)
0.22
7(3%)
6(3%)
2(2%)
9(5%)
048
61(25%
50(22%
21(25%
60(34%
0.07
26(11%)
12(5%)
12(14%)
11(6%)
003
46(26%)
39 (16%)
37(20%
16(19%)
0.T3
15(8%)
36(15%)
17(9%)
15(18%)
0.04
9(5%)
4(5%)
O.f7
46(26%
6106%
43 23%
26(31%
0.68
17(9%)
18 (8%)
17(9%)
IP
The detection limit of mutation detection was determined by mixing wild type DNA
isolated from the CaCo2 cell line with decreasing concentrations of mutated DNA which was
prepared from the homozygously mutated colorectal cell line SW480 The lowest level of
detection was five percent mutant DNA in a background of wild type DNA as found in three
independent experiments
To establish the reproducibility of the mutation analysis, 32 NLCS adenocarcinoma
specimens were subjected twice to the complete procedure, from tissue sectioning to DNA
sequencing In 88% (28/32) of the samples, the same K-ras status was observed in the
duplicate experiments.
Types of Mutations
In the exon 1 fragment of the K-ras oncogene, a total of 281 mutations was found in 271
(37%) out of 737 patients. No significant differences were observed in mean age at
diagnosis (67.75 ± 4.21 versus 68.29 ± 4.32), sex (55% versus 57%) and family history of
CRC (11% versus 9%) between patients without and patients with one or more K-ras
oncogene mutations in the tumour (table 1).
For ten patients, two different mutations were observed in exon 1 In six of these
patients, both mutations were found in codon 12, and the other four patients showed one
mutation in codon 12 or codon 13 and one mutation in another codon In eighteen patients
without aberrations in codon 12 or codon 13, a mutation was found in codons 8, 9, 10, 15,
16, 20 or 25
Table 2 summarises the frequencies of genetic aberrations by type of mutation, affected
codons and corresponding amino acids in the exon 1 fragment of the K-ras oncogene The
most frequently observed mutations in the gene are G>A transitions, G>T transversions and
G>C transversions, i.e. 55% (155/281 mutations). 32% (90/281 mutations) and 9% (24/281
mutations), respectively Of the total number of mutations in the exon 1 fragment, 72%
(201/281) was observed in codon 12 (GGT) and 22% (62/281) in codon 13 (GGC). In codon
12, the GAT codon (37%) leading to aspartic acid and the GTT codon (35%) leading to
valine were the most frequently observed (table 2) In codon 13. the G>A transition at the
second base, which would lead to substitution of a glycine by aspartic acid, was by far the
predominant mutation (94%). Furthermore, the point mutations (17/281) observed in codons
8, 10, 15, 16. 19, 20 and 25 were all transitions In one case, an insertion of 6 nucleotides
was observed in codon 9, leading to one altered codon and two inserted codons, however,
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without a frameshift in the gene (table 2). The only alteration in the protein is the insertion of
two extra amino acids
Tumour Sublocalisation
Patients with rectal tumours have relatively the highest frequency of K-ras mutations as
compared to patients with proximal or distal colon tumours or patients with a rectosigmoid
tumour (42% versus 38%, 30% and 40%, respectively; p=0.09) (table 3). Moreover, different
tumour sublocalisations showed different frequencies of G>T transversions as well as
different frequencies of codon 12 or codon 13 mutations Patients with a rectal tumour have
the highest frequency of G>T transversions (16% versus 11%, 9% and 14% for proximal,
distal and rectosigmoid tumours, respectively; p=0 22) and codon 12 mutations (34% versus
25%, 22% and 25%, respectively; p=0.07) (table 3). It should be noted that most G>T
transversions are confined to codon 12 (table 2) Patients with a tumour in the rectosigmoid,
however, have the highest frequency of codon 13 mutations (14% versus 11%, 5% and 6%
for proximal, distal and rectal tumour, respectively; p=0 03) (table 3) Stratification by sex, in
addition, reveals that women with a rectal tumour have the highest prevalence of K-ras
mutations (53% versus 37%, 23% and 37% for proximal, distal and rectosigmoid tumour,
respectively; p=0 001). This difference was confined, in particular, to the G>T transversions
(27% for rectal tumour versus 8%, 11% and 7% for proximal and distal colon tumour and
rectosigmoid tumour, respectively; p=0 002) (table 4).
Table 4 Stratification by sex with respect to tumour sublocalisation
Man
SublocalltatJon*
Proximal colon
Distal colon
KOCwtlQfliOw
Hectum
Women
Sublocalisation'
Proximal colon
Distal colon
Rectosigmoid
Rectum
p-va/ue"
WMtVM
K-fM
252
71 (81%)
84 64%)
25 57%)
/2 (64%)
206
78 (63%)
72(77%)
26 (63%)
30 (47%)
K-rt«
mbwiivir
151
45 (39%)
47 (36%)
19j43%)
40(36%)
116
46 (37%)
21 (23%)
15(37%)
34 (53%)
0.001
0>A
transition'
87
25 (22%)
27(21%)
9(20%)
24(21%)
0.99
66
30 (24%)
11(12%)
11(27%)
13(20%)
0.09
G>T
transvtrelon'
47
17(15%)
10(8%)
9(21%t
11(9%)
0.07
40
10(8%)
10(11%)
3(7%)
17(27%)
0.002
• For 5 male patients and 3 female patents without a K-ras mutaton and 2 mate patients and 2 female patients with at leas
onernutat>on.tt»ji*ofk*ai*atkx\infcecolonaxjWn(>tbede»
• comoariians between oatents without a K-ras mutation and patents wMi at least one K-/ss mute*on. Datents with at
G>C
transvtfsion'
11
0(0%)
6(5%)
1 (?%>
5(4%)
0.13
12
7(6%)
0(0%)
1(2%)
4(6%)
0.J0
t
p p
least one G>A transition. G>T or G>C transverann
• The frequencies of G>A transition. G>T or G>C transverenn per tublocathafon and sex was calculated by dividing the
number ol patients with G>A transitions (for example) through the total number of CRC patients
We also evaluated the K-ras mutational status for tumours in the proximal and distal colon
and for tumours in the colon versus the rectum (tumours in the rectosigmoid were excluded
for this analysis). It was found that patients with a proximal colon tumour had a higher
frequency of G>A transitions as compared to patients with a distal colon tumour (p=0.11)
(table 3). This difference in frequencies of G>A transitions with respect to proximal and distal
colon tumours was more pronounced for women (p=0.02) (table 4). Patients with a rectal
tumour showed a relatively higher frequency of K-ras mutations (p=0.08), and in particular
G>T transversions (p=0.06), as compared to patients with a colon tumour. Again, this
difference was due to the high frequency of G>T transversions in rectal tumours observed in
women (p=0.0OO3) (table 4).
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Dukes'Stage
Most tumours were staged as Dukes' B (35%. 238/685), and tumours with Dukes' D
stage (12%. 85/685) constitute the smallest group (table 3). Patients with a Dukes' A staged
tumour more often have G>A transitions (26% versus 16%. 20% and 19% for Dukes' B, C
and D. respectively; p=0 13), whereas patients with a Dukes' D staged tumour have
relatively a higher frequency of G>T transversions (18% versus 8%, 15% and 9% for Dukes'
A, B or C. respectively; p=0 04) No clear differences were observed in the frequencies of
codon 12 or codon 13 mutations with respect to the Dukes' stage of the tumour (table 3).
Tumour Differentiation
No differences were observed in frequencies of K-ras mutations. G>A transitions. G>T
or G>C transversions or mutations in codon 12 or codon 13 (p>0.05) with respect to tumour
differentiation.
DISCUSSION
Overall, we observed that the frequency of K-ras oncogene mutations in a large
representative sample of CRC patients from The Netherlands (age at diagnosis between 57
and 76 years) was 37% The frequency of K-ras gene mutations in CRC patients reported in
the literature, ranges from 30-60% (3.9.11.12.16-27). This broad range of reported
frequencies of K-ras mutations may be due to vanous factors, such as the sensitivity and
specificity of mutation detection methods, small senes of, selected, patients
(3.12.17.20,21,23) and/or variability in analysed gene region, i.e. only codons 12 (21), 13
(12.20,22.23,28) and/or 61 (11) Also, environmental factors may be involved Techniques
used for mutation screening such as temperature gradient gel electrophoresis (TGGE) (3) or
SSCP (17,29) and methods for mutation detection like PCR-restnction fragment length
polymorphism (RFLP) (20,28) or PCR-based mutant allele-specific amplification (MASA)
(20) may show differences in sensitivity and/or specificity of mutation detection in the K-ras
gene. In this study, the analysis of K-ras mutations is based on a highly sensitive and
specific detection method, i.e. direct sequencing of purified PCR fragments This method
identifies mutations in DNA samples which contain at least five percent or more mutated
DNA The reported frequency of K-ras mutations could, therefore, be an underestimation.
Direct sequencing was validated by mutation analysis of five CRC cell lines, and of adjacent
blocks with paraffin-embedded and fresh tissue from a series of 10 CRC specimens. The
mutation analysis of five CRC cell lines confirmed the reported sequences of exon 1
fragments of the K-ras oncogene (30). In addition, the K-ras mutation status as determined
in paraffin-embedded tumour tissue was also found in fresh tumour tissue in 9 out of 10
specimens. In one specimen, the mutation detected in paraffin-embedded tissue was not
found in fresh tissue which may be related to heterogeneity in the tumour tissue or a lack in
the reproducibility of this sample. These results indicate that tissue processing does not
significantly affect the reliability of mutation analysis in archival specimens The
reproducibility of the identification technique used in this study was found to be good, since
duplication of the complete analytical procedure yielded the same results for 28 out of 32
(88%) adenocarcinomas The K-ras gene mutation analysis is based on a relatively large
series of non-selected, incident CRC patients, which indicates that the found frequency of
K-ras mutations is representative for CRC patients in the Dutch population
Slattery eJ a/ (31) have evaluated the association between several genetic alterations
and the presence or absence of family history of colorectal cancer using incident colon
cancer cases These authors did not find an association with overall K-ras mutations,
although patients with a G>T transversion of the second base of codon 12 were more likely
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to have a family history of colorectal cancer compared to those without this specific type of
point mutation In our study, no significant differences were observed in family history of
CRC between patients without and with a K-ras mutation Our findings suggest that these
genetic alterations in sporadic colorectal tumours are not associated with family history of
CRC and that therefore diet, environment and/or lifestyle factors may contribute to the
acquirement of K-ras gene mutations involved in the early phases of carcinogenesis.
However, more studies evaluating other genetic markers and/or a different kind of
population study, i.e twin studies, may be necessary to address this issue.
Studies from various countries have analysed the frequency of the type of K-ras point
mutation in colorectal cancer. These studies were conducted in the UK (24,25), former
Yugoslavia (12), Czech Republic (21), Norway (9). Switzerland (18). Mexico (11), USA (26)
and The Netherlands (17,19,20) All studies, except for the study performed in former
Yugoslavia (12), have identified the G>A transition as the most frequently found type of K-
ras mutation In the current study, the G>A transition appeared also to be the predominant
mutation. The pattern of specific alterations observed, i.e. G>A transitions and G>T
transversions, could be due to differences in diet and/or other lifestyle factors. N-nitroso
compounds, for example, in red and processed meat could induce G>A transitions (25) and
this is supported by previous experimental studies (32,33) Two mechanisms, which could
explain the G>A transition are the formation of guanine-adducts in the DNA and the
silencing of the O*-methylguanine DNA methyltransferase (MGMT). MGMT is a DNA repair
protein that removes adducts from the Opposition of guanine (34) in DNA. Promotor
hypermethylation of the MGMT gene, a phenomenon often seen in colon cancer cells
(28,35) and which leads to silencing of the gene, results in conversions of guanine-cytosine
pairs to adenine-thymine pairs Guanine-to-thymine transversions, however, are more likely
to be induced by carcinogenic agents like the polycyclic aromatic hydrocarbons (PAHs)
found in smoked and barbecued meat (36), dietary fats (37) and cigarette smoke (38)
In the present study, codons 12 and 13 were affected in 94% of the tumours with a
K-ras mutation in the exon 1 fragment, and the majority of mutations would result in an
amino acid substitution of glycine by aspartic acid (57%) or by valine (33%). Mutations in
either of these codons could lead to an activated Ras protein. Al-Mulla ef a/ (39) compared
detailed crystal structures of the Ras protein with these two most frequently observed
mutations in codon 12, i.e. substitutions of glycine by aspartic-acid or valine. The tightly
bound complex of GTP in codon 12 glycine-to-valine mutant Ras protein may generate a
more stable signal as compared to the codon 12 glycine-to-aspartic acid mutant Ras protein
or the codon 12 wild type Ras protein. Moreover, Andreyev ef a/ (27) have shown that the
presence of the glycine to valine substitution in codon 12 leads to a decreased survival of
CRC patients and suggest this alteration is important for cancer progression and also that it
may predispose to a more aggressive biological behaviour in patients with advanced CRC.
Span ef a/ (19) also observed an association between specific K-ras point mutations and
cancer progression. Recently, Bazan ef a/ (40) reported biological relevance for codon 13
mutations in terms of colorectal cancer clinical outcome, such as Dukes' stage (p<0.05).
They also reported a possible role for codon 12 mutations in the mucinous differentiation
pathway. Associations between specific K-ras point mutations and cancer progression were,
however, not supported by our and other studies (3,26,41).
Eighteen patients were observed with an affected codon other than codons 12 or 13. It
is unknown whether mutations in these codons lead to a constituent activation of the Ras
protein. Our results show that mutations in codons other than codons 12 or 13 of exon 1 are
rare. The observed pattern of mutated codons, i.e. 94% of the mutations were found in
codons 12 and 13, is probably due to a selective growth advantage (42).
Previous studies have presented frequencies of K-ras mutations based on tissue
samples of selected series of patients with various distributions of Dukes' staged tumours.
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Some suggested an increase in the frequencies of the K-rss oncogene mutations with more
advanced stages of Dukes classification (12.17), whereas others (3.9,42) did not find any
association between frequencies of point mutations and Dukes' stage In the current study,
all incident CRC cases were included regardless of the Dukes' stage No significant
differences in the distribution of Dukes' stage were observed between patients without a
K-ras mutation and those with a specific K-ras gene mutation It suggests that K-ras
mutations are not involved in the progression of adenocarcinomas and that genetic
aberrations occur in pathways, which do not depend on K-ras mutations during the more
advanced stages of cotorectal cancer
Various topographical subdivisions of the large intestine have been proposed,
according to different criteria (22,43,44,45). The so-called rectosigmoid can be considered
as a rather more clinically applied term than an anatomically defined transitional zone
between the colon and rectum Although the rectum is considered to compnse the last 12
cm of the intestine proximal of the anal verge, clinicopathological data are inconsistent as to
whether the tumours in this region can be assigned to the colon or rectum (46) In our study,
the NCR database contains the clinicopathological data, including the sublocalisation of the
tumour, as supplied by the clinicians. Therefore, in the current multicenter study, for so-
called rectosigmoid tumours it was not possible to definitively assign a tumour to either the
colon or rectum Consequently, the rectosigmoid was excluded from analysis when
comparing colonic versus rectal adenocarcinomas Among similar lines, another
topographical issue which we addressed was the comparison of proximal versus distal colon
tumours. Differences could be expected between these two with respect to faecal content
and composition, microbial flora and activity, and the local variations in distribution of
intestinal epithelial cell types Owing to the mentioned unclear definition of the term
rectosigmoid tumour, analyses were performed with both the ex- and inclusion of
rectosigmoid tumours within the group of distal colon tumours The resulting asymmetry
between proximal and distal colon tumours was maintained, regardless of these differences
in type of analysis.
Patients with a rectal tumour have a relatively higher frequency of G>T transversions as
compared to patients with a distal colon tumour and this difference appeared to be most
pronounced for female patients. This was not found in other studies (3,21,26,44). However,
Breivik ef a/ (9) reported that K-ras mutations were not found in tumours located proximal to
the descending colon of men under the age of 70, whereas rare mutations such as G>C
transversions were almost exclusively observed in tumours of the rectum of women Again,
results based on a smaller number of samples (123 men and 125 women, stratified by age)
could lead to biased, inconsistent associations. In the current study, G>C transversions also
constitute a small group of specific point mutations, but were mainly observed in men with
tumours in the distal colon and in women with tumours in the proximal colon. Plausible
explanations for differences in tumour site could be the role of diet with respect to bowel
transit time and bacterial fermentation of carbohydrates (47), production of volatile fatty
acids (9) or exposure of colonic epithelium to potential dietary carcinogens (48) The
relatively high frequency of G>T transversions in the rectum of women might be related to
sex differences in faecal concentration and transit time. Both bowel transit time and
frequency of constipation have been reported to be substantially higher in women than in
men under similar conditions (49). The G>T transversions and also the generally higher
frequency of K-ras mutations in women might be related to the time of contact with, and the
concentration of, particular carcinogens. More aetiological insight in the underlying
mechanisms is required to clarify this issue.
The K-ras mutational status was evaluated for differences in frequencies with respect to
tumour differentiation. Most tumours were classified as 'moderately' differentiated.
Generally, the distinction between good or moderately differentiated tumours is often
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ambiguous Therefore, the classification of tumour differentiation could be biased. Our
findings do not support a role of the K-ras oncogene in tumour differentiation
In conclusion, we observed a frequency of 37% for mutations in exon 1 fragment of the
K-ras oncogene, predominantly in codons 12 and 13. The G>A transition and the G>T
transversion are the most frequently observed mutations, with the G>T transversion
primarily confined to codon 12. Patients with a rectal tumour have a relatively higher
frequency of G>T transversion as compared to patients with distal colon tumour and this is
confined to female patients The pattern of K-ras point mutations observed in the several
sublocalisations of the colorectal tract is suggestive for the involvement of dietary factors.
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ABSTRACT
Associations between meat and fish consumption and K-ras mutations in colon and
rectal cancer were investigated in The Netherlands Cohort Study on diet and cancer.
After 7.3 years of follow-up, excluding the first 2.3 years, 448 colon and 160 rectal
cancer patients, and 2948 subcohort members were available for data-analyses K-ras gene
mutation analysis was performed on all archival adenocarcinomas. Case-cohort analyses
were used to compute adjusted incidence rate ratios (RR) and 95% confidence intervals (Cl)
for colon and rectal cancer and for K-ras mutation status subgroups.
Total fresh meat, most types of fresh meat and fish were not associated with colon or
rectal cancer, neither overall nor with K-ras mutation status. However, several weak
associations were observed for wild type K-ras, i.e. an increased association for beef and
colon tumours, and an inverse association for pork and colon and rectal tumours. For meat
products, an increased association was observed with wild type K-ras tumours in the colon.
Although neither total fresh meat nor fish appeared to be associated with colon or rectal
cancer risk, beef, pork and meat products are differentially associated with colon and rectal
cancer risk, depending on K-ras mutation status.
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INTRODUCTION
The current epidemic-logical evidence for associations of different types of meat, meat
products and fish with colorectal cancer (CRC) nsk is controversial (1-3) These observed
inconsistencies could, in part, be due to the heterogeneity of the colon and rectal cancer
endpoint that is studied Associations may become more apparent when the molecular
events involved in colorectal carcmogenesis are taken into account
The majority of colon and rectal tumours develops from small adenomatous polyps
through a well-defined sequence of morphological changes (4). a process that is associated
with the acquisition of somatic mutations (5.6) A genetic alteration that occurs in adenomas
(10%) as well as in carcinomas (40%) of the colon and rectum, is the oncogenic activation of
the K-ras gene by mutations Activating mutations are mainly found in codons 12 and 13
(5,7-9) The most frequently observed types of point mutations are the G>A transitions. G>T
and G>C transversions (9-11)
The link between several types of fresh meat, meat products and fish, and the pattern of
K-ras mutations in human colon and rectal cancer is not clear To date, only a few case-
control and case-case studies have been conducted on the association between the
consumption of dietary factors and K-ras mutation status (12-17). Four studies reported on
several types of meat consumption (12,14,15,17).
It has been suggested that N-nitroso compounds, present In processed meat or
endogenously formed (12), may induce G>A transitions at the second base of codon 12 or
13 of the K-ras gene in the human colon (13) High temperature cooking of meat proteins
generates heterocychc aromatic amines (HAA). whereas the process of grilling and smoking
of meat generates polycyclic aromatic amines (PAH) as a result of fat dropping on open
flames. HAA-DNA-adducts can cause transitions and transversions. whereas PAH's could
induce G>T transversions in the K-ras gene Results from animal experiments, however, are
not consistent (14)
Consequently, high consumption of meat and fish could contribute to the acquired
genetic alterations in the K-ras oncogene observed in colon and rectal tumours Therefore,
associations between dietary consumption of different types of meat, meat products and
fish, and the risk of specific point mutations in the K-ras oncogene in patients with colon and
rectal cancer were studied within the framework of The Netherlands Cohort Study on diet
and cancer (NLCS).
MATERIALS AND METHODS
Study Population
The study subjects are incident colon and rectal cancer cases and subcohort members
from the NLCS, which has been described in detail elsewhere (15) Briefly, the cohort study
was initiated in 1986 and includes 58,279 men and 62,573 women, aged 55-69 years old at
baseline, who originated from 204 Dutch municipalities with computerized population
registries A self-administered questionnaire on diet and other risk factors for cancer was
completed at baseline. The entire cohort is being monitored for cancer occurrence by annual
record linkage to The Netherlands Cancer Registry (NCR, nine cancer registries in The
Netherlands) and to PALGA, a nationwide network and registry of histo- and cytopathology
(wwwpalga.nl) (16). In the municipalities included in the NLCS, the NCR and PALGA,
together, have nearly 100% coverage since the start of the study (17-19) PALGA also
provides necessary information on the identification of the pathology laboratory location of
the storage of paraffin-embedded blocks of the eligible CRC patients Accumulation of
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person-time in the cohort has been estimated through biennial vital status follow-up of a
subcohort of 3,500 men and women who were randomly selected after baseline exposure
measurement. Cases with prevalent cancer other than non-melanoma skin cancer were
excluded from the subcohort, which left 3,346 men and women for analyses.
The first 2.3 years of follow-up were excluded due to incomplete coverage of PALGA
alone in some of the municipalities included in the NLCS. Within this period. 83 subcohort
members were either deceased or diagnosed with cancer other than non-melanoma skin
cancer, leaving 3,263 men and women for analysis From 1989 till 1994, 929 incident cases
with histologically confirmed CRC were observed of whom 819 could also be linked to a
PALGA report of the lesion. The PALGA database was used to identify and locate tumour
tissue in Dutch pathology laboratories. CRC was classified according to site as follows:
colon i.e. cecum through sigmoid colon (ICD-O-1 codes: 153 0, 153.1, 153 2, 153.3. 153 4,
153.5, 153.6, 153 7, 153.8, 153 9), rectosigmoid (ICD-O-1 code 154 0) and rectum (ICD-O-1
code 154 1) Information about age at baseline, sex and family history of CRC (at baseline)
was retrieved from the NLCS database
Tissue Samples
This study is based on data of gene mutation analysis from CRC patients, described in
detail elsewhere (9) Briefly, tumour material of all CRC patients was collected after approval
by the Medical Ethics Committees of Maastricht University, the NCR and PALGA.
Subsequently, all pathology laboratories in The Netherlands agreed to make relevant tissue
samples available upon request from PALGA Tissue samples of the 819 cases were
distributed among 54 pathology laboratories throughout The Netherlands Tumour tissue
specimen collection started in August 1999 and was completed in December 2001. The loss
to follow-up of tissue samples of cases amounted to 5% Tissue samples from nine patients
registered in one pathology laboratory could not be retrieved due to administrative
inconsistencies, leaving 810 tissue samples for collection. For 34 cases, paraffin-embedded
material was not available in the archives of pathology laboratories, leaving 776 cases for
the determination of the K-ras mutation status. For 39 cases (5%), the K-ras mutation status
could not be determined, i.e. for 20 cases only normal colonic mucosa was available, 10
cases were revised with an benign adenoma (AdB) instead of an adenocarcinoma, for six
cases the yield of DNA was not sufficient to determine K-ras mutation status and for three
cases the available tissue did not include malignant CRC tissue. Finally, tumour material
from 737 incident colorectal adenocarcinoma cases was available of whom 476 were colon
cancer cases, 85 were rectosigmoid cancer cases and 176 were rectal cancer cases.
Statistical analyses were performed separately for colon and rectal cancer as differences in
the aetiology of colon and rectal cancer have been reported (1). Since the rectosigmoid can
be considered as a clinically applied term rather than an anatomically defined transitional
zone between the colon and rectum, patients with a rectosigmoid tumour were excluded
from data-analyses. Moreover, the number of patients with a rectosigmoid tumour was too
small for adequate stratified analyses (9).
Detection of Af-ra* Mutations
Mutation analysis of the exon 1 fragment of the K-ras oncogene, spanning codons 8-29,
was performed on archival colorectal adenocarcinoma specimens of all 737 CRC patients
using macrodissection, nested Polymerase Chain Reaction (PCR) and direct sequencing of
purified fragments, which has been described in detail elsewhere (9). The method of
mutation detection was validated by the confirmation of reported K-ras status in CRC cell
lines and a good correlation between fresh-frozen and routinely-fixed, paraffin-embedded
tissue The detection limit was 5% mutated DNA Duplicate analyses revealed a good
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reproducibility (88%) (9) Two observers (GR and ML) independently performed evaluation
of mutation analysis and data entry.
The Food Frequency Questionnaire
The dietary section of the questionnaire was a 150-item semi-quantitative food
frequency questionnaire, which concentrated on habitual consumption of food and
beverages during the year preceding the start of the study Daily mean nutrient intakes were
calculated using the computerized Dutch food composition table (20), by multiplying
frequencies and portion sizes of all food items with their tabulated nutnent contents The
questionnaire was validated against a 9-day diet record (21) The Spearman correlation
coefficients for total fresh meat, meat products and fish were 0.46, 0 54 and 0.53,
respectively (21) Questionnaire data were key-entered twice and processed for all incident
cases in the cohort and for all subcohort members in a manner blinded with respect to
case/subcohort status. This was done in order to minimise observer bias in coding and
interpretation of the data
For 257 subjects (28 incident colon adenocarcinoma cases. 16 incident rectal
adenocaranoma cases and 215 subcohort members; two subcohort members were also
colon or rectal cancer cases), dietary data were incomplete or inconsistent, and they were
excluded from the analyses These subjects either 1) left 60 or more (out of 150)
questionnaire items blank and ate fewer than 35 items at least once per month and/or 2) left
one or more item blocks (groups of items, i.e., beverages) blank Additional details are given
elsewhere (21) Hence, 448 colon and 160 rectal cases and 3048 subcohort members were
available for data-analyses.
The food frequency questionnaire contained 14 items on the consumption of meat with
the main (hot) meal (mainly fresh meat, including chicken), 5 items on the consumption of
meat products, which are used as sandwich filling, and 3 items on fish consumption For the
serving size of total fresh meat, a question was included on the quantity of meat usually
purchased (per person, per meal). Fresh meat is defined as meat that has not undergone
some form of preservation, i.e. smoking, fermentation, and/or treatment with nitrate and/or
nitrite salt ("curing") and which includes beef, pork, minced meat, chicken, liver and other
meat (i.e. sausages). Coding of fresh meat items was based on raw weight to take into
account the amount of fat originally present in the meat but ultimately ending up into the
gravy, which is usually consumed as well. Meat products are defined as meat items that
have undergone some form of preservation (mostly cured, sometimes also smoked or
fermented). For chicken and fish, standard serving sizes were used. Meat items included in
the questionnaire were converted into mean daily consumption in grams.
Quartiles of the consumption of total fresh meat, beef, pork, liver, minced meat, other
meat, and meat products were computed for men and women separately, based on the
distribution of subcohort members as described in detail later. For chicken and fish, groups
were classified into a non-user and three user categories (5.3-13.2, 13.2-22.8 and 222.8
g/day for chicken and 0-10, 10-20 and £20 g/day for fish) and this classification was used for
both men and women.
Daily intake of dietary fibre (g/day), alcohol (g/day), fruit (g/day), vegetables (g/day) and
total energy (kcal/day) and age at baseline (years), sex (men/women), Quetelet Index (Ql;
kg/m'), physical activity (<30 min/d, 30-60 min/d, 60-90 min/d, >90 min/d), family history of
CRC (yes/no) and smoking status (never/ex/current) were regarded as potential
confounders
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Table 1 Meat variables and other characteristics (mean ± SD) of the study population at baseline
N
Sex (% Men)
Afle(y)
MeaJ variables
Total fresh meat (g/day)
Beefta/day)
Pork g/day)
Mnoed meat (g/day)
U w (g/day)
Chicken (g/day)
Other meal (g/day)
Meat product* (g/day)
Fish and shellfish (g/day)
Ofher dwfa/y /actors
Fiber (g/day)
Alcohol (g/day)
Fruit (g/day)
Vegetable (a/day)
Energy (kcal/day)
Other c/MrsctoritMci
Ql(kg/m>)
Family history of CRC (% Yes)
Smoker (%)
Never
Ex smoker
Current smoker
Physical activity (%)'
<30 minutes/day
30-60 minutes/day
60-90 minutes/day
>90 tniiuites/day
Subcohort
3048
48.4
61.4 ±4.2
99.7 ±42 2
25 7 ± 22 5
38.4 ±30 3
18 3 ±17.3
2.0 ±4 4
13 7 ±15.6
2.5 ±6.4
13.2 ±15.0
12.7 ±15.0
27 0 ± 8.2
10.1 ±14.1
176.3 ±117.7
193 6 ± 82 3
1919 4 ±518.1
251 ±3.1
56
37.0
352
27.8
20.9
327
30.9
15.5
WMtypeK-m
297
51.5
62.7 ±4.0
98.4 ± 37 0
27.9 ±21.8
36 3 ±30.1
17 2 ±13.4
1.9 ±4.2
13.2 ±15.5
2.9 ± 8.0
15.0 ±16.6
11.4 ±13.5
26.7 ± 7.6
11.0 ±15.4
172.7 ±123.7
183.3 ± 78.2
1916 5 ±494.4
25.5 ±3.2
13.5
36.7
43.1
20.2
19.7
33.7
29.6
17.0
Colon cancer
Mutated K-ns
151
58.9
63.8 ±4.1
99 3 ±39.1
27.6 ± 23.6
37.6 ± 29.6
18.0 ±16.0
18 ±4.1
12.4 ±15.2
2.7 ± 5.9
11.7 ±13.2
13.2 ±15.7
27 7 ±8.8
10.8 ±14.2
176.9 ±122.2
198.0 ±87 0
19027 ± 472.9
25.8 ±3.3
93
37.1
46.4
16.6
20.3
324
29.1
18.2
' compiling uisos with at least one K-rss mutation to cases without a K-ras mutation
' 6 out ol 151 colon cancer cases had more than one K-ras mutation
' 3 out of 67 rectal cancer cases had more than one K-rss mutation
• For 41 subcohort members and 9 colorectal cancer cases, information on physical activity was not available
Statistical Analysis
The overall frequency of K-ras mutations as well as the type of mutation were computed
for all colon and rectal cancer cases as described elsewhere (9). Mean values of the
continuous variables age at baseline (years), consumption of total fresh meat, beef, pork,
minced meat, chicken, liver, other meat, meat products, fish, dietary fiber, alcohol, fruit,
vegetables, total energy and Ql were evaluated for subcohort members and colon and rectal
cancer cases with wild type and mutated K-ras gene. Distributions of the categorical
variables sex, family history of CRC, smoking status and physical activity were evaluated for
subcohort members and colon and rectal cancer patients with wild type and mutated K-ras
gene and tested for differences between patient groups with the x^-test. Differences in mean
values of the continuous variables between patients with wild type and mutated K-ras gene
were tested with the Student T-test or the Mann-Whitney-lMest if the variables were not
normally distributed. The statistical software package SPSS (version 9) was used for these
analyses
Incidence rate ratios (RR) and corresponding 95% confidence intervals (Cl) were
estimated for colon and rectal cancer cases with wild type or mutated K-ras gene tumours.
RRs were computed using Cox regression models with the STATA statistical software
package (intercooled STATA, version 7) according to consumption of quartiles or
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Table 1 continued
pMfcr
0.M
0.006
0.82
0.90
0.67
0.57
029
0.55
095
002
0.24
002
0.59
0.73
0.07
0 78
0.42
0.20
0.62
0.98
VnM typo K<4M
93
72.0
62.6±41
100 6 ±40.3
27 6 ± 24 6
32 2 ± 27 0
23 2 ± 25 2
21 ± 4 1
14.5 ±15 6
2.2 ± 4 1
13.5 ±14.7
12.4 ±13.1
27 8 ± 8 0
138 ±17 6
184 3 ±145 8
192 9 ± 72 4
2027.3 ±517.4
24.9 ± 2 8
9.7
258
419
323
18 5
272
32.6
21.7
Rectal cancer
MutaMK-ras
67
552
62.2 ±4.0
95 7 ± 36 6
22 5 ± 23 3
40 8 ± 29.3
16 7 ±12.4
1.9 ±4.4
12 3 ±12.8
2.7 ±4 8
15.0 ±12.9
11.0 ±10.3
27.6 ±7.8
11.2 ±12.2
180 7 ±129 9
188.0 ±110 6
1997 0 ±4491
25 5 ± 2.9
11.9
343
433
224
22.7
273
34.8
15.2
0.03
0.50
0.43
019
0.06
0.03
aeo
0.62
0.84
o.st
0.71
087
030
087
0 74
0 70
0.20
0.66
0.3»
0.73
categories and one standard deviation (SD) of increase in fresh meat, meat products and
fish, all based on the distribution in the subcohort. The lowest quartile or category of
consumption was regarded as the reference category The personyears at risk, estimated
from the subcohort, were used in the denominator of the incidence rates (15). Standard
errors were estimated using the robust Huber-White sandwich estimator to account for
additional variance introduced by sampling from the cohort. This method is equivalent to the
variance-covariance estimator as presented by Barlow (22). The proportional hazards
assumption was tested using the scaled Schoenfeid residuals (23). Those variables that
were found to contribute substantially (p<0.10) to the multivariate model for colon and/or
rectal cancer (age, sex, Ql, smoking, energy intake and family history of CRC) were
included as covariates in all multivariate analyses. Interactions between total fresh meat,
meat products and fish consumption on one hand and sex on the other hand were tested for
colon and rectal cancer separately and not found to be statistically significant Therefore,
results for men and women are presented together. Finally, age at baseline, sex. family
history of CRC, smoking status, Ql and the intake of energy were confounders for either one
or both of the models, i.e. with colon or rectal cancer cases, and were therefore included as
covariates for all models to be tested For each analysis, linear trends were evaluated with
the Wald test of the regression coefficient estimate by fitting ordinal exposure variables
(quartiles/categones of consumption) as continuous terms.
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Table 2 Incidence rate ratios (RR) and 95% confidence intervals (Cl) for colon (N=448) and rectal
(N=160) cancer patients overall according to the intake of total fresh meat, meat products and
fish
Tow frifh m#ft
Median intake (g/d)
men
woman
coton cancer cases
n»c/um cancec cases
penonyears
RR (95% Cl)2 colon
rectum
RR (95% Cl)' colon
ractum
Beaf
Median Intake (g/d)
man
women
coton cancer catea
wc/um cancer caaai
panony»a/j
RR (95% CIF colon
rectum
RR (95% Cip coton
rectum
Pork
Median intake (g/d)
men
Women
coton cancer cases
recfum cancer cases
personyears
RR (95% Cl)' colon
reclum
RR (95% Cl)> colon
rectum
Mlncad Meat
Median intake (g/d)
men
Women
coton cancer cases
raeh/m cancer cases
pereonyeare
RR (95% Cl)' colon
rectum
RR (95% Cl)' colon
rectum
Liver
Median intake (g/d)
men
Women
coton cancer cases
recfum cancer cases
personyeare
RR (95% CIP colon
rectum
RR (95% Cl)' colon
rectum
1'
61.0
507
ros
40
366 f
100
100
1.00
1.00
41
3.0
too
39
3648
100
1.00
100
1.00
79
5.0
f2T
44
3659
1.00
1.00
1.00
1.00
3.2
0.0
fO4
33
3648
1.00
1.00
1.00
1.00
0.0
0.0
295
99
9589
1.00
1.00
1.00
1.00
2
910
80.3
M2
48
370)
1.03(0.77-1.37)
1.21 (0.78-1.86)
105(0.78-1.41)
1.11(0.71-1.73)
161
14.0
98
49
3742
0.94(0.70-1.27)
1.22(0.79-1.88)
0.98(0.72-1.33)
1.25(0.80-1.96)
280
22.5
J20
46
3658
1.03(0.78-1.35)
1.07(0.70-1.64)
0.98(0.74-1.30)
1.01 (0.66-1.56)
11.5
9.6
Jf9
38
37J8
1.12(0.84-1.49)
1.13(0.70-1.82)
1.11 (0.83-1.50)
1.06(0.66-1.73)
4.1
3.7
153
6)
5t48
1.02(0.83-1.26)
1.16(0.83-1.62)
1.04(0.84-1.29)
1.11(0.79-1.57)
BuarilWCahgor)
3
110.7
103.4
f23
40
3660
1 16(0 88-1 54)
103(0.65-1.61)
1.12(0 83-1 49)
0.93(0.59-1.47)
30.0
25.5
fO8
32
3507
1.08(0.80-1.44)
0 84(0.52-1.37)
1.09(0.81-1.48)
0.82(0.49-136)
44.3
40.1
»09
36
3688
0.94(0.71-1.24)
0.84(0.53-1.33)
0.90(0.67-1.20)
0.81 (0.51-1.28)
21.0
18.1
J28
54
3692
1.28(0.97-1.70)
1.67(1 07-2 61)
1.26(0.94-1.69)
1.60(1.01-2.52)
of Intake
4
150.8
139.2
fO4
32
3715
0.99(0.74-1.33)
0 82(0.51-1.33)
0.96(0.70-1.31)
0.72(0.44-1.19)
S1.4
46J
f42
40
3840
1.23
090
0.93-163)
0.57-1.43)
1.28(0.96-1 72)
0.92(0.57-1 49)
76.0
98
34
3733
0.86(0.76-1.37)
0.80(0.50-1.28)
0.77(0.57-1.04)
0.70(0.43-1.13)
37.8
32.9
97
35
3679
0.95(0.70-1.28)
1.07(0 66-1.74)
0.93(0.68-1.27)
1.01 (0.62-1.67)
Pfor
frem/
0.80
0.33
0.92
0.J4
009
0.35
0.06
0.38
0.24
0.22
0.07
0.09
0,99
0.38
0.88
0.50
0.84
0.38
0.7J
0.54
RR (95% Cl) for
one SD increase
in intake*
0.97(0.89-1.07)
0.94(0.80-109)
0.96(0.87-1.06)
0.89(0.76-1.05)
1.05(0.96-1.15)
0.95(0.79-1.13)
1.06(0.97-1.17)
0.94(0.78-1.14)
0.96(0.87-1.07)
0.90(0.76-1.07)
0.93(0.83-1.04)
0.87(0.72-1.03)
0.95(0.86-1.04)
1.09(0.94-1.26)
0.95(0.85-1.05)
1.08(0.92-1.27)
1.00(0.91-1.11)
1.02(0.88-1.18)
1.02(0.92-1 12)
1.02(0.88-1.18)
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CNdwn
Marian intake (g/d)
wen/women
colon cancercases
ndum cancer cases
parsornwars
RR(95%CI)* colon
rectum
RR(95%CI>> colon
rectum
Other meat
Median intake (9/d)
men
Women
coton cancer cases
/edum cancer cases
personyears
RR (95% CIF colon
rectum
RR(95%CI>' colon
rectum
Meat products
Median intake (g/d)
men
women
coton cancer cases
recfum cancer cases
personyesrs
RR (95% CIH colon
rectum
RR (95% Cl)> colon
rectum
Fish
Median intake (g/d)
men
women
coton cancer cases
recfum cancer cases
personyears
RR (95% CIF colon
rectum
RR (95% Ciy colon
rectum
1'
0.0
125
35
3457
1.00
100
1.00
1.00
0.0
0.0
3f3
f05
7O42f
100
1.00
1.00
100
1.0
0.0
m44
3558
1.00
1.00
1.00
1.00
0.0
0.0
123
48
4235
1.00
1.00
1.00
1.00
m
2
5.3
JOf
44
3564
081(061-107)
126(0.80-2.00)
0.85(0.63-114)
1.26(0.79-2.03)
60
7.0
f35
55
4316
1.13(0.91-1.41)
1.29(0.91-1.81)
1.16(0.92-1.46)
1.34(0.95-1.91)
74
4.3
94
30
3624
0.87(0.65-1.17)
0.70(0.43-1.12)
0.89(0.65-1.21)
0.68(0.41-1.11)
4.6
4.6
f22
33
3238
1.31 (1.00-1.73)
0 86 (0.54-1 36)
1.30(0.97-1.73)
0.88(0.55-1.43)
KH miu r\-fCH» niljuauum ui spun
QuartWCatoBoryoflRWn
J
M
M
3816
0 78(0 58-104)
0 92(0 56-150)
0.81 (0.60-1.08)
0.94(0.57-155)
1SJ
104
ff»
39
3794
1.06(0.80-140)
0.88(0.57-138)
1.06(0.78-1.42)
0.84(0.53-1.35)
14J
15.5
ff6
48
4444
0.92(0.70-1.21)
0.93(0.62-1 41)
0.82(0.62-1.09)
0.97(0.64-1.48)
4
22 8
J2<
48
4ffJ0
0 86(0 66-113)
118(0 76-1.86)
0.87(0.66-1.15)
1.12(0.70-1.79)
333
224
f23
47
3732
1.13(0.86-149)
1.09(0.71-166)
117(0.86-159)
1.04(0.64-1.68)
30.5
28.2
87
3f
2820
1.05(0 78-141)
0.89(0 56-1.42)
1.03(0.76-1.40)
0.94(0.59-1.52)
Plbr
tWttf
030
0.77
034
0.96
0.25
0.5
0.20
O.fO
022
0.54
Of 9
0.70
0.64
0.70
0.40
0.89
m ana rvcm cancer
RR (95\ Cl) for
one SD increase
m Intake*
• ' . , " ' • • . • « - ; ; • • • ; • • . . ' '
0.96(0.86-107)
1.00(0.86-116)
0 95(085-1.07)
0.96(0.83-1.14)
105(096-115)
098(066-111)
1.06(0 98-116)
1.00(0 68-1 15)
104(0 95-114)
1.01(0 89-1 16)
1.05(0 94-1.16)
0.97(0.84-1.13)
0 94(0.85-104)
0.91 (0 79-1 06)
0.93(0.83-1.04)
0.93(0.80-1.06)
' reference category/quartile of intake
' RR adjusted for age and sex
' RR adjusted for age. sex. 01. smoking, energy intake and family rmtory of CRC
• see for one standard deviation of increase based on the mtak» of tie tubcohort (table 1)
' RR per increment of 15 g/day (SD in subcohort). equivalint to one standard sandwich Wng
RESULTS
The overall frequency and spectrum of mutations in the K-ras gene have been
presented in detail elsewhere (9). In brief, a total of 227 mutations was found in 218 (36%)
out of 608 colon and rectal cancer patients. The most frequently observed mutations are the
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Table 3 Adjusted RR' for colon and rectal cancer patients with a K-ras mutation status' according
to the intake of fresh meat, meat products and fish
QmrtWCtttgory of Intake
Pfor
1'
RR (95% Cl) for
one SD increase
in intake*
Total fresh meat
coton 68/35 8(>29
wdurn 25/f5 2f/24
RR*«(95%CI) colon 1.00 1.16(0.82-1.64
rectum 1.00 0.85(0.47-155!
colon 1.00 0.83(0.50-1.37
rectum 1.00 1.53(0.80-2 94
76745
25/J4
1.05(0.74-149)
1.02(0 58-1.80)
1.25(0.79-2.00)
0.82(0.39-1.72)
6635
0 94(0.65-1.36)
0.76(0.41-1 44)
1.01(0.61-1.66)
0.68(0.31-1.47)
0.6f
0.56
0.57
O.fO
0.95(0.84-1.07)
0.93(0.75-1.15)
0.99(0.85-1.16)
0.85(0.67-
- .
1.07)
coton 62/32
rectum 2f/f6
RR*«(95%CI) colon 1.00
rectum 1.00
W W ( 9 5 % C I ) coton 1.00
rectum 1.00
66/29
25/23
1 04(0 72-1 49)
1.16(0.64-2.12)
0.87(0 52-1.47)
1.36(0 70-2.63)
66739
fa/72
1.05(0 72-1.51)
0.89(0.46-1.71)
96744
25/M
1.36(0.96-1.93)
1.06(0.57-1.94)
0.06
0.93
1.18(0.73-1.92) 1.14(0.71-1.83) 0.38
0.74(0.34-1.61) 0.75(0.35-1.61) 0.20
1.08(0.97-1.20)
1.02(0.81-1.27)
1 04 (0.89-1 22)
0.84(0.61-1.16)
POfn
Cases (K-/as-/K-ras+)
coton 85/33
reefwn 3I/J2
RFW(95%CI) colon 100
rectum 1.00
74/42
25/J9
0 86(061-1.20,
0.81(0.48-1.39]
68/40
ta/ia
0 77(0.55-1.08)
0.58(0.32-1.04)
63/29
J5/f6
0.72(0.51-1.02)
0.50(0.26-0.93)
0.05
O.Of
RAc*. (95% Cl) colon
rectum
100
1.00
Minced Meaf
Cases (K-fss-/K-ffls»j
co/on 66/34
recfum f9/J4
R R K , » ( 9 5 % C I ) colon 1.00
rectum 1.00
1.30(0 80-2 09) 124(0 76-202) 0 90(0.53-1.53) 0.68
1.52(0 73-3 17) 138(065-294) 121(0.56-2.60) 0.75
0.91 (0.80-1.05)
0.74 (0.57-0 96)
0.97(0.82-1.15)
1.03(0.82-1.29)
79/37
1.16(0.82-1.64)
0.89(0.46-1.74)
89/36
32/20
1.37 (0.97-1.92)
1.77(0.99-3.19)
56/37
27/12
0.85 (0 58-1.25) 0.68
1.17(0.62-2.19) 0.2J
RR«™.(95%CI) colon
rectum
1.00
1.00
1.04(0.64-1.68) 1.06(0.64-1.74) 1.07(0.65-1.75) 0.78
1.28 (0 64-2.56) 1.36(0.68-2.72) 0.81(0.37-1.79) 0.66
0.93 (0.82-1.04)
1.18(0.99-1.40)
0.98(0.83-1.16)
0.87(0.68-1.12)
Tlver
Cases fK-rasVK-rss+)
coton f84/98
recfum 55/4 f
RR«™(95%CI) colon 1.00
rectum 1.00
R R A ~ . ( 9 5 % C I ) colon
rectum
1.00
1.00
J06/46
34/24
1.10(0.86-1.42'
1.15(0.74-1.79!
0.92(0.63-1.33)
1.07(0.63-1.80)
0.44
0.54
0.65
0.80
1.02(0.91-1.14)
1.05(0.89-1.24)
1.01 (0.85-1.19)
0.97(0.74-1.28)
Chicken
Cases (K-rssvX-ras+j
coton 73/42
rec/um 20/13
RR««-(95% Cl) colon 1.00
rectum 1.00
RR*™ (95% Cl) colon
rectum
1.00
1.00
73/27
24/f9
0,96(0 68-1.36)
1.19(0 64-2.18)
0.64(0 39-1.06)
1.39(0.68-2.85)
62/35
f6/f7
0.81 (0.57-1.16)
0.76(0.39-1.49)
82/40
29/16
0.91 (0.65-1.28) 0.44
1.23(0.69-2.21) 0.75
0.80(0.51-1.28) 0.80(0.51-1.26) 0.52
1.20(0.57-2.53) 0 97(0.46-2.03) 0.75
0.96(0.84-109)
1.04(0 85-1.26)
0.95(0 79-1.14)
0.88(0.68-1.15)
Other meat
coton 20J/JJ0
f«cft/m 57/43
R I W ( 9 5 % C I ) colon 1.00
rectum 1.00
89/43
32/22
1.16(0.89-1.52)
0.90(0.63-2.23)
0.28
0.T4
1.08(0.96-1.21)
0.97(0.81-1.17)
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Other ntMt
RR>—(95%CI) colon
rectum
1»
100
1.00
QuvtiUCateooryof'InUw
2 3 4
1.16(0.79-1.70)
U 4 (0.73-2.10)
Pfcr
trand
0.44
0.43
IW ( W i CJ) for
ont SO incrMM
M flttafct'
1.07(0.93-1.23)
1.04 (0.87-1.24$
atari product*
C K ^ C
coton 66/40
recfum 28/J4
RR,«(95%CI) colon 100
rectum 100
RfW(95%CI ) colon 1.00
rectum 1.00
5033
2<W
0.91(0 63-133)
0.71(0 39-130)
76/4 f
J6V70
110(0.76-1.57;
062(0 34-1 16
9030
23/M
1.42(100-2.03) 0.03
084(0 45-158) 0.5f
0.84(0.52-13:
062 0 26-1
1-1.37) 100(0.63-159) 0 77(0.45-1.32) 0.5J
^  46) 1.26(0.61-261) 1.41 J0.67-2.99J O.f7
1.115(0.99-125)
0.91(0 73-1.14)
0 90(0 73-111)
105(0.86-1.27)
colon
recfum
R r W (95% Cl) colon
rectum
RrW(95%CI ) colon
rectum
84/07
2Sf9
100
100
1.00
100
8»/36
2Q/1f
1.30(0.93-1.81)
0.97(0 53-1.79)
1.29(0.79-2.10)
0.76(0.35-1.61)
74/35
24/24
0.80(0 57-112)
0.86(0.48-152)
0.87(0.54-1.42)
1.13(0.61-2 07)
5J/36
20/Tf
0.87(0 60-126)
1.06(0.58-1.94)
138(085-2 25)
0 78(037-1.65)
0f3
099
052
084
0 88(0.77-1.02)
0 97(0 81-117)
100(0 85-119)
0.86(0.69-1.07)
' Muftvanato ad)usled RR he age. wx 01. smoking, energy u M i and tamiy hMory of CRC aid her 95%
contdence intervals
' WM type K-«« (K-/»s^ no mutaton m the exon 1 fragment o( he gene, mutated K-«s ( X - m * | H I M H ont
mu*Mon in fwexon 11nQnMntof Vw gsrw
• Ratoranca otagoiyqualia of intake
• Saa tor on* standard deviation of ncreaee baaed on the intake of»»tubcohoit (late 1)
• RR par nenmant of 15 gttay (SO m subconort), equvalant to one standard landwfcnMng
G>A transitions (54%), G>T transversions (33%) and G>C transversions (7%). The
observed frequencies of the mutations in this series of patients are similar to the frequencies
of the 737 CRC cases, including the rectosigmoid cancer cases, for whom K-ras mutation
status was determined (9).
Table 1 shows the baseline characteristics of the study population. Colon and rectal
cancer cases were more often men, were older, more frequently reported a family history of
CRC, had a higher daily alcohol intake and were less frequently never smokers as
compared to the subcohort. Colon cancer cases with a K-ras mutation in their tumour had a
lower daily consumption of meat products, a higher intake of dietary fibers and were
significantly older than colon cancer cases with a wild type K-ras tumour (p-values 0.02,
0.02 and 0.006, respectively). There were no statistically significant differences between
colon cancer cases with and without a K-ras mutation in their tumour in dietary consumption
of total fresh meat, beef, pork, minced meat, liver, chicken, other meat, fish and other factors
presented in table 1. Rectal cancer cases with a K-ras mutation in their tumour had a lower
daily consumption of minced meat, a higher daily consumption of pork and were less
frequently men than rectal cancer cases with a wild type K-ras gene in their tumour
(p-values 0.03, 0.06 and 0.03, respectively). No statistically significant differences were
observed between rectal cancer cases with and without a K-ras mutation in their tumours for
other factors presented in table 1.
Associations between the consumption of total fresh meat, different types of fresh meat,
i.e. beef, pork, minced meat, liver, chicken and other meat, meat products and fish, and the
risk of colon or rectal cancer are presented in table 2. RR and 95% Cl for colon and rectal
cancer were presented after adjustment for age and sex and after adjustment for age,
51
Chapter 3
Table 4 Adjusted RR' for colon and rectal cancer patients with specific point mutations' in the K-ras
oncogene according to the intake of fresh meat, meat products and fish
QuartWCatogory of intake
1>
RR (95*/. Cl) for
~P7o7 one SO increase
(rentf in intake'
Total freth men
Cases (G>/VG>r or C)
coton 16/16
rectum ff/5
R R < M ( 9 5 % C I ) colon 100
rectum 100
RRo,tc(95%CI) colon
rectum
1.00
1.00
16/12
12/13
0.98(0 48-198)
1.11 (0.49-2.51)
0.75 (0.35-1 61)
2.44 (0 86-6 92)
31/13
7/5
1.81 (0.97-3.40)
0.62(0 24-1.64)
0.83(0.40-1.73)
1.01 0.31-3.27)
19/15
3/B
1.11(0 55-2.22)
0.28(0.08-103)
1.00(0.48-2.08)
1.19(0 38-3.68)
0.34
0.02
0.97
0.62
1.02(0.85-1.22)
0.71 (0.554.93)
1.01(0.78-1.32)
0.94(0 65-1.36)
RRo>*(95%CI)
coton 16/14
rectum 7/9
colon 1.00
rectum 100
19/7
14/8
1.13(0 57-2.26)
2.00(0 79-5.06)
19/18
7/5
113(0.57-2 21)
1.08(0.37-3.11)
28/17
S3
1.41 (0.74-2 66)
0 68 (0.21-2.26)
0.30
0.25
RRo.rc (95% Cl) colon
rectum
1.00
1.00
0.48(019-1.19) 1.26(0.62-2.58) 1.02(0.50-2.08) 0.47
0.81 (0.31-2.17) 0.63(0.21-1.87) 0.82(0.30-2 21) 0.64
1 11(0.91-1.36)
0.67 (0.47-0.95)
0.99(0.78-1.26)
1.06(0 69-1.61)
R R < M ( 9 5 % C I )
g
coton 19/13
rectum 6/5
colon 100
rectum 100
23/18
JO/Jf
1.23(0 65-2 30)
167(0 60-4 66)
25/12
f(V7
1.28(0.69-2.40)
171(0.60-4.90)
15/13
7/B
0.77(0.38-1.56) 0.53
1.23(0.40-3.77) 0.72
RRO.T c (95% Cl) colon 1.00
rectum 1.00
Minced meat
143(0.68-2 98) 098(0.43-2.22) 1.07(0.48-2.41) 0.88
1.72(0.63-4.71) 0.99(0.33-2.97) 1 07(0.37-3.13) 0.74
0.86(0.70-1.06)
0.92(0.68-1.25)
1.10(0.83-1 46)
1.06(0.74-1.51)
coton 20/J2
recfum 7/7
R R O M ( 9 5 % C I ) colon 100
rectum 1.00
RRo.i.c(95%CI) colon
rectum
1.00
1.00
15/18
tr/8
0.71 (0.36-1.40)
1.56(0.61-4.01)
1.44(0.69-3.04)
1 06 (0.39-2.89)
0.94(0.49-1.81)
1.27(0.47-3.47)
28/10
1.34(0.73-2.46
0.90 (0.30-2.72
0.24
0.75
1.36(0.62-2.95) 0.83(0.36-1.95) 0.64
1.51(0.59-3.88) 0.77 (0.25-2.38) 0.85
1.09(0.91-1.31)
0.86(0.61-1.22)
0.89(0.67-1.18)
0.88(0.61-1.27)
Liver
Cases (G>A/G>r or C)
coton 5S/36
recrum 23/18
RRO>A(95%CI) colon 1.00
rectum 1.00
RRO»T.C(95%CI) colon
rectum
1.00
1.00
26/20
10/14
0.91 (0.55-1.49)
0.79(0.38-1.65)
1.12(0.64-1.94)
1.45(0.69-3.05)
0.70
0.53
0.70
0.32
1.01 (0.82-1.26)
0.53(0.31-0.91)
1.10(0.90-1.36)
1.18(0.92-1.50)
Chicken
Cases (G>A/G>r or Cj
coton 24/17
recfi/m 7/6
RRo*(95%CI) colon 1.00
rectum 1.00
RRo.ic(95%CI) colon 1.00
rectum 1.00
14/10
ft/10
0.57(0 29-1.13
1.59(0 61-4 19'
21/13
84
0.84(0.46-1.53)
1.08 0.38-3.07
23/16
7/7
0.78 (0.43-1 42)
0.85 (0.29-2.46)
0.66
0.52
0 59(0.27-1.29) 0.74(0.36-53) 0.81 (0.41-1 61) 0.70
1.52(0.55-4.19) 1.36(0.47-3.91) 0.86(0.29-2.59) 0.65
0.94(0.74-1.18)
0 88(0.59-1.32)
0 95(0 69-1 30)
0.80(0.54-1.18)
Other meat
Cases(G>A/G>rorC)
coton 55/42
recfum 20/22
R R O M ( 9 5 % C I ) colon 1.00
rectum 1.00
27/14
13/10
1.33(0.82-2.17)
1.57 (079-3.13)
0.25
0.20
1.12(0.97-1.31)
1.15(0 95-1.39)
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continued
(95% Cl) colon
rectum
1>
1.00
1.00
Meat and / w a s mutations
QuartMCatogoryofMrt*
2 3 4
0.94(0.50-177)
110(0 50-2.41)
in sporadic colon and rectal canotr
Ptef
frwttf
085
0.8f
• -
RR (95S Cl) for
oot SO IncnMt*
tntntotw*
0.99(076-1.29)
0.90(0.63-1.27)
MMt products*
Cases f6>/V6>r or C)
coton 20/16
recfum 6/7
RfW95%CI ) colon 100
rectum 1.00
R R » T C ( 9 5 % C I ) colon 1.00
rectum 1.00
16/16
0.79(0 40-155)
0.89(027-2.99)
24/16
11/fO
111(0 60-208)
1.98(0 69-5 62)
22/8
fi/10
108(0 54-2.16) 0.61
2 37(0 75-7.51) 007
1.06(0.52-217) 1.03(050-211) 0 53(0.22-128) 0.20
0.65(0.20-2.16) 1.16(0.41-3.24) 1.08(0.384.05) 0.63
098(078-123)'
114(0.90-1.45)'
082(0.55-1.23)'
1.02 (077-1,38)'
FSfi
Cases (G>A/G>r or Cj
coton 20/16
recfum 10/9
R R O A ( 9 5 \ C I ) colon 100
rectum 100
RRO>T.C(95%CI) colon 1.00
rectum 100
19/14
5/5
1.27(0.65-248)
061(021-181)
1&/16
16/10
081(042-1.57
142(0 65-312
25/10
2 *
173(0.92-3.24) 0.27
0 28(0 06-126 048
1.19(0.57-2 50) 098(0.48-1.98) 095(043-2.10) 0.80
0.78(0.25-2.40) 1.01(0.40-2.51) 120(045-3.22) 0.68
112(0.91-136)
0 78(0.58-106)
0.83(0.65-1.07)
0.96 J0.72-1.281
' I n pwwnc* o( G>A taniitoni or G>T or G>C ttnrarnorw m lh» won 1(ragmanl of trw K-TM oant
' rtfannca cMgoryAguaH* ol • * * •
' RR ptr incnmart o( 15 gtiay (SO m tubcohort). equivalent to one standard undwKh Mng
sex, smoking, Ql, energy intake and family history of CRC The age-and-sex adjusted RR
and the multivariate RR were similar. Frequent consumption of total fresh meat, minced
meat, liver, chicken, other meat, meat products and fish was not significantly associated with
the risk of colon or rectal cancer (table 2). A high intake of beef was borderline positively
associated with the risk of colon cancer (RR for highest versus lowest quartiie of
consumption 1.28, 95% Cl 0.96-1.72; pueno 0.06). There was no association between beef
and rectal cancer risk. A high consumption of pork was, however, borderline inversely
associated with the risk of colon cancer (RR for highest versus lowest quartiie of
consumption 0.77, 95% Cl 0.57-1.04; pt,ena 0.07) and rectal cancer (RR for highest versus
lowest quartiie of consumption 0.70, 95% Cl 0.43-1.13; p,,«nd 0.09).
Associations of total fresh meat, beef, pork, minced meat, liver, chicken, other meat,
and meat products and fish with wild type or mutated K-ras gene in colon or rectal tumours
are presented in table 3. Results will first be presented for tumours with a wild type K-ras
gene. No clear associations were observed for the highest versus the lowest consumption of
total fresh meat, minced meat, liver, chicken, other meat and fish and colon and rectal
tumours with a wild type K-ras gene. A nonsignificant, increased association was observed
between beef and wild type K-ras colon tumours (RR for highest versus lowest quartiie of
consumption 1.36, 95% Cl 0.96-1.93; pveno 0.08). No association was observed for beef and
rectal tumours with a wild type K-ras gene. On the other hand, a high consumption of pork
was inversely associated with wild type K-ras colon and rectal tumours (RR for highest
versus lowest quartiie of consumption 0 72, 95% Cl 0.51-1.02 and 0 50, 95% Cl 0.26-0.93,
respectively). A high consumption of meat products showed a significant increased
association with colon tumours with a wild type K-ras gene (RR for highest versus lowest
quartiie of intake 1.42, 95% Cl 1 00-2 03; pireod 0.03) No clear association was found for
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high consumption of meat products and rectal tumours with a wild type K-ras gene
Regarding colon and rectal tumours that harbour a K-ras mutation, no clear associations
were observed between highest versus lowest quartile of consumption of different types of
fresh meat, meat products and fish
Subgroup analyses were performed to evaluate the associations between total fresh
meat, different types of fresh meat, meat products and fish, and specific types of K-ras point
mutations (G>A transitions and G>T or G>C transversions) in colon and rectal tumours
(table 4) Results will first be presented for tumours with a G>A transition in the K-ras gene.
Total fresh meat consumption was not associated with G>A transitions in the colon tumours,
but an inverse association with G>A transitions in the rectal tumours was observed.
However, none of the specific types of fresh meat, i.e. beef, pork, minced meat, liver,
chicken, other meat, neither fish were associated with the risk of G>A transitions in both
colon and rectal tumours. For meat products, a borderline significant trend with increased
risk of rectal tumours harbouring G>A transitions was observed (RR for highest versus
lowest quartile of intake 2 37, 95% Cl 0 75-7 51; p,,,,*, 0.07). Regarding G>T or G>C
transversions in colon and rectal tumours, no clear associations were observed for total
fresh meat, the different types of fresh meat, meat products and fish.
DISCUSSION
In this large cohort study with 448 incident colon and 160 incident rectal cancer
patients, no associations were observed between total fresh meat and fish, and the risk of
colon or rectal cancer, either overall or after K-ras mutation status was taken into account.
This was also observed for specific types of fresh meat. However, several weak
associations were observed regarding tumours harbouring a wild type K-ras gene. An
increased association for high consumption of beef and an inverse association for high
consumption of pork, and the risk of colon tumours were observed. In addition, consumption
of pork was also inversely associated with rectal tumours with a wild type K-ras gene. For
meat products, an increased association was observed with wild type K-ras tumours in the
colon and with G>A transitions in the K-ras gene in rectal tumours.
Earlier results on meat and CRC in the NLCS, based on 3.3 years of follow-up, showed
no association for high consumption of total fresh meat and fish and colon cancer risk in
men and women. A positive association for both men and women was observed for meat
products which consists mainly of cured meat (24). Rectal cancer was not included in these
analyses. These findings were in line with the findings of a meta-analysis conducted by
Norat ef a/ (3). In total, 29 studies were evaluated, including 22 case-control and 7 cohort
studies for investigating the association between processed meat and CRC. A high
consumption of processed meat was found to be associated with a moderate, but significant,
increase in CRC risk. In the current study, after 7.3 years of follow-up and with the exclusion
of the first 2.3 years, these findings were similar to the earlier results on meat and CRC in
the NLCS, i.e. neither an association was observed for total fresh meat, different types of
fresh meat, nor for fish. However, in the current study, no significant association was
observed between meat products and colon or rectal cancer risk overall.
With regard to K-ras mutations, two case-control studies with colon cancer patients, one
with 2418 patients and 2410 controls (25), the other with 185 patients (26,27), and one
cross-sectional case-case study with rectal cancer patients (28) have previously been
conducted and have reported on the association between meat consumption and K-ras
mutations. In none of these studies an association between meat consumption and colon or
rectal cancer was observed after the K-ras gene mutation status was taken into account.
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The current cohort study on total fresh meat, different types of fresh meat, meat products
and fish and specific K-ras mutations is. to our knowledge, the only prospective study
performed to date The prospective design of this study and the high completeness of follow-
up of cancer incidence and of the subcohort, make information and selection bias unlikely. In
addition, as a result of the exclusion of the first 2 3 years of follow-up, the chance of
information bias due to potential preclinical colorectal cancer is minimal.
Epidemiological studies have indicated that consumption of broiled, fried, barbequed or
smoked meats may increase the nsk of CRC (29-31), although these findings were not
consistent. Augustsson ef a/ (31) observed an inverse association between high intake of
heterocyclic aromatic amines (HAA) and the risk of colon and rectal cancer However,
Gerhardsson de Verdier er a/ (29) observed an increased association for total meat intake
as well as frequent consumption of brown gravy and a preference for a heavily browned
meat surface and the risk of CRC. The relative nsks (RR) were higher for rectal than for
colon cancer. High temperature cooking of meat proteins generates HAA, whereas the
process of grilling and smoking of meat forms polycyclic aromatic amines (PAH) as a result
of fat dropping on open flames Animal and /n w'fro studies have shown that HAA-DNA-
adducts can cause transitions and transversions. as observed in the K-ras oncogen*.
However, results from animal experiments are not entirely consistent (14) In humans, a
higher prevalence of G>T transversions in the K-ras gene was observed in 37 colorectal
tumours from Yugoslavia which the authors explain as possibly being due to the extensive
use of barbequed and smoked meat throughout the year in Yugoslavia (11) Unfortunately,
information on meat preparation was not collected at baseline in the current study An
increased association was found for high consumption of beef and overall colon cancer risk
When taking into account the presence or absence of a K-ras mutation, this association
appeared to be confined to colon tumours with a wild type K- ras gene A high consumption
of pork, however, appeared to be inversely associated with both colon and rectal cancer with
a wild type K-ras gene. In addition, consumption of beef and pork was not associated with
the risk of colon and rectal tumours harbouring K-ras point mutations Consequently,
consumption of beef and pork seems to be of importance for colon and rectal tumours with a
K-ras wild type genotype and may, exert its action through another pathway than the K-ras
signalling route. The inverse associations for high consumption of pork can not readily be
explained and need replication in other studies. In general, multiple comparisons were
performed and. therefore, it could be that some of the observed associations are chance
findings. Therefore, caution is warranted in interpreting the results.
It is hypothesized that fat content of meat could influence CRC risk by increasing the
excretion of bile acids (3). The products of the bile acid excretion may act as tumour
promoters by a non-specific effect that increases cell proliferation in the mucosa layer (3).
However, total fat intake (32) as well as total fresh meat consumption were not associated
with overall colon and rectal cancer risk nor with K-ras mutation status. In the previous study
(32). only OJ-6 polyunsaturated fat (PUFA) was observed to be associated with specific K-ras
mutations, however, this type of fat is not predominantly present in meat.
In the current study, no clear association was observed for daily consumption of meat
products and overall colon and rectal cancer risk When the absence or presence of K-ras
mutations was taken into account in the current study, a high intake of meat products was
found to be positively associated with colon tumours with a wild type K-ras gene. As for high
consumption of beef, the high consumption of meat products may be positively associated
with colon cancer risk, although through another pathway than the K-ras signalling route. In
addition, subgroup analysis of specific point mutations in the K-ras gene showed that high
consumption of meat products is positively associated with rectal tumours harbouring a G>A
transition. This is in line with the biological evidence obtained in animal studies (33) and
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humans (13). A plausible explanation is the action of alkylating agents, such as
nitrosamines. Nitrosamines and their precursors are compounds observed in red and
processed meat (34) or can be endogenously formed (35). Alkylating DNA agents like
nitrosamines could generate 0®-methylguanines and these have been detected in human
colonic tissue (36) N-nrtroso compounds could also induce G>A transitions in codons 12 or
13 of the K-ras gene of rat colon carcinomas (33,37,38) or in human colonic tissue (35).
Why the association in our study is confined to the rectum and is not observed for the colon
remains unclear. A plausible explanation for differences in tumour site could be due to the
duration of contact with, and the concentration of, the potential dietary carcinogens like
nitrosamines. Possibly, the lower transit time of stool in the rectum as compared to the colon
leads to an increased exposure time for the rectum. However, more aetiological insight in
the underlying mechanisms is required to clarify this issue.
Our results suggest that total fresh meat and fish are not associated with colon or rectal
cancer risk or with the K-ras mutation status of these cancer types. A high consumption of
beef, pork and meat products is of importance, in particular for the aetiology of colon
tumours without a K-ras mutation Therefore, beef, pork and meat products may exert their
actions in colon cancer through another pathway, which does not depend on the K-ras
mutation status Regarding rectal cancer, a high consumption of meat products appears to
be a risk factor for G>A transitions in the K-ras gene.
In conclusion, although neither total fresh meat nor Fish appeared to contribute to the
risk of colon and rectal cancer, the consumption of beef, pork and meat products is
differentially associated with colon and rectal cancer risk depending on K-ras mutation
status.
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ABSTRACT
Associations between dietary intake of various fats and specific K-ras mutations in
colon and rectal cancer were investigated within the framework of The Netherlands Cohort
Study on diet and cancer.
After 7.3 years of follow-up and with exclusion of the first 2 3 years, 448 colon and 160
rectal cancer patients and 2948 subcohort members (55-69 years at baseline) were
available for data-analyses. Mutation analysis of the K-ras gene was performed on all
archival colon and rectal adenocarcinoma specimens. Case-cohort analyses were used to
compute adjusted incidence rate ratios (RR) and 95% confidence intervals (Cl) for colon and
rectal cancer cases and for K-ras mutation status subgroups.
Intake of total, saturated and monounsaturated fat was not significantly associated with
colon or rectal cancer. High intake of dietary polyunsaturated fat (PUFA) and, specifically,
linoleic acid is associated with an increased risk of mutated K-ras colon tumours. The RRs
for one standard deviation of increase of PUFA and linoleic acid were 1.21 (95% Cl 1.05-
1.41) and 1.22 (95% Cl 1.05-1.42). respectively and similar associations were observed for
both G>A transitions and G>T or G>C transversions in the colon. In contrast, no significant
associations were observed with rectal cancer risk, overall or with specific K-ras mutation
status.
A high intake of PUFA, in particular linoleic acid, may be an important dietary risk factor
for K-ras mutated colon tumours, possibly by generating G>A transitions or G>T or G>C
transversions in the K-ras oncogene.
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INTRODUCTION
The current epidemiological evidence for the association of total fat and specific fatty
acids with colorectal cancer (CRC) risk is controversial (1,2). The observed inconsistencies
could, in part, be due to the heterogeneity of the colon and rectal cancer endpoint that is
studied Associations may become more apparent when the molecular events involved in
colorectal carcinogenesis are taken into account.
The majority of colon and rectal tumours develops from small adenomatous polyps
through a well-defined sequence of cytological and morphological changes (3), a process
that is associated with the acquisition of somatic mutations (4,5) A genetic alteration that
occurs in adenomas (10%) as well as carcinomas (40%) in colon and rectal cancer, is the
oncogenic activation of the K-ras gene by mutations Activating mutations are mainly found
in codons 12 and 13 (4,6-8) The most frequently observed types of point mutations are G>A
transitions (8,9), and G>T and G>C transversions (10)
The link between fat intake and the pattern of mutations in human colon and rectal
cancer is not clear. Only a few epidemiological studies have been conducted up to date on
the association between the intake of fat and K-ras mutation status (11-14) and results are
inconsistent Experimental studies suggest that peroxidation of u>-6 poly-unsaturated fats
(PUFA) could lead to the accumulation of by-products like malondialdehyde (MDA) and
4-hydroxynonenal (4-HNE) These compounds could react with DNA to form adducts, mainly
the pyrimidopurinone adduct of deoxyguanosine (MiG) (15-17). The presence of the
M-|G-adducts resulted predominantly in G>A and G>T, with very few G>C transversions in
bacteria (16.18,19)
Consequently, exposures to specific dietary fat and fatty acids could contribute to the
heterogeneity of acquired genetic alterations in the K-ras oncogene observed in colon and
rectal tumours Associations between dietary intakes of fat and specific fatty acids and the
risk of specific point mutations in the K-ras oncogene in patients with colon and rectal cancer
were studied within the framework of the Netherlands Cohort Study on diet and cancer
(NLCS).
MATERIALS AND METHODS
Study Population
The participants in this study are incident, colon and rectal cancer cases and subcohort
members from the NLCS, which has been described in detail elsewhere (20). Briefly, the
study was initiated in 1986 and includes 58.279 men and 62,573 women, aged 55-69 years
old at baseline, who originated from 204 Dutch municipalities with computerized population
registries. A self-administered questionnaire on diet and other risk factors for cancer was
completed at baseline. The entire cohort is being monitored for cancer occurrence by annual
record linkage to the Netherlands Cancer Registry (NCR, nine cancer registries in the
Netherlands) and to PALGA, a nationwide network and registry of histo- and cytopathology
(www.palga.nl) (21). In the municipalities included in the NLCS, the NCR and PALGA,
together, have nearly 100% coverage since the start of the study (22-25). PALGA also
provides necessary information on the identification of the pathology laboratory location of
the storage of paraffin-embedded blocks of the eligible CRC patients Accumulation of
persontime in the cohort has been estimated through biennial vital status follow-up of a
subcohort of 3,500 men and women who were randomly selected after baseline exposure
measurement (21). Cases with prevalent cancer other than non-melanoma skin cancer were
excluded from the subcohort, which left 3,346 men and women for analysis.
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Table 1 Nutrient intake (mean ± SD) and
N
Sax (% Man)
A«a(y)
Far vanabfes'
Total (at (o/d)
Saturated M (g/d)
MUFA(gAJ)"
PUFA (g/d)"*
Lindenic aad (g/day)
LinoteK actd (g/day)
O0»rtf»fary factor)
Fiber (g/d)
AlcohoT(g/d)
Fruit (g/d)
Vegetable (g/d)
Energy (kcal/d)
Otfwr c/iaracfem/es
Ql (kg/nV)
Family history* (% Yes)
Smoker (%)
Never
Ex smoker
Current smoker
Physical activity (%)
<30 minutes/day
30-60 minutes/day
60-90 minutes/day
Subcohort
2948
48.2
61.3 ±4.2
83.8 ±158
33.2 ± 7 5
31.4 ±7.0
17.3 ±7.5
1.3 ±0.6
16.0 ±7.5
27 0 ± 8.2
10.1 ± 14.1
177.0 ±118.0
193 8 ± 82.2
1919.1 ±517.1
251 ±3.1
5.7
369
352
278
20.1
322
31.1
IS 4
other characteristics
W H type K-fas
297
51.5
62.7 ±4.0
84.3 ±15.4
33.5 ±6.9
31 7 ±6.5
17.2 ±7.3
16.1 ±7.3
1.2 ±0.5
26.7 ± 7.6
11.0 ±15.4
172.7 ±123.7
183.3 ± 78 2
1916.5 ±494.4
25.5 ± 3.2
13.5
36.7
43.1
202
19.7
33.7
29.6
of the study population at baseline
Colon cancer
Mutated K-ns
151
58.9
63.8 ±4.1
86.7 ±14.8
33.6 ±6.7
32.1 ±6.9
19.3 ± 7.6
1.3 ±0.6
18.0 ±7.7
27.7 ±8.8
10.8 ±14 2
176.9 ±122.2
198.0 ±87.0
1902.7 ± 472.9
25.8 ± 3.3
9.3
37.1
46.4
16.6
20.3
32.4
29.1
comparing c o m with at least one K-fas mutation to cases without a K-ras mutation
' adjusted for energy by the residual method (45)
" monounsaturated fat
" • polyunsaturated (at
l family history of CRC
The first 2.3 years of follow up were excluded due to incomplete coverage of PALGA
alone in some of the municipalities included in the NLCS. Within this period, 83 subcohort
members were either deceased or diagnosed with cancer other than non-melanoma skin
cancer, leaving 3,263 men and women for analysis. From 1989 till 1994, 929 incident cases
with h i s t o r i c a l l y confirmed C R C where observed of whom 819 could also be linked to a
PALGA report of the lesion. The PALGA database was used to identify and locate tumour
tissue in Dutch pathology laboratories. C R C was classified according to site as follows:
colon i.e. cecum through sigmoid colon ( ICD-O-1 codes: 153.0, 153 .1 , 153.2, 153.3, 153.4,
153.5, 153.6, 153.7, 153.8, 153.9), rectosigmoid ( ICD-O-1 code 154.0) and rectum ( ICD-O-1
code 154.1). Information about age at baseline, sex and family history of C R C (at baseline)
was retrieved from the NLCS database
Tissue Samples
This study is based on data of gene mutation analysis from C R C patients, described in
detail elsewhere (8). Briefly, tumour material of all C R C patients was collected after approval
by the Medical Ethics Committees of Maastricht University, the N C R and PALGA.
Subsequently, all pathology laboratories in The Netherlands agreed to make relevant tissue
samples available upon request from PALGA. Tissue samples of the 819 cases were
distributed among 54 pathology laboratories throughout The Netherlands Tumour tissue
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Table 1 Continued
RocW cancer
MM typo K<#ss
93
720
62.6 ±41
86 7 ±15 3
34 1 ±68
32 2 ±66
18 5 ± 8 9
1.2 ±0.6
174 ± 8 9
27 8 ± 8 0
13 8 ±17 6
184 3 ±145 8
192 9 ± 72 4
2027.3 ±517.4
24 9 ± 2 8
97
25J
41.9
324
185
275
32.6
21.7
Mutated ff<4M
67
55.2
62 2 ± 4 0
86 0 ±14 2
34 3 ± 6 9
32 5 ± 56
17 5 ± 8 2
13 ± 0 5
162±83
27 6 ± 78
11 2 ±12 2
180 7 ±129 9
188.0 ±110 6
1997 0 ±4491
25 5 ± 2 9
119
34.3
43.3
22.4
22.7
27.3
34.8
15.2
0.03
0.50
076
087
080
046
04*
0.41
087
030
087
074
070
020
068
03f
073
O.»4
0006
a
aw
054
0.006
0f8
0009
ao2
ft»
a 73
7
a«2
0.98
specimens collection started in August 1999 and was completed in December 2001 The
loss to follow-up of tissue samples of cases amounted to 5% Tissue samples from nine
patients reistered in one pathology laboratory could not be retrieved due to administrative
inconsistencies, leaving 810 tissue samples for collection. For 34 cases, paraffin-embedded
material was not available in the archives of pathology laboratories, leaving 776 cases for
the determination of the K-ras mutation status For 39 cases (5%), the K-ras mutation status
could not be determined, i.e. for 20 cases only normal colonic mucosa was available, 10
cases were revised with an benign adenoma (AdB) instead of an adenocarcinoma, for six
cases the yield of DNA was not sufficient enough to determine K-ras mutation status and for
three cases the available tissue did not include malignant CRC tissue. Finally, tumour
material from 737 incident colorectal adenocarcinoma cases was available of whom 476
were colon cancer cases, 85 were rectosigmoid cancer cases and 176 were rectal cancer
cases Statistical analyses were performed separately for colon and rectal cancer as
differences in the aetiology of colon and rectal cancer have been reported (1) Since the
rectosigmoid can be considered as a clinically applied term rather than an anatomically
defined transitional zone between the colon and rectum, patients with a rectosigmoid tumour
were excluded from data analyses. Moreover, the number of patients with a rectosigmoid
tumour was too small for adequate stratified analyses (8).
Detection of /T-res Mutations
Mutation analysis of the exon 1 fragment of the K-ras oncogene. spanning codons 8-29,
was performed on archival colorectal adenocarcinoma specimens of all 737 CRC patients
using macrodissection, nested Polymerase Chain Reaction (PCR) and direct sequencing of
66
Chapter 4
purified fragments, which has been described in detail elsewhere (8). The method of
mutation detection was validated by the confirmation of reported K-ras status in CRC cell
lines and a good correlation between fresh-frozen and routinely-fixed, paraffin-embedded
tissue. The detection limit was 5% mutated DNA. Duplo analyses revealed a good
reproducibility (88%) (8). Evaluation of mutation analysis and data entry was independently
performed by two observers (GR and ML).
The Food Frequency Questionnaire
The dietary section of the questionnaire was a 150-item semi-quantitative food
frequency questionnaire, which concentrated on habitual consumption of food and
beverages during the year preceding the start of the study Daily mean nutrient intakes were
calculated using the computerized Dutch food composition table (26), by cumulating the
multiplied frequencies and portion sizes of all food items with their tabulated nutrient
contents. The questionnaire was validated against a 9-day diet record (27). Crude and
energy-gender-adjusted (in parentheses) correlation coefficients were 0 72 (0 52) for total
fat, 0 73 (0 58) for saturated fat and 0 73 (0.75) for PUFA (27) For energy intake the
correlation coefficient was 0.74. On average, the questionnaire covered 91% of the record
intake explaining part of the underestimation of energy intake from the questionnaire data
(as presented in table 1) Questionnaire data were key-entered twice and processed for all
incident cases in the cohort and for all subcohort members in a manner blinded with respect
to case/subcohort status. This was done in order to minimise observer bias in coding and
interpretation of the data
For 257 subjects (28 incident colon adenocarcinoma cases. 16 incident rectal
adenocarcinoma cases and 215 subcohort members, two subcohort members were also
colon or rectal cancer cases), dietary data were incomplete or inconsistent, and they were
excluded from the analyses These subjects either 1) left 60 or more (out of 150)
questionnaire items blank and ate fewer than 35 items at least once per month and/or 2) left
one or more item blocks (groups of items, e.g., beverages) blank. Additional details are
given elsewhere (27). Hence, 608 colon and rectal cancer cases and 3048 subcohort
members were available for data analyses.
Intake of specific fatty acids was based on a food composition database with specific
fatty acids derived from the TRANSFAIR study (28). For this database, the hundred foods
that contributed most to fat intake in the Dutch dietary pattern were sampled and analysed
as methyl esters of the fatty acids present in the foods. In the database, total fat includes
triglycerides and other lipids such as phospholipids and sterols. The percentage of
triglycerides in total fat is assumed to be on average 93 percent, but varies across food
sources. Daily intakes of total fat (g/day), saturated fat (g/day), monounsaturated fat (MUFA)
(g/day), PUFA (g/day), and linolenic acid (g/day) and linoleic acid (g/day) as main
constituents of PUFA, were used as exposure variables. Linolenic and linoleic acid were
used as the most abundant sources of UJ-3 PUFA and w-6 PUFA. For data-analyses,
quartiles of the intake of fat and fatty acids were computed based on the distribution of
subcohort members. Daily intake of dietary fiber (g/day), alcohol (g/day), fruit (g/day),
vegetables (g/day) and total energy (kcal/day) and age at baseline (years), sex
(men/women), Body Mass Index (Ql; kgW), physical activity (<30 min/d, 30-60 min/d, 60-90
min/d, >90 min/d), family history of CRC (yes/no) and smoking status (never/ex/current)
were regarded as potential confounders.
Statistical Analysis
The overall frequency of K-ras mutations as well as the type of mutation was computed
for all colon and rectal cancer cases as described elsewhere (8) Fat intake was adjusted for
energy by the residual method (29) Mean values of the continuous variables age at
Fat and K-/ss mutations in sporadic colon and rectal canoar
baseline (years), intake of total fat. saturated fat. MUFA. PUFA. linolenic acid, linoleic acid,
dietary fiber, alcohol, fruit, vegetables and total energy and Ql were evaluated for subcohort
members and colon and rectal cancer cases with wild type and mutated K-ras gene.
Distributions in the categorical variables sex. family history of CRC. smoking status and
physical activity were evaluated for subcohort members and colon and rectal cancer patients
with wild type and mutated K-ras gene Differences in mean values of the
continuous variables and the distributions in categoncal vanables between patients with wild
type and mutated K-ras tumours were tested with the Student T-test and X^-test,
respectively, using the statistical software package SPSS (version 9)
Incidence rate ratios (RR) and corresponding 95% confidence intervals (Cl) for colon
and rectal cancer cases with wild type or mutated K-ras gene tumours were estimated
according to intakes of quartiles (with the lower quartile of intake regarded as the reference
group) and of one standard deviation (SD) of increase of intake of total fat. saturated fat,
MUFA. PUFA. linolenic acid and linoleic acid using Cox proportional hazards models with
the STATA statistical software package (intercooled STATA, version 7) The total person-
years at nsk. estimated from the subcohort. were used in the analyses (27) Standard errors
were estimated using the robust Huber-White sandwich estimator to account for additional
vanance introduced by sampling from the cohort This method is equivalent to the vanance-
covanance estimator as presented by Barlow (30) The proportional hazards assumption
was tested using the scaled Schoenfeld residuals (31) Using the backwards stepwise
procedure, all confounders were tested in the overall colon and rectal cancer models
separately Interactions between fat and specific fatty acid intake and sex were tested for
colon and rectal cancer separately and never found to be statistically significant Therefore,
results for men and women are presented together Finally, age at baseline, sex, family
history of CRC, smoking status. Ql and the intake of energy were confounders for either one
or both of the models and were therefore included as covanates for all models to be tested
Since 100 subcohort members had missing values for Ql. results in the tables will be
presented for 2948 subcohort members For each analysis, trends were evaluated with the
Wald test by fitting ordinal exposure variables (quartiles of intake) as continuous terms
RESULTS
The overall frequency and spectrum of mutations in the K-ras gene have been
presented in detail elsewhere (8). In brief, a total of 227 mutations was found in 218 (36%)
out of 608 colon and rectal cancer patients. The most frequently observed mutations are the
G>A transitions (54%), G>T transversions (33%) and G>C transversions (7%). The
observed frequencies of the point mutation are similar to the frequencies of the 737 CRC
cases, including rectosigmoid cancer cases, for whom K-ras status was determined (8).
Table 1 shows various types of fat intake and other baseline characteristics of the study
population. Colon and rectal cancer cases were more often men, were older, more
frequently reported a family history of CRC and had a higher daily alcohol intake as
compared to the subcohort Colon cancer cases with a mutated K-ras tumour were
significantly older, had higher daily intakes of PUFA, linoleic acid, fibers and vegetables than
colon cancer cases with a wild type K-ras tumour. There were no statistically significant
differences between colon cancer cases with a wild type K-ras tumour and a mutated K-ras
tumour in dietary intakes of total fat. saturated fat. MUFA, linolenic acid and other factors
presented in table 1 Rectal cancer cases with a mutated K-ras tumour were less frequently
men as compared to rectal cancer cases with a wild type K-ras tumour No statistically
significant differences between rectal cancer cases with mutated K-ras tumours and wild
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Table 2 Incidence rate ratios (RR) and 95% confidence intervals (Cl) for colon (N=448) and rectal
cancer patients (N=160) according to the intake of total fat and specific fatty acids
T o W M
Medton intake (g/d)
Women
cotan cancer cases
/•ctum cancer cases
per»<y?>«»»ffl
RR (95% CIF colon
rectum
RR (95% Cl)» colon
rectum
Saturated fat
Median intake (g/d)
men
Women
coton cancer cases
rectum cancer cases
person/Mrs
RR (95% Cl)> colon
rectum
RR(95%CIP colon
rectum
MUFA"
Median intake (g/d)
men
iimiieii
colon cancer caws
/•cft/m C « K » / c « w
person/ears
RR (95% Cl>2 colon
rectum
RR (95% Cl)= colon
rectum
PUFA"*
Median intake (g/d)
men
Women
coton cancer cases
rectum cancer cases
person/ears
RR (95% CIH colon
rectum
RR(95%CI)> colon
rectum
Llnolenlc add
Median intake (g/d)
men
Women
coAyi cancer cases
rectum cancer cases
personyears
RR (95% CIF colon
rectum
RR (95% Cl)> colon
rectum
1'
78.1
630
»f3
43
3657
1.00
1 00
1.00
100
269
239
fOf
43
3645
100
1.00
1.00
1.00
28.2
224
fOf
45
3660
1.00
100
1.00
1.00
11.6
8.8
95
47
3656
1.00
1.00
1.00
1.00
0.8
0.6
ros44
3642
1.00
100
100
1.00
Quartile of intake
2
90.3
71.5
f26
42
3675
109(0 82-143)
0 96(062-149)
1.09(0.82-1.44)
0 89(0 56-139)
33.7
278
f23
35
3703
120(0 90-159)
080(0.50-1.26)
1 19(0.88-1.60)
0 79(0 49-128)
33.2
26.1
f24
34
3650
1.23(0.92-1.63)
0.76(0.48-1.21)
1.19(0.89-1.60)
0.70(0.44-1.13)
16.0
12.4
f24
33
3683
1 35(1 01-1.81)
0.71(0.45-1.13)
1.38(1.02-1.86)
0.74 (0.46-1.19)
1.2
0.9
toe
40
3684
0.97(0.73-1.30)
0.89(0.57-1.38)
0.95(0.70-1.30)
0.91 (0.57-1.47)
3
96.5
77.6
05
34
374f
0 80(0 60-108)
0 75(0.47-1.20)
0.74(0.55-1.01)
0.74(0.46-1.19)
38.3
31.0
40
3709
1 14(0.85-1.51)
1.04(0.67-1.59)
1 10(0 82-1 49)
102(0 65-1.59)
36.9
28.9
ff»
47
37f4
1.17(0.88-1.56)
0.91(0.59-1.41)
1.12(0.82-1.51)
0.91 (0.57-1.44)
20.9
16.2
ftt
39
3726
1.23(0.92-1.66)
0.84(0.54-1.30)
1.24(0.91-1.68)
0.86(0.55-1.34)
1.5
1.2
124
36
3657
1.15(0.87-1.52)
0.81(0.51-1.28)
1.10(0.82-147)
0.87(0.55-1.38)
4
109.1
853
ff4
40
3664
0.99(0.74-132)
0.92(0.59-1.44)
0.95(0.71-1.27)
0.86(0.55-1.36)
45.8
366
J05
36
3679
0.97(0 72-1.30)
0 80(0.51-1 26)
0 93(0 69-1 26)
0.73(0.46-1.17)
425
33.0
4(7
37f3
1.03(0.76-1 37)
0.89(0.57-1.38)
0.98(0.73-1.33)
0.87(0.56-1.37)
29.1
22.5
ff6
41
3667
1.24(0.92-1.66)
0.87(0.56-1.34)
1.21 (0 89-1.64)
0.83(0.53-1.29)
2.0
1.6
?08
40
3750
1 01 (0 76-1.35)
0.90(0.58-1.41)
1.01 (0.75-1.36)
0.91(0.58-1.44)
Pfor
(rend
0.49
0.52
0.28
0.4^
0.72
0.58
0.5J
0.37
0.97
0.77
0.77
0.80
0.26
0.68
0.37
0.54
0.65
0.59
0.70
0.67
RR (95% Cl) for
one SD increase
in intake*
1.02(0.90-1.15)
0 94(0.78-1.13)
1.00(0.88-1.13)
0.91(0.76-1.09)
0.98(0.89-1.09)
0.97(0.83-1.15)
0.97 (0.87-1 08)
0 95(0.80-1.12)
1.00(0.89-1.11)
0.93 (0 79-1.10)
0.99(0.88-1.12)
0.93(0.78-1.11)
1.05(0.96-1 16)
1.00(0.84-1.19)
1.03(0.94-1.14)
0.98(0.83-1.16)
0.99(0 90-1.09)
0,94 (0.79-1.11)
0.98(0 89-109)
0.95(0.80-1.12L
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Table 2 continued
QuartkoflntakT
Flor O M S O I A C I M Mtnlntokt*
RR(95%O>> colon 1.00
rectum 1.00
138(102-186)
0.74 (0.46-1.19)
124(091-168)
0.86(0 55-1.34)
121(0.89-1.64)
0.83(0.53-1.29)
037
0.54
1.03(0.94-1.14)
0.96(0.83-116)
UnoWcadd
MM
Wbmn
cotoftcanovci MS
/•dumcanoircaiK
fwrsonyears
RR(95%CIH
RR(95%CI)>
colon
rectum
colon
rectum
vgybytwn
10.0
7.4
9f
4f
365S
1.00
1.00
1.00
1.00
wdutfmtf
14.8
111
f26
40
3700
144(107-192)
0 98(063-154)
149(110-2.02)
1.03(065-1.64)
»d(«5)
195
14.9
ff3
35
3699
129(096-1.73)
0.86(0.54-1.37)
1.32(0.97-180)
090(0 56-145)
27.9
21.2
ff«
44
3676
130(097-1.75)
106(068-164)
131(0 97-177)
103(066-162)
Of 7
096
Of 9
096
107(097-1 18)
102(086-121)
1.06(0.96-1.17)
100(0.84-1.18)
•
moncuiuluraM f«
type K-ras tumours were observed for total fat, specific fatty acids and other (dietary)
factors.
Associations between the intake of total fat. saturated fat. MUFA, PUFA. llnolenlc add
and hnoleic acid with the risk of colon or rectal cancer are presented in table 2 Incidence
rate ratios (RR) and 95% Cl for colon and rectal cancer are adjusted for age and sex and for
age, sex, smoking, Ql, energy intake and family history of CRC The age-sex adjusted RR
and the multivariate RR were similar. Frequent consumption of total fat, saturated fat,
MUFA, PUFA, linolenic acid and linoleic acid were all not associated with the risk of colon or
rectal cancer (table 2).
Associations of total fat, saturated fat, MUFA, PUFA, linolenic and linoleic acid with wild
type K-ras tumours and mutated K-ras tumours in the colon or rectum are presented in table
3 Results will first be discussed for wild type K-ras tumours No clear associations were
observed for high intakes of total fat, saturated fat. MUFA, PUFA, linolenic acid and linoleic
acid and the risk of colon and rectal cancer with a wild type K-ras gene With regard to the
colon mutated K-ras tumours, positive associations were observed for high intakes of PUFA
(RR for highest versus lowest quartile of intake 2.09, 95% Cl 1.25-3.49, pt,.no 0 002) and
specifically linoleic acid (RR for highest versus lowest quartile of intake 2.19. 95%CI 1 30-
3 67, p^nd 0 002), but not linolenic acid. These positive associations were also observed for
one SD of increase of intake (table 3) No significant associations were observed for rectal
mutated K-ras tumours and for highest versus lowest intakes of total fat, saturated fat,
MUFA and linolenic acid and colon and rectal cancer with mutated K-ras tumours
Subgroup analyses were performed to evaluate the associations between total fat,
saturated fat, MUFA, PUFA, linolenic acid and linoleic acid intakes and specific types of
K-ras point mutations (G>A transitions and G>T or G>C transversions) in colon and rectal
tumours (table 4). High intake of PUFA and specifically linoleic acid showed positive
associations with colon tumours harbouring G>A transitions (RR for highest versus lowest
quartile of intake 1.95, 95% Cl 1.01-3.77 and RR 1 80. 95% Cl 0 92-3.51, respectively) or
G>T or G>C transversions (RR 2.17. 95% Cl 0.98^ 80 and RR 2.69, 95% Cl 1 19-608,
respectively) These positive associations were also observed for one SD of increase of
intake (table 4). There were no associations found between PUFA and linoleic acid intake
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Table 3 Adjusted
mutated
RR' for colon and
K-ras gene (K-ras*
1» 2
rectal cancer patients with wild type K-ras gene (K-ras) and with
) according to the intake of total fat and specific fatty acids
Quertile offcrtafc*
3 4
Pfor
trwtd
RR (95% Cl) for
one SD increase
in intake*
Total f i t
coton 75/35
wcfum 25/18
RR«»(95%CI) colon 100
rectum 1.00
RR«..(95%CI) colon
rectum
1.00
1.00
81/44
26/13
104(0.74-1.45)
1.00(0.57-1.76)
1.19(0 75-1.90
0.72 0.35-1.51
57/32
2f/t2
0.71 (0 49-1 02)
0.80(0.44-1.47)
0.82(0.49-1.36
0.65 0.31-1.37
77/33
16/22
0 99(0 70-1.38) 0.48
0.63(0.33-1.20) O.tf
0.88(0.54-1.44)
1.18(063-2.23)
0.32
0.65
0 98(0 84-1.13)
0 81 (0.64-1.02)
1.03(0.84-1.26)
1.07(0.81-1.41)
Saturated M
Caws (K-r»svX-«3+j
coton
recfc/m
RR*»(95%CI) coton 100
rectum 1.00
6<V39
RrW(95%CI) colon
rectum
100
1.00
06/34
21/13
142(099-2 02)
0.82(0.45-152)
085(0 52-138
0.75 0.35-1.59
7609
26/18
122(0.84-175)
102(0 57-180)
0.92(0.58-148)
1.02(0^2-2.01)
6&O2
17/16
1 06(0 74-1 54)
0 64(0 34-1 21)
0.73(0.45-118]
0.86 0.43-1.72
0.96
0 28
0.26
0.89
101(0.89-1.15)
0.86 (0.70-1 06)
0.90(0.75-1.07)
1.08(0.85-1.39)
MUFA
RR«» (95% Cl)
RR,—(95XCI)
coton
recfum
colon
rectum
coton
rectum
6f/37
29/15
100
100
100
1.00
81/41
19/12
127(0 89-1.82)
064(0.35-1.17)
1.06(0.66-1.70]
0.81 (038-1 76
73/40
21/f9
1 16 (0.80-1 68)
0 71(0 39-1.28)
1.04(0.64-1.69)
1.31 (0.64-2.68)
75/26
1 18(0.82-1.68)
0 69(0 38-1.24)
0.67(0.40-1.13)
1.22(0.61-2.44)
0.53
0.27
014
034
1.01(0.88-1.17)
0.82(0.64-1.06)
0.94(0.77-1.16)
1.10(0.89-1.37)
PUF*
Cases fK-/as-/K-/as+)
coton 66V23
recfum 24/21
R R K « . (95% Cl) colon 1.00 1 36(1.00-1.91)
0 76(041143)
25/14
1.05(0.73-1.49)
63/49
22/16
0.91 (0 63-1.31) 0.32
rectum 1.00  6(0.41- .  1.03(0.58-1.82) 0.89 (0.49-1.62) 0.96
RRj«..(95%CI) coton
rectum
1.00
1.00
1.44(0.82-2.52)
0.72(0.36-1.45)
1.83(1.08-3.11)
0.67 (0.33-1 34)
2.09(1.25-3.49)
0.75(0.39-1.44)
0.002
0.38
0.94(0.83-1.07)
0.97(0.78-1.21)
1.21 (1.05-1.41)
0.99(077-1.27)
Llnownlc acid
Cases (K-r8SiK-ras+)
coton 69/38
recrum 30/12
RR««(95%CI) colon 1.00
rectum 1.00
R R K ~ . ( 9 5 % C I ) colon 1.00
rectum 1.00
7W3
2f/17
1.02(0.70-1.46)
0.65(0.36-1.18)
0.84(0.50-1.41)
1.57(0.71-3.50)
7*38
18/18
1.16(0.82-1.64)
0.57(0.32-1.04)
1.00(0.62-1.60)
1.62(0.76-3.45)
71/35
20/18
1.05(0.74-1.49) 0.63
0.66(0.37-1.17) 0.T4
0.95(0.59-1.55)
1.54(0.73-3.25)
0.97
0.27
0.95(0.85-1.08)
0.86 (0.70-1.11)
1 04 (0.88-1.23)
1.07(0 88-1.29)
Unolelc add
Cases (K-rasvK-ras+)
coton
rectum
fVW(95%CI) coton
rectum
RfW(95%CI ) coton
rectum
64^2
20/19
1.00
1.00
1.00
1.00
89/33
26/13
1.46(1.03-2.06)
1.32(0.73-2.39)
1.60(0.92-2.80)
0.72(0.34-1.51)
72/40
20/15
1.14(0.79-1.63)
0.99(0.53-1.86)
1.87(1.09-3.22)
0.81 (0.40-1.63)
65/49
23/18
1.01 (0.70-1.45) 0.63
1.12(0.61-2.07) 0.97
219(1.30-3.67)
0.93(0 48-1.79)
0.002
09f
0.97(0.86-1.10)
0 99(0.80-1.23)
1.22(1.05-1.42)
1.00(0 77-1.29)
' MuWvartal* tdjusM RR lor age. sex. 01. smoking, energy intake and family history of CRC and their 95% confidence intervals and adjusted
tor tnetgy by the residual method (45)
' rtfectnc* category of qoartles of intake
• see for one standard deviation of increase table 1
" monounsaturated fat
"'pofyunsaturated fat
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and rectal tumours with G>A transitions or G>T or G>C transverstons In addition, no
significant associations were observed between highest versus lowest quartile of intake of
total fat. saturated fat. MUFA and Imolenic acid and the risk of G>A transitions or G>T or
G>C transverstons in colon and rectal tumours.
DISCUSSION
In this study, no associations were observed between intakes of specific fats or fatty
acids and overall colon and rectal cancer risk However, associations were observed when
taking into account the presence or absence of specific point mutations in the K-ras gene of
colon and rectal cancer patients No significant associations were observed for total fat,
saturated fat, and MUFA intakes and the nsk of colon and rectal tumours without or with a K-
ras mutation In contrast, positive associations were observed for high intake of PUFA,
specifically linoleic acid but not linolenic acid, and the risk of colon tumours harbouring K-ras
oncogene mutations Subgroup analyses of specific point mutations in the K-ras gene
revealed that these positive associations were observed for G>A transitions and G>T and
G>C transversions
This cohort study on fat and specific fatty acids intake in relation to specific K-ras
mutations in colon and rectal cancer is, to our knowledge, the only prospective study
performed to date One large case-control study with colon cancer patients (11), two case-
control studies of limited size among colon (13). and colon and rectal cancer patients (12)
and one cross-sectional case-case study with colorectal adenoma patients (14) have
previously been conducted The prospective design of the current study and high
completeness of follow-up of cancer incidence and subcohort. make information and
selection bias unlikely In addition, as a result of the exclusion of the first 2 3 years of follow-
up, the chance of information bias due to potential preclinical colorectal cancer is minimal.
Finally, tumour tissue was available for 84% of the eligible cases (776 out of 929) and there
were no significant differences in fat intake levels nor in clinicopathological characteristics of
the tumour (Dukes' stage and differentiation grade) of these patients compared to the CRC
patients with a known K-ras mutation status of their tumour (data not shown) Therefore,
selection bias due to loss to follow-up is unlikely.
In general, the validation of the fat intake variables was satisfactory (see methods
section and (27)). Although total fat intake and energy intake may have been under-
estimated as compared to the nine-day record method in the validation study (27) and, in
addition, there is inevitably a certain degree of misclassification of fat intake variables, it is
not expected that this is differential with respect to the K-ras mutation status of the tumour
Therefore, the associations observed in this study are probably attenuated In other
epidemiological studies similar inaccuracies occur in the measurement of fat intake since
similar methods of intake assessment were employed (11,12,14).
One of the hypotheses for the association between fat intake and CRC is that meat
consumption instead of fat intake determines the increased risk We also investigated meat
consumption as a potential risk factor for K-ras mutations in colon and rectal cancer, and
total fresh meat was not associated with risk Therefore, we did not additionally adjusted for
this potential confounder in these analyses.
In the current study, a high intake of total and saturated fats was not associated with
overall colon or rectal cancer risk and with K-ras mutation status and these findings are
supported by others (11,13,14) Bautista ef a/(12) observed an inverse association between
a high intake of total fat and colorectal tumours with a K-ras wild type gene (odds ratio for
highest versus lowest tertile of intake 0.47, 95% Cl 0.22-0.99) However, the results were
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Table 4 Adjusted RR' for colon and rectal cancer patients with G>A transitions or with G>T or G>C
transversions in the K-ras oncogene according to the intake of intake total fat and specific
fatty aods
Quartfla of fritatT
1»
T»(95%CI)for
Pfor one SO increase
fraud in intake*
ToUlfat
Cases ( G v f O T or Q
coton
rectum
RRo>« (95% Cl) colon
rectum
RR»T.C(95%CI) coton
rectum
20/f5
12/7
100
100
1.00
100
23/20
6/7
111 (060-2.07)
0.45(0.17-1.22)
17/12
6/7
0.78(0.40-1.52)
043(0.16-1.19)
22/9
9/ff
1.02(0.54-1.90)
0.74(0.31-1.79)
0.79
0.50
126(064-2.48) 0 72(0 33-1.56) 0.57(0.25-1.30) 0.07
1.09(0 37-3.20) 1.07(0.37-3.11) 1.50(0.58-3.89) 0.42
1.09(0.82-1.44)
0.87(0.57-1.32)
0.90(0.69-1 17)
1.17(084-1 63>
Saturated ftt
RROM(95%CI)
RRO>TC(95%CI)
coton
recfi/m
coton
rectum
colon
rectum
23/J4
100
100
100
100
f6/f7
SB
0 69(0 36-1.34)
0 51 (0 17-1 55)
23/J5
13/3
0 95(0 52-174)
131(0.55-3.10)
20/JO
6/fi
076(041-142)
0.64(0.23-1.84)
060
0 88
1.19(0 57-2.47) 1.00(047-210) 063(0.28-143) 0 2?
0.91(0.34-2.44) 0.33(0.08-125) 1.07(045-2.55) 0.84
0 95(0.75-1 19)
1 01 (0.70-1.45)
0 79(0 62-101)
1.15(0.80-1.64)
M U M "
RR»,(95%CI)
RRo.ic(95%CI)
g
coton
rectum
colon
rectum
colon
rectum
P0FA™
Cases (G>/VG>r or Q
fO/4
100
100
100
1.00
2f/ffl
6/7
109(0.57-2.09)
0 53(019-146)
101(0 51-198)
2.00(0.57-7.07)
2S/f3
7/f3
134(0.70-2.56)
0 59(0 22-166)
0 72(0 34-151)
4.00(1.25-12.8)
J7/8
JO/8
0.84(043-1.66)
0 96 (040-2.33)
0.46(0.20-1.07)
1.93(0.57-6.56)
0.78
099
O.f2
1.05(0.80-1.39)
1 06(0 71-1 60)
0.78(0.60-1.02)
1.12(0.91-1.37)
RR<M (95% Cl)
RRO»T.C(95%CI)
coton
recfum
colon
rectum
colon
rectum
J4/9
rt/to
1.00
1.00
1.00
1.00
J8/J3
&9
1.44(0.71-2.94)
0 51 (0.18-1.43)
1 51 (0.64-3 60)
1.10(0.44-2.74)
tf/4
1 76 (0.89-3.49)
0.86(0.35-2.11)
1 57 (0.67-3.70)
0.45(0.14-1.46)
27/20
1.95(1.01-3.77)
0.42 (0.14-1 20)
2.17(0.98-4.80)
0.94 (0.38-2.30)
0.04
0.2?
0.06
0.59
1.18(0.97-1.42)
0.80(0.57-1.12)
1.24(0.98-1.57)
1.02(0.72-1.45)
Llnolenic add
Cases(G>A/G>rorg
coton
recfum
RRo,<(95%CI) colon
rectum
RRO»T.C(95%CI) colon
rectum
100
1.00
1.00
1.00
0 54(0.26-1.11)
1.04(0.33-3.28)
1.26(0.57-2.80)
1.91 (0.64-5.66)
24/J4
9/Jf
1.02(0.57-1.85)
1.39(0 47-4.04)
1 00 (0.47-2 14)
2.21 (0.81-6.03)
2f/fO
0.91 (0 49-1.70)
1.75(0.62-4.95)
0.75(0.32-1.72)
1.09(0 35-3.38)
0.79
0.22
0.38
0.75
1.04(0.83-1.29)
1.21 (0.92-1.59)
0.95(0.73-1.25)
0.92(071-1.20)
Linolwc acid
Cases fG>/VG>7"orC)
coton
rectum
RRc* (95% Cl) colon
rectum
RRO>T.C(95%CI) coton
rectum
ff/fO
1.00
1.00
1.00
1.00
6/7
1 51 (0 75-3.07)
0.56(019-1.60)
1.83(0.76-4.40)
0.83 0.31-2.27
24/t2
185(0 93-3.66)
0 89 (0 35-2 26)
1.52(0.61-3.77)
0.70(0 25-1.94)
2W2
7/9
1.80(0.92-3.51)
0 65 (0.24-1 74)
2.69(1.19-6.08)
0.94(0 38-2.31)
0.06
0.59
0.03
0.83
1.19(0.98-144)
0.81 (0.57-1.15)
1.27(1.00-1.61)
1.06(0.74-1.53)
Multvanate adjusted RR tor age, sex. 01. smoking, energy intake and family history of CRC and their 95% confidence intervals and adjusted
for energy by the residual method (45)
reference ditgory of qmrtte of intake
i e * for one standard deviation of increase table 1
* monounsaknMfat
"potyunsatmMW
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based on only 108 CRC cases in a population-based case-control setting, and therefore
estimates of associations must be interpreted with caution.
Animal studies indicated an inverse association of high MUFA intake, derived mainly
from oleic acid with CRC risk (32.33) However, in epidemiological studies, no clear
associations were observed with CRC nsk (34-36) Regarding the K-ras mutation status, no
associations were observed for high intake of MUFA and the nsk of colon and rectal cancer
in the current study This is in line with Slattery's observation (11) However. Bautista ef a/
(12) observed that a high intake of MUFA was inversely associated with the risk of having a
witd type K-ras gene This study was conducted in Spain where the mam source of oleic
acid is olive oil This is not the case for the current cohort and could be an explanation for
the different findings The association was not reported in the other studies (13,14)
To our best knowledge, this is the first study reporting on specific polyunsaturated fatty
acids in relation to K-ras mutation status Overall PUFA intake was studied by Slattery ef a/
(11) and Bautista er a/ (12) and no associations were observed with K-ras mutation status
In the current study, no clear associations were observed between the high intake of
linolenic acid as the main source of w-3 PUFA, and the nsk of colon or rectal cancer with or
without specific point mutations in the K-ras gene Epidemiological, clinical, and
experimental data indicate a protective effect of fish oil-derived u>-3 PUFA on overall colon
cancer (35,37-44) Collect ef a/ (37) demonstrated that the major UJ-3 PUFA constituent of
fish oil. docosahexaenoic acid (DHA) reduces the Ras protein localization to the plasma
membrane without affecting posttranslational lipidation and lowers the GTP-binding of the
Ras protein in mouse colonocytes treated with azoxymethane (colon carcinogen) These
findings were corroborated by /n wvo studies (45) Another hypothesis is that the tumour-
promoting activity of o>-6 PUFA was abrogated by competitive inhibition of w-3 PUFA from
the metabolism of arachidonic acid and therefore reducing malondialdehyde (MDA) levels
and subsequently pyrimidopurinone-deoxyguanosine (M-|G) adducts MiG>T and MiG>C
transversions (38). Summarized, w-3 PUFA may exert their effect through inhibition of the
Ras protein activity and not by generating functional aberrations in the exon 1 fragment of
the K-ras oncogene This could explain the lack of association between linolenic acid and K-
ras mutation status of colon or rectal tumours in this study.
In the current study, no significant association was observed for Imoleic acid, as the
main source of io-6 PUFA intake, and the overall risk of colon or rectal cancer. This is in line
with most epidemiological evidence up to date (46) However, a positive effect was found
between high intake of linoleic acid and colon tumours harbouring K-ras gene mutations
Subgroup analyses of specific point mutations in the K-ras gene revealed that colon tumours
harbouring G>A transitions or G>T or G>C transversions are positively associated with high
linoleic acid intake. These associations are in line with the biological evidence (16,18) and
are possibly the result of an increased formation of G-adducts resulting in G>A transitions or
G>T or G>C transversions. Increased intake of UJ-6 PUFA enhances tumongenesis in
experimental animals and in vitro systems by several mechanisms (47) The conjugated
double bonds in poly-unsaturated fatty acids are highly sensitive to lipid peroxidation, and
may generate fatty acid hydroperoxides. These hydroperoxides will be reduced by
glutathione peroxidase to non-reactive fatty acid alcohols or may react with metal ions to
yield alkoxyl radicals. The fatty acid alcohols do not lead to DNA damage and will not be
discussed further. However, alkoxyl radicals are reduced to aldehydes, with 2,3-epoxy-4-
hydroxynonanal (4-HNE) and MDA as the most prominent forms. The bifunctional alkylating
agent 4-HNE can react with DNA to yield etheno and other base adducts which are thought
to promote the carcinogenic process. Etheno-dG induces mainly transitions to A and
transversions to T in bacteria (16,33,48,49) and etheno-dC induces transitions to T in the
kidneys of monkeys (50) MDA is a major genotoxic carbonyl compound, which is also a
by-product of the arachidonic acid metabolism in the synthesis of prostaglandines. MDA is
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mutagenic in bacterial and mammalian cells, and carcinogenic in rats (18). MDA reacts with
DNA to form adducts, predominantly with deoxyguanosine to generate MiG (15). The most
common mutations in progeny molecules are G>T transversions and G>A transitions, with a
minor contribution by G>C transversions (16,18,19). In the current study, the associations
with G>A transitions, G>T and G>C transversions in the K-ras oncogene were only
observed for colon cancer patients and not for rectal cancer patients. The reason for this
apparent difference in the aetiology remains unclear. In addition, the observed significant
association found for colon cancer could be a result of a type I error due to the numerous
associations analysed in this study Although the studied associations were mainly
hypotheses-driven, caution is warranted in interpreting these results and further
investigations are needed
Our results suggest that PUFA, and in particular linoleic acid, is an important dietary risk
factor for colon tumours with K-ras mutations possibly by generating G>A transitions or G>T
or G>C transversions in the exon 1 fragment of the K-ras oncogene This implies that, for
some dietary exposures like polyunsaturated fat intake, it is meaningful to account for
somatic mutations in the K-ras oncogene in the aetiology of colon and rectal cancer.
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Dietary folate and K-<as mutations in sporadic colon and I
ABSTRACT
The association between dietary folate and specific K-ras mutations in colon and rectal
cancer was investigated in The Netherlands Cohort Study on diet and cancer
After 7.3 years of follow-up. 448 colon and 160 rectal cancer patients and 3048
subcohort members (55-69 years at baseline) were available for data-analyses Mutation
analysis of the K-ras gene was performed on all archival adenocarcmoma specimens. Case-
cohort analyses were used to compute adjusted incidence rate ratios (RR) and 95%
confidence intervals (Cl) for colon and rectal cancer overall and for K-ras mutation status
subgroups according to 100 pg/d increased intake in dietary folate
Dietary folate intake was not significantly associated with colon cancer risk for men or
women, either overall or with K-ras mutation status For rectal cancer, high folate intake was
inversely associated with the disease risk in men and was most pronounced for K-ras
mutated tumours, whereas an increased association was observed for women Regarding
the K-ras mutation status in women, an increased association was observed for both wild
type and mutated K-ras tumours Specifically, folate intake was positively associated with
G>T and G>C transversions in rectal tumours (RR 2 69. 95% Cl 1 43-5.09), but inversely
associated with G>A transitions (RR 0.08, 95% Cl 0 01-0.53)
Our data suggest that the effect of folate intake on rectal cancer risk is different for men
and women, and depends on the K-ras mutation status of this cancer type.
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INTRODUCTION
To date, results from epidemiological studies (1^4) generally show an inverse
association between dietary folate and the nsk of colorectal cancer (CRC) However,
associations may be different for men versus women and for colon versus rectum (4,5) In
addition, the results from most animal studies support the epidemiological data, but results
were not always consistent (1.2)
Folate plays an important role in one-carbon metabolism, a series of interrelated
biochemical reactions involved in DNA synthesis and methylation of DNA, RNA, and
proteins (6) in animals and humans Two pathways have been described linking a low folate
status to colon and rectal carcinogenesis (6,7) First, a deficient intracellular form of folate, 5,
10-methylenetetra-hydrofolate (5, 10-methyieneTHF) leads to a decreased availability of
methyl groups for uracil which may result in less available thymine Eventually, the
increased uracil incorporation in DNA may lead to DNA strand breaks and chromosome
instability Secondly, sub-optimal folate status may result in global DNA hypomethylation
and regional hypermethylation in gene promoters which interferes with gene expression and
can impair DNA repair (8.9) DNA strand breaks, global DNA hypomethylation and regional
promoter hypermethylation are common events in colon cancer
The association between folate and CRC was evaluated earlier in The Netherlands
Cohort Study on diet and cancer (NLCS). based on 7 3 years of follow-up (3,10). In this
study (3), the association between folate intake and colon cancer tended to be inverse for
men and women after the exclusion of the first year of follow-up, but did not reach statistical
significance For rectal cancer, folate was inversely associated with the disease risk in men,
although borderline significant, but not in women Evaluating these findings, it would be
interesting to study the association between dietary folate and CRC when specific mutations
in genes involved in colorectal carcinogenesis are taken into account.
The oncogenic activation of K-ras by mutations is a genetic alteration that occurs in
adenomas (10%) as well as in carcinomas (40%) in colon and rectal cancer. Activating
mutations are mainly found in codons 12 and 13 (11-14) The most frequently observed
types of point mutations are G>A transitions, and G>T and G>C transversions (14-16).
Possibly, the G>A transitions frequently observed in the K-ras gene are a result of impaired
promoter methylation of the DNA-repair gene O^-methylguanine DNA methyltransferase
(MGMT) (9) which could, in part, be due to a low folate status (10).
To date, only three epidemiological studies report on the association between folate
intake and K-ras mutation status in colorectal adenomas (7) and in colon(rectal) tumours
(17.18) with varying results However, it is difficult to compare the results from different
studies due to differences in case groups and reference groups. In the current study, the
association between dietary folate intake and the risk of specific point mutations in the K-ras
oncogene in patients with colon and rectal cancer were studied for men and women within
the framework of the NLCS.
MATERIALS AND METHODS
Study Population
The participants in this study are incident colon and rectal cancer cases and subcohort
members from the NLCS, which has been described in detail elsewhere (19) Briefly, the
study was initiated in 1986 and includes 58,279 men and 62,573 women, aged 55-69 years
old at baseline, who originated from 204 Dutch municipalities with computerized population
registries A self-administered questionnaire on diet and other risk factors for cancer was
completed at baseline The entire cohort is being monitored for cancer occurrence by annual
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Table 1 Nutrient intake (mean ± SD) and other characteristics among colon cancer cases and
subcohort members
N
Age(y)
FoMe(ug/day)
Of/wr dierary /actors
Alcohol (g/day)
Fiber (g/day)
Energy (kcal/day)
Fresh meat (g/day)
Vitamin B6 (mg/day)
Vitamin C (mg/day)
Iron (mg/day)
Methionine (g/day)
Offwc/iaracferitfci
Ql (kg/m>)
Family history (% Yes)
Smoker (%)
Never
Ex smoker
Current smoker
Physical activity (%)
<30 minutes/day
30-60 minutes/day
60-90 minutes/day
>90 minutes/day
Subcohort
1475
61 3 ±4.2
224 2 ± 72.0
14.5 ±16.4
28 7 ± 8.8
2165.6 ± 512.1
105.9 ±43.3
1.5 ±0.4
981 ±41.5
13 2 ± 3 2
1.7 ±0.4
25.0 ± 2.6
57
13.4
51.3
353
15.0
297
348
204
WHd type K-ret
153
62.5 ± 4.2
225.4 ± 62.9
15.7 ±16 4
28.8 ± 7.2
2157.1 ±452.6
101.5 ±35.9
1.6 ±0.3
100.9 ±41.5
13.5 ±2.9
1.7 ±0.4
253 ± 2.6
13.7
11.8
62.1
26.1
106
31.8
325
25.2
Men
Colon cancer
K-fts mutation
89
63.7 ±4.2
2251 ±83.6
15 6 ± 15 9
29.7 ± 8 9
2069.4 ± 438.6
103.6 ± 36.9
1.6 ±0.4
108.5 ±42.9
13 7 ±3.3
1.7 ±0.4
25.9 ± 3.1
11.2
11.2
674
213
11.4
27.3
386
22.7
p-vafoe*
0(W
0.97
0.95
0.40
0 J4
0.66
0.90
018
0 68
0.16
Off
0.58
0.67
0.76
• comparing c a m wlih at least one K-ras mutation to cases vrilhout a K-fss mutation
' 2 oul o( 89 male colon cancer cases had more than one K-ras gene mutation
M oul o( 62 (emale colon cancer cases had more than one K-ras gene mutation
' For 41 subcohort members and 6 colon cancer cases, information on physical activity was not available
record linkage to The Netherlands Cancer Registry (NCR, nine cancer registries in The
Netherlands) and to PALGA, a nationwide network and registry of histo- and cytopathology
(www.palga.nl) (20). In the municipalities included in the NLCS, the NCR and PALGA,
together, have nearly 100% coverage since the start of the study (21-23). PALGA also
provides necessary information on the identification of the pathology laboratory location of
the storage of paraffin-embedded blocks of the eligible CRC patients. Accumulation of
persontime in the cohort has been estimated through biennial vital status follow-up of a
subcohort of 3,500 men and women who were randomly selected after baseline exposure
measurement. Cases with prevalent cancer other than non-melanoma skin cancer were
excluded from the subcohort, which left 3,346 men and women for analysis.
The first 2.3 years of follow-up were excluded due to incomplete coverage of PALGA
alone in some of the municipalities included in the NLCS. Within this period, 83 subcohort
members were either deceased or diagnosed with cancer other than non-melanoma skin
cancer, leaving 3,263 men and women for analysis. From 1989 till 1994, 929 incident cases
with histologically confirmed CRC were observed of whom 819 could also be linked to a
PALGA report of the lesion. The PALGA database was used to identify and locate tumour
tissue in Dutch pathology laboratories. CRC was classified according to site as follows:
colon i.e. cecum through sigmoid colon (ICD-O-1 codes: 153.0, 153.1, 153.2, 153.3, 153.4,
153.5, 153.6, 153.7, 153.8, 153.9), rectosigmoid (ICD-O-1 code 154.0) and rectum (ICD-O-1
code 154.1). Information about age at baseline, sex and family history of CRC (at baseline)
was retrieved from the NLCS database
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Table 1 Continued
Subcohort
M M type J M N
WotlMfl
Colon cantor
13M
614 ±43
199.8 ±64.7
5 7 ± 94
25.5 ±7.2
169141408 5
93.8140 4
1.3 ±0.3
108 2 ± 43 8
11.7 ±2.7
1.5 ±04
25.1 ± 3.5
5.5
591
202
207
263
35.4
27.3
11.0
144
62 8 ±41
189.4 ±67.3
60 ±124
244 ± 74
1660 9 ±400.7
95 2 ± 38.0
1.3 ±0.3
102.0 ±47.1
11.4 ±24
1.5 ±0.3
25.7 ±3.7
13.2
632
22.9
13.9
29.4
35.7
26.6
8.4
63 9 ± 3.6
192.9 ±61.6
3.9 ± 70
24 9 ± 7 9
1663 5 ±4167
931 ±41 6
1.3 ±0.3
105 7 ±47 4
11.2 ±2.9
1.5 ±04
25.5 ±3.6
6.5
742
16.1
9.7
33.3
40.0
15.0
11.7
aot
a 72
022
a«
a»7
a 73
ass
aet
an
a *
arc
ate
0.34
Tissue Samples
Tumour material of all CRC patients was collected after approval by the Medical Ethics
Committees (MEC) of Maastricht University, the NCR and PALGA (14). Subsequently, all
pathology laboratories in The Netherlands agreed to make relevant tissue samples available
upon request from PALGA. Tissue samples of the 819 cases present in 54 pathology
laboratories throughout The Netherlands were collected between August 1999 and
December 2001. For 43 (5%) untraceable tumour tissue specimens and 39 specimens (5%)
with insufficient CRC tumour material, K-ras mutation status could not be determined.
Finally, tumour material from 737 incident colorectal adenocarcinoma cases was available of
whom 476 were colon cancer cases, 85 were rectosigmoid cancer cases and 176 were
rectal cancer cases. Statistical analyses were performed separately for colon and rectal
cancer as differences in the aetiology of colon and rectal cancer have been reported (24).
Since the rectosigmoid can be considered as a clinically applied term rather than an
anatomically defined transitional zone between the colon and rectum, patients with a
rectosigmoid tumour were excluded from data-analyses. Moreover, the number of patients
with a rectosigmoid tumour was too small for adequate stratified analyses (14).
Detection of Af-r»* mutations
Mutation analysis of the exon 1 fragment of the K-ras oncogene, spanning codons 8-29,
was performed on archival colorectal adenocarcinoma speamens of all 737 CRC patients
using macrodissection, nested PCR and direct sequencing of purified fragments, which has
been described in detail elsewhere (14).
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Table 2 Nutrient intake (mean ± SD)
cohort members
N
Age(y)
Folate (pg/day)
OtfwroVetoryfocfo/s
Alcohol (g/day)
Fib* (g/day)
Energy (kcal/day)
Frwn meal (g/day)
VTttmir* B6 (mg/day)
VHamtne C (mg/day)
Iron (mg/day)
Meltwnme (g/day)
Offter c/iaracferisfka
Ql (kg/m>)
Family history (% Yes)
Smoker (%)
Novor
Ex smoker
Current smoker
Physical activity (%)'
<30 minutes/day
30-60 minutes/day
60-90 minutes/day
>90 minutes/day
Subcohort
1475
61.3 ±4 2
224.2 ± 72.0
14.5 ±16.4
28.7 ± 8 8
2165.8 ±512.1
105 9 ±43.3
1.5 ± 0 4
98.1 ±41.5
13.2 ±3.2
1.7 ±0.4
25.0 ± 2 6
5.7
134
51.3
353
15.0
29.7
34.8
20.4
and other characteristics among rectal
WttdtypeK-rt»
67
62.3 ± 4.2
222.4 ± 52 5
16.9 ±19.3
292 ± 8 3
2182.6 ± 483.2
101 3 ±38.6
1.5 ±0.4
108 5 ±46 8
13.6 ±2.9
1.7 ±0.4
24.9 ±2.5
7.5
90
55.2
35.8
91
27.3
37.9
25.8
Han
Rectal cancer
K-n« mutation
37
62.4 ±4.1
212.3 ± 67 6
14.7 ±12.5
29 9 ± 91
2165.0 ±467.0
92.8 ± 40.2
15 ±0.4
105.0 ± 56.9
13.3 ±3.1
1.6 ±0.4
251 ± 2 7
16.2
135
54.1
32.4
16.7
30.6
30.6
22.2
cancer cases and sub-
p-traJ^a
0.89
0.40
0.53
0.67
0.86
0.30
0.91
0.74
0.83
0.20
0.66
atr
0.76
0.64
'comparing c a m with at kMtt on* K-ras mutation to cases without a K^« mutation
' 2 out of 37 male rectal cancer cases had more Man one K-ras gene mutation
' 1 out ol 30 female rectal cancer cases had more than one K-ras gene mutation
' For 41 subcohort members and 2 rectal cancer cases, information on physical activity was not available
The Food Frequency Questionnaire
The dietary section of the questionnaire was a 150-item semi-quantitative food
frequency questionnaire, which concentrated on habitual consumption of food and
beverages during the year preceding the start of the study. Daily mean nutrient intakes were
calculated by cumulating the multiplied frequencies and portion sizes of all food items with
their tabulated nutrient contents from the Dutch food composition table (25). The
questionnaire was validated against a 9-day diet record (26). Questionnaire data were key-
entered twice and processed for all incident cases in the cohort and for all subcohort
members in a manner blinded with respect to case/subcohort status. This was done in order
to minimise observer bias in coding and interpretation of the data.
Folate data were derived from a validated liquid chromatography trienzyme method (27)
used to analyse the 125 most important dutch foods contributing to folate intake (28). The
mean daily intakes of all other relevant nutrients were calculated using the computerized
Dutch Food Composition Table (25). For data-analyses, an increment of 100 pg/day
increase in folate intake for men and women was computed based on the current
recommendations of the Dutch Health Council.
For 257 subjects (28 incident colon adenocarcinoma cases, 16 incident rectal
adenocarcinoma cases and 215 subcohort members; two subcohort members were also
colon or rectal cancer cases), dietary data were incomplete or inconsistent, and they were
excluded from the analyses. These subjects either 1) left 60 or more (out of 150)
questionnaire items blank and ate fewer than 35 items at least once per month and/or 2) left
one or more item blocks (groups of items, i.e., beverages) blank. Additional details are given
elsewhere (26). Hence, 608 colon (242 men and 206 women) and rectal cases (104 men
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Table 2 Continued
Rtwcancf
wM typ> K-/x
1573
614 ±4 3
199 8164.7
5.7 ± 94
25.5 ±7.2
1691 4 ±408.5
93 8 ± 40.4
1.3 ±0.3
108 2 ±43 8
11 7 ±2.7
1.5 ±0.4
25 1 ± 3 5
55
591
20.2
20.7
263
35.4
27.3
11.0
26
63.5 ±4.0
212 2 ±70.7
5 3 ± 6 5
24 2 ± 59
16270 ± 370.6
98 8 ± 45 2
1.4 ±0.3
109 5 ± 43.1
11.6 ±2.2
16 ±04
25.1 ±3.5
15.4
802
7.7
23.1
42J
20.9
192
11.5
30
62 0 ±39
216 2 ± 94 8
6.6 ±10.3
24 6 ±45
1789 7 ± 328.4
99 2 ±32 0
1.4 ±03
111.3 ±458
11.6 ±2.2
1.5 ±0.3
26.0 ±3.1
67
60.0
30.0
10.0
30.0
233
40.0
6.7
0T7
086
060
0 74
009
097
088
0.88
095
063
0.27
o.»
007
0.39
and 56 women) and 3048 subcohort members (1475 men and 1573 women) were available
for data-analyses.
Daily intake of dietary fibre (g/day), vitamin B2 (mg/day), vitamin Be (mg/day), vitamin C
(ng/day), iron (mg/day). alcohol (g/day), fresh meat g/day), and total energy (kcal/day) and
age at baseline (years), Quetelet Index (Ql; kg/m ), physical activity (<30 min/d, 30-60
min/d, 60-90 min/d, >90 min/d), family history of CRC (yes/no) and smoking status
(never/ex/current) were regarded as potential confounders.
Statistical Analysis
Analyses were conducted for men and women separately The overall frequency of
K-ras mutations as well as the type of mutation were computed for all colon and rectal
cancer cases as described elsewhere (14). Mean values of the continuous variables age at
baseline (years), intake of total folate, dietary fiber, alcohol, fresh meat, vegetables and total
energy and Ql were evaluated for subcohort members and colon and rectal cancer cases
with wild-type and mutated K-ras gene. Differences in mean values of the continuous
variables between patients with wild type and mutated K-ras gene were tested with the
Student T-test or the Mann-Whitney-U-test if the variables were not normally distributed.
Distributions of the categorical variables family history of CRC, smoking status and physical
activity were evaluated for subcohort members and colon and rectal cancer patients with
wild-type and mutated K-ras gene and tested for differences between patient groups with the
X^-test. The statistical software package SPSS (version 9) was used for these analyses.
Age-adjusted and multivariate-adjusted incidence rate ratios (RR) and their 95%
confidence intervals (Cl) for colon and rectal cancer risk were calculated for men and
women separately, using Cox regression models with the STATA statistical software
package (intercooled STATA, version 7) Standard errors were estimated using the robust
Huber-White sandwich estimator to account for additional variance introduced by sampling
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from the cohort. This method is equivalent to the variance-covariance estimator as
presented by Barlow (29). The proportional hazards assumption was tested using the scaled
Schoenfeld residuals (30). Those variables that were found to contribute substantially
(p<0.10) to the multivariate model for colon and/or rectal cancer (age, smoking. Ql, total
fresh meat consumption, and intake of iron and vitamin C) were included as covariates in all
multivariate analyses. Additional adjustment for dietary fiber and energy intake was
performed, in line with the previous report on folate and overall colon and rectal cancer risk
in the Netherlands Cohort Study (3) The personyears at risk, estimated from the subcohort,
were used in the analyses.
To date, foods are not fortified with folic acid in The Netherlands. For the time being, an
intake of 200 g of vegetables and two pieces of fruit daily is recommended This is
approximately twice the amount of fruit and vegetables found to be consumed in the Dutch
National Food Consumption Survey (DNFCS) carried out in 1992. The fruit and vegetable
intake accounts for approximately 50 n9 folate (28). We calculated RRs according to an
increase in intake of 100 ng/d of folate Approximately twice this additional amount would be
necessary to reach the US recommended daily allowance of 400 ng/d in the majority of the
men and women of this cohort.
RESULTS
The overall frequency and spectrum of mutations in the K-ras gene have been
presented in detail elsewhere (14) In brief, a total of 227 mutations was found in 218 out of
608 (36%) colon and rectal cancer patients The most frequently observed mutations are the
G>A transitions (54%), G>T transversions (33%) and G>C transversions (7%). The
observed frequencies of the mutations in this series of patients are similar to the frequencies
of the 737 colorectal cancer cases (including the rectosigmoid) for whom K-ras status was
determined (14).
Table 1 shows the folate intake and other baseline characteristics for colon cancer
cases and subcohort members, separately for men and women. The mean age of the
subcohort members was 61.3 years for men and 61.4 years for women. Overall, colon
cancer cases were older than the subcohort members. Colon cancer patients with a mutated
K-ras gene were significantly older than the patients with a wild type K-ras gene (p-values
0.04 and 0.06 for men and women, respectively). Dietary folate intake was higher among
subcohort members as compared to the different colon cancer subgroups. No statistically
significant differences for other (dietary) factors were observed for colon cancer cases
without and with a K-ras mutation in men and women as presented in table 1.
For rectal cancer cases and subcohort members, the mean folate intake and other
baseline characteristics are presented in table 2. Rectal cancer patients were older than the
subcohort members. Dietary folate intake among subcohort members and the different rectal
cancer subgroups was similar. Women with a mutated K-ras rectal tumour were more often
ex-smoker as compared to women with a wild type K-ras rectal tumour and subcohort
members. No statistically significant differences for other (dietary) factors were observed for
rectal cancer cases without and with a K-ras mutation in men and women as presented in
table 2.
For colon cancer, associations between folate intake and risk of disease, as well as
K-ras mutation status are presented for men and women in table 3. No significant
association was observed between dietary folate and overall colon cancer risk or with the
K-ras mutation status after adjustment for age, Ql, smoking, alcohol, fresh meat, energy
intake and family history of CRC, iron intake, vitamin C intake and dietary fibre.
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Table 3 Incidence rate ratios (RR) and 95% confidence intervals (Cl) for colon cancer patients overall
and with a (specific) K-ras mutation status (N=448) according to dietary lolate intake
colon cancer
RR'
RR>
RR>
RR*
O *
RR»
G>T-, G>C-
RR'
N
231
231
148
83
47
29
RR (95% Cl) per incrwiMnt of 100 pgMay Incnm* of
dtotary foiato kitak*
M M
108(091-130)
0.87(066-1.14)
0 94(069-1.27)
0 76(0.47-1.22)
0.78(0.40-1.53)
0 77(0 41-1.45)
N
199
199
141
58
34
25
WnHIMft
087(067-115)
098(062-1.56)
069(0 52-1.52)
1.22(052-2.82)
129(048-349)
1.56(0.494.95)
' RR adjusM tor age
'RR adjusted lor age 01. sinking. alcohol, ton meat energy intake and hmfty history ol CRC. vHamm C. iron. «ber
For rectal cancer, associations between folate intake and nsk of disease overall, as well
as K-ras mutation status are presented for men and women in table 4 A significant, inverse
association was observed between folate and overall rectal cancer risk in men (RR 0 58,
95% Cl 0 36-0 93), as well as with a K-ras mutation in the tumour (RR 0 40, 95% Cl 0 17-
0 89) The association was strongest for G>T or G>C transversions in the K-ras gene (RR
0.19, 95% Cl 0 03-1 07) For women, a significant positive association was observed
between folate and overall rectal cancer risk (RR 1.85. 95% Cl 1.13-3 02) and this
association was observed for rectal tumours without and with a K-ras oncogene mutation
(RR 1.94, 95% Cl 1 03-3.66 and 1.83, 95% Cl 0.91-3 68, respectively) After taking into
account the specific point mutations in the K-ras gene, an increased risk was observed for
rectal tumours harbouring G>T or G>C transversions (RR 2 69, 95% Cl 1 43-5 09).
However, a significant inverse association was observed between folate and G>A transitions
(RR 0.08, 95% Cl 0.01-0.53).
Table 4 Incidence rate ratios (RR) and 95% confidence intervals (Cl) for rectal cancer patients overall
and with a (specific) K-ras mutation status (N=160) according to dietary folate intake
rectal cancer
RR'
RR'
RR'
K-ras-
RR'
G>A-
RR'
G>T-. G>C-
RR'
N
99
99
63
36
22
13
RR (95% Cl) par Incramant of 100 pg/day Incraaaa of
Man
0 89 (0.68-1 16)
0 58 (0 36-0 93)
0 69(0.40-1.19)
0.40(0.17-0.89)
0 68(0 36-128)
0.19(0.03-1.07)
dietary MateMaka
N
51
51
24
27
11
17
mini , . .
TTvfnVtl
1.43(0 98-2.08)
185(113-3.02)
194(103-366)
1 83(0 91-368)
0 08(0 01-0.53)
2.69(1.43-5.09)
' RR adjusted for age
'RR adjusted for age. 01 smoking, alcohol. Iresh meat energy make and brmry history of CRC, vitamin C. iron, ftor
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DISCUSSION
In a large cohort with 448 incident colon cancer patients and 160 incident rectal cancer
patients, no significant associations were observed between folate intake and the risk of
colon cancer in men and women, either overall or after the K-ras mutation status was taken
into account. For men, a protective effect was observed for folate and rectal cancer risk,
overall and most pronounced, with K-ras mutated tumours For women, however, an
increased association was observed between folate and rectal cancer risk, overall and also
when the K-ras mutation status was taken into account. Regarding the specific point
mutations in the K-ras gene of rectal tumours in women, dietary folate was positively
associated with G>T or G>C transversions, however, inversely associated with G>A
transitions
The current cohort study on folate intake and specific K-ras mutations is, to our
knowledge, the only prospective study performed to date taking into account the K-ras
mutation status. The prospective design of this study and high completeness of follow-up of
cancer incidence and subcohort make information and selection bias unlikely. In addition, as
a result of the exclusion of the first 2 3 years of follow-up, the chance of information bias due
to potential preclinical CRC is minimal
Although several epidemiological studies have been conducted on dietary factors and
K-ras mutations in colon and rectal cancer, only three have reported on folate intake, i.e one
large case-control study with colon cancer patients (17), one case-control study with colon
and rectal cancer patients (20) and one cross-sectional case-case study with colorectal
adenoma patients (7) Slattery ef a/ (17) observed a statistically significant inverse
association between low dietary folate intake and the risk of colon tumours with a wild type
K-ras gene (odds ratio (OR) for the lowest versus the highest tertile of intake 1.4, 95% Cl
1.1-1.8; pirend<0.01). In another smaller case-control study with colon and rectal cancer
patients, no statistical differences in dietary folate intake as observed between cases with a
K-ras mutation compared to cases with a wild type K-ras (18). Therefore, case-control
analyses regarding dietary folate intake was not further explored in the study by Bautista ef
a/ (18). In a large case-case comparison of colorectal adenoma patients (7), individuals in
the upper tertile of total folate intake (dietary and supplemental folate), compared with
individuals in the lowest tertile, had a nearly 50% lower risk of having K-ras mutation-positive
adenomas (OR 0.52, 95% Cl 0.30-0.88; ptrend 0.02). This reduction in risk of K-ras mutation-
positive adenomas was not observed for dietary folate intake alone (OR 0.91, 95% Cl 0.50-
1.64; pirand 0.75). Caution is warranted in interpreting these results, because case-case
comparisons, including both male and female colon and rectal adenomas, were performed.
Case-case comparisons are valuable for the estimation of etiologic heterogeneity with
regard to K-ras mutation status. However, they do not give information on the direction of
the association between folate and K-ras wild type or mutated tumours, respectively. This
can only be obtained with case-control comparisons. In addition, we observed distinct
differences in associations between men and women and colon and rectal cancer. Our
results do not support the protective effect of folate for mutated K-ras colon tumours
observed in the other studies. One explanation could be that dietary folate intake in The
Netherlands is too low to evoke its potentially protective effect in colon and rectal cancer,
although a protective effect was observed for male rectal cancer. In the NLCS, 22% of the
study population used vitamin B supplements in 1986 (31). However, due to legislative
restrictions in The Netherlands, it was not allowed until 1994 to use folic acid in vitamin
supplements. Therefore, the overall effect of folic acid supplements in this cohort is
presumably negligible.
In the current study, an inverse association was observed for both men and women
between high folate intake and rectal tumours harbouring a G>A transition in the K-ras
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oncogene This was also observed by Slattery ef a/ (17), although not statistically significant,
for G>A transitions at the second position of codon 12 (OR for lowest tertile versus highest
fertile of intake 0 7, 95% Cl 0.4-1.3; p&»«jO 11) This could be an indirect consequence of
promotor hypermethyiation of mismatch repair genes, like the O*-methylguanme DNA
methyltransferase (MGMT) gene Van Engeland ef a/ (10) evaluated the association
between promoter hypermethyiation of genes involved in colorectal carcinogenesis, like
MGMT. and folate and alcohol intake within the framework of the NLCS MGMT is a DNA
repair protein that removes adducts from the O* position of guanine (32) in DNA. thereby
preventing G>A or C>T mutations Despite the limited size of the study performed by van
Engeland ef a/ (10). the data suggest that low folate and high alcohol intakes may be
associated with promoter hypermethyiation in genes involved in CRC, i.e. MGMT No clear
associations were observed for folate and G>A transitions in men, either in the colon or the
rectum More aetiological insight in the underlying mechanisms relating the differences in
tumour site, gender and K-ras mutation status in CRC is required to clarify this issue.
Moreover, due to the overall small number of cases when studying subgroups of K-ras
mutated tumours, the results of this study should be interpreted with caution, and need
replication in future larger studies
We observed an increased risk of rectal cancer with increased folate intake in women.
This was observed for both wild type and mutated K-ras gene, i.e G>T and G>C
transversions, but not for G>A transitions as described above For men, however, an inverse
association with G>T and G>C transversions in rectal tumours was observed Another
recent study also showed elevated risks for rectal cancer in women with increased dietary
folate intake, though not statistically significant (4). With the folate food fortifications and
extensive use of (multi)vitamin supplements including folate in different countries, It Is
important to further investigate this issue in prospective studies.
In conclusion, in this study dietary folate is not significantly associated with colon cancer
risk, either overall or with the K-ras mutation status Moreover, our data suggest that the
effect of high folate intake on rectal cancer risk is different for men and women, and
depends on the K-ras mutation status of the tumour.
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General Discussion
INTRODUCTION
In this molecular epidemiological investigation, alterations in the K-ras oncogene were
studied with respect to their frequency and relation to dietary nsk factors in sporadic
colorectal adenocarcinomas In the current chapter, the findings and methodology of other
relevant molecular epidemiological studies and our study on K-ras, dietary factors and CRC
are compared and its merits are discussed Current epidemiological evidence, including the
results of this thesis, on meat, fat and folate in the diet in relation to K-ras mutations in
colorectal tumours is summarized in tables 1. 2 and 3. Next, the strengths and limitations of
epidemiological studies incorporating molecular endpoints will be discussed Finally, the
implications for the interpretation of our findings and for future research will be addressed.
EPIDEMIOLOGICAL EVIDENCE FOR ASSOCIATIONS BETWEEN DIETARY FACTORS
AND Af/MS MUTATIONS IN COLORECTAL CANCER
The current evidence
The molecular epidemiological investigations conducted to date include two cross
sectional studies (1. 2). three case-control studies (3-5), and our prospective cohort study
The main findings of these studies are presented in tables 1, 2 and 3
Red meat was not related to the K-ras status, of either colorectal adenomas (1) or
colorectal carcinomas (2) (table 1) in the cross-sectional studies In addition, Slattery ef a/
(4) did not observe a significant association between red meat or processed meat and the
risk of colon cancer with or without K-ras mutations (table 6 1) within a case-control study In
case-case comparisons within the case-control study by Kampman ef a/ (3), the
consumption of poultry was associated with a 15-fold increased risk of K-ras mutations in
codon 12 compared with mutations in codon 13. To further evaluate the observed
aetiological heterogeneity between codons 12 and 13 for poultry consumption, these authors
compared both case groups with a population-based control group A non-significant,
positive association was observed with codon 12 mutations (OR 1.2, 95% Cl 0.8-1.6),
whereas a non-significant, inverse association was found with codon 13 mutations (OR 0.4,
95% Cl 0.1-1.2). No substantial differences in K-ras mutation status were observed with
regard to the consumption of total red meat, beef, processed meat and fish Our results
(table 6 1 and chapter 3). on the other hand, suggest that beef, pork and meat products
exert their effect via another route than the K-ras signalling pathway, since associations
were mainly observed with wild type K-ras.
The associations between total fat and specific fatty acids and the risk of K-ras
mutations in CRC risk were studied by Martinez ef a/ (1), Bautista ef a/ (5), Kampman er a/
(3), Slattery e? a/ (4) and Brink er a/ (6) (table 2). Except for Bautista ef a/ (5), none of the
cross-sectional or case-control studies (1,3) reported significant associations between total
fat and the K-ras mutation status in CRC A strong association for total fat and mono-
unsaturated fat (MUFA) with an increased risk of mutated K-ras tumours was observed for
K-ras mutated CRC patients compared to wild type K-ras CRC patients (5) Results from
case-control analyses showed that the strong associations with total fat and MUFA were
restricted to CRC patients beanng a wild type K-ras gene, i.e. there was a significant
protective effect of MUFA on wild type K-ras tumours These associations were not reported
in the other studies (1,3). In addition, no associations were observed between total fat and
MUFA and K-ras mutation status in the current study (table 2) The study by Bautista ef a/
(5) was conducted in Spain where olive oil is the main source of oleic acid and thus of
MUFA This is not the case for the current cohort and this could be an explanation for the
different findings Results from our study indicate an increased association between the risk
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Table 1 Main findings of the molecular epidemiological studies on the associations between the
consumption of meat, meat products and fish, and K-ras mutations in sporadic CRC
Study
population
678cokxectal
adenoma
cases
f999(f;
43 left-sided
colorectal
cancer cases
O'Snvneft/,
2000(2;
185 colon
CflnO9TCM9t
Kammanef
. / O/W) /I)
0/, /UW (J/
1428 colon
cancer cases
and 2406
controls
S/afferyefa/,
2000(4;
608 incident
colon and
rectal cancer
cases and
2948
subcohort
members
6rin* ef a/.
2004 (6;*
Dietary factor
red meat
red meat
total red meat
beef
pwoamd meat
poulttry
flsh
red meat
processed meat
total fresh meat
(beef, pork.
minced meat,
liver, chicken,
other meat)'
meat products
Contrast Comparison
Cn>ss-s«ctfo/M/ study
highest (>71 g/day) vs
lowest (<33.3 g/day)
tortile
mean intake mutated
K-ras (92 4 > 9 7 g/day)
vs. wild type K-ras (82.3
±7.7 g/day)
mutated K-ras/wild type K-ras
mutated K-ras/wild type K-ras
Case-confro/ study
increment of 43 g
increase/day
increment of 26 g
increase/day
increment of 23 g
mcrease/day
increment of 17 g
increase/day
increment of 20 g
increase/day
highest (>1.0 g/1000
kcal) vs. lowest (<0.3
g/1000 kcal) fertile
highest (>0.23 g/1000
kcal) vs. lowest (£0.08
g/1000 kcal) tertile
mutated K-ras/wiM type K-ras
codon12/codon 13
transition/transversion
mutated K-ras/wild type K-ras
codon12/codon 13
transition/transversion
mutated K-ras/wild type K-ras
codon12/codon 13
transition/transversion
mutated K-ras/wild type K-ras
codon12/codon 13
transition/transversion
mutated K-ras/wild type K-ras
codon12/codon 13
transition/transversion
mutated K-ras/controls
wild type K-ras/controls
mutated K-ras/wild type K-ras
muutated K-ras/contols
wild type K-ras/controls
mutated K-ras/wild type K-ras
Cohort study
highest (150.8 g/day)
vs. lowest (61.0 g/day)
quartile for men,
highest (139 2 g/day)
vs. lowest (50 7 g/day)
quartile for women
highest (33.3 g/day) vs.
lowest (1.0 g/day)
quartile for men.
highest (22 4 g/day) vs.
lowest (0.0 g/day)
quartile for women
Co/on
wild type K-ras/subcohort
mutated K-ras/subcohort
Recfum
wild type K-ras/subcohort
mutated K-ras/subcohort
Co/on
wild type K-ras/subcohort
mutated K-ras/subcohort
Recfum
wild type K-ras/subcohort
mutated K-ras/subcohort
OR or RR* (95% CQ
1 13(0.63-2.05)
difference in mean
intake is not statis-
tically significant
1.1(0.8-1.6)
1.3(0.5-3.4)
1.4 (0.7-2.9)
1.0(0.7-1.4)
1.7(0.7-4.2)
0.9(0 5-1.8)
1.0(0 7-1.5)
1.0(0 5-2.2)
11(0.6-1.8
1.1(0.8-1.5)
15.0(1.4-160.0)
0.9(0.5-1.8)
1.2(1.0-1.5)
1.8(0.8-4.4)
0.9(0.7-1.1)
0.9(0.6-1.3)
1.1 (0.9-1.4
0.8(0.6-1.2
0.9(0.7-1.2)
1.0(0.8-1.3)
0.9(0.6-1.2)
0.94(0.65-1.36)
1.01(0.61-1.66)
0 76(0 41-1.44)
0 68(0 31-1.47)
1.42(1.00-2.03)
0.77(0.45-1.32)
0.84(0.45-1.58)
1.41 (0.67-2.99)
98
Table 1 continued
population Dietary factor C « * M t Companion
COnOff SlUOy
Qtnmi MmiMton
ORofWJWXCI)
606 incident
colon and
rectol cancer
2946
subcohort
fish h i g h * (30.5 a/day) vs
lowaatfO.OgMay)
quanlttormen.
NgnMt(28.2g/day)vs
lowatt(6.0o/riay)
Quartlt for women
Coton
wild type K-res/subeohort
mutated K-ra*subc»hoft
r?ecfum
w * j lype K-ms/aubcohort
mutated K-flw/subcohort
087(0 60-126)
1.38(0 85-2.25)
106(0 58-1.94)
078 0 37-165
Srnft t f *
2004(6)'
• RR orty m study by Bra* « * . m ai otter ( tr ies tie OR auesd «
' RRi (or t » spec* types o( maal M * chapter 3 o( tie tieeis
of colon tumours with a mutated K-ras gene and u>-6 PUFA intake, in particular linoleic add
(table 2) Moreover, these associations were also observed for G>A transitions and G>T and
G>C transversions in the K-ras gene (chapter 4) To our knowledge, the association
between w-6 PUFA, in particular linoleic acid, and K-ras mutation status and the specific
K-ras point mutations has not been investigated previously in CRC
For total (dietary+supplemental) folate intake (table 3). Martinez ef a/ (1) observed a
substantial inverse association for the risk of colorectal adenomas with a mutated K-ras
gene as compared to adenomas with a wild type K-ras gene, but these authors did not
observe an association for dietary folate alone (table 3) Slattery ef a/ (4) found that a low
intake of dietary folate was associated with an increased risk of wild type K-ras colon
tumours versus controls. No association was observed for mutated K-ras colon tumours
versus controls However, low intake of dietary folate was associated with an inverse risk of
G>A transitions in codon 12 of the K-ras gene in colon tumours versus wild type K-ras colon
tumours. In the current study, an inverse association was seen for dietary folate and
mutated K-ras rectal tumours in men, whereas an increased association was found for
women (table 3 and chapter 5) For men, this inverse association was observed for G>A
transitions as well as G>T or G>C transversions (chapter 5). For women, the increased
association was confined to G>T or G>C transversions, whereas an inverse association was
observed for G>A transitions.
Case-case comparisons versus case-control comparisons
In reviewing the molecular epidemiological evidence, as summarised in tables 1 to 3, it
is important to distinguish between results based on case-case comparisons and case-
control/subcohort comparisons Although case-case comparisons may give information on
the degree of heterogeneity of risk factors between cases with a mutated K-ras tumour and
cases with a wild type K-ras tumour, these comparisons can not give any information on the
risk of mutated K-ras or wild type K-ras tumours versus a control group, i.e. a non-case
group. Case-case comparisons may give clues as to whether risk factors differ for
subgroups, but additional case-control/subcohort comparisons are necessary to elucidate
the direction and strength of associations For example. Bautista er a/ (5) observed a strong
association for MUFA intake with mutated K-ras CRC cases versus wild type K-ras cases
However, additional case-control analyses were conducted and showed an inverse
association between MUFA and the risk of wild type K-ras colorectal tumours, whereas no
significant association with the risk of mutated K-ras tumours was found. Thus, MUFA
appears to be a protective factor for wild type K-ras CRC cases, whereas it has no effect on
K-ras mutated CRC cases. Thus, the case-case comparisons could be misleading if case-
control comparisons are not presented
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The choice of dietary factors evaluated in the current thesis was based on biological
mechanisms enumerating from previous experimental and molecular epidemiological
studies (see chapters 3 through 5). Biological mechanisms for meat, fat and dietary folate in
relation to K-ras mutations as described in the literature support the associations that we
found between these dietary factors and the risk of colorectal tumours with a K-ras mutation
(chapters 3 through 5). With respect to wild type K-ras tumours, inverse associations were
observed in two prior studies for folate (4) and MUFA (5). None of the other molecular
epidemiological studies presented associations between the dietary factors under study and
the risk of wild type K-ras tumours (1-3). Therefore, in order to evaluate the differential
effects of dietary factors on the risk of tumours with and without a K-ras mutation, case-
cohort analyses were performed for these different categories of cases.
STRENGHTS AND L IM ITAT IONS OF EPIDEMIOLOGICAL STUDIES
INCORPORATING MOLECULAR ENDPOINTS
The degree of coverage and completeness of the follow-up will be discussed in order to
Table 2 Main findings of the molecular epidemiological studies on the associations between fat intake
and K-ras mutations in sporadic CRC
Study
population
678 colorectal
adenoma cases
Ma/inez ef«/,
108 colorectal
cancer cases and
295 controls
T997 f5;
185 colon cancer
cases
Kampmanela/,
Dtotiry factor
total fat
saturated fat
total fat
MUFA
PUFA
saturated fat
total fat
saturated fat
Contnwt Companion
CroM-sectfona/ study
highest (>82 3 g/day)
vs. lowest (<55.5 g/day)
tertile
highest (>27.2 g/day)
vs. lowest (S18.0 g/day)
tertile
mutated K-ras/wild type K-ras
mutated K-ras/wild type K-ras
Case-confro/ study
highest vs. lowest tertile
highest vs. kwest tertile
highest vs. lowest tertile
highest vs. lowest tertile
increment of 20 g
increase/day
increment of 16 g
increase/day
mutated K-ras/wild type K-ras
mutated K-ras/controls
wild type K-ras/controls
mutated K-ras/wild type K-ras
mutated K-ras/controls
wild type K-ras/controls
mutated K-ras/wild type K-ras
mutated K-ras/controls
wild type K-ras/controls
mutated K-ras/wild type K-ras
mutated K-ras/controls
wild type K-ras/controls
mutated K-ras/wikj type K-ras
codon12/codon 13
transition/transversion
mutated K-ras/wild type K-ras
codon12/codon 13
transition/transversion
OR or RR* (95% CI)
1.55(0.76-3.16)
1.06(0.54-2.07)
3.04 (0.95-9.76)
1.4 (0.55-3.7)
0.47 (0.22-0.99)
10.71 (2.8440.4)
1.6(0.63-4.2)
0.25 (0.10-0.60)
0.73(0.25-2.18)
0.46 0.18-1.2)
0.86(0.43-1.7)
0.53(0.16-1.71)
0.90 (0.34-2.4)
0.79(0.38-1.7)
1.2(0.9-16)
1.2(0 6-2.3)
0.9(0.6-1.4)
1.1(0.8-14)
1.4(0.7-2.6)
1.1 (0.7-1.6)
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Table 2 continued
Study
population DMary factor Co•matt Convarte«
Css#cofilrof study
General Discussion
OKorlWOSXCI)
1428 colon
cancer cases and
2406 c o n t t *
2000 M
608 modem
colon and rectal
cancer cases and
2948 subcohort
members
8nn*era/ . 2004
total fat
saturated tat
MUFA
PUFA
total fat
saturated fat
MUFA
PUFA
Snolenic acid
hrtoJeic acid
highest (>40.0gnOOO
teal) vs lowest (S300
g/1000teal)tMtJh>
Nghest(>150 g/1000
teal) vs lowest (S100
g/1000 teal) tort*
hghest(>i4 2 g/1000
kcal)vs lowest (S11.0
9/1000 kcal) terbte
highest (>8 0 g/1000
teal) vs lowest (s5 5
g/1000 kcal) terttte
w n type K«/iewortroe}
mutated Kv»s\ t fd type *•*»$
m U M Q f\*rSSrOOn«Ni
wid type K-flMfantoolB
mutMed K-/Bs/wid type K ^ w
mutated K-«s/contro*i
wid type Kvtt&onlPols
mutated K-nsAwW type K-ra»
mutttod K-fBs/contois
wHQ Type A-rVanJOnVM
mutated K-rasnwU type K-m
Cohort ituoY
rwghest(1091 g/day)
vs lowest (78 1 g/day)
quartile for men.
highest (85 3 g/day) vs
lowest (63 0 g/day)
quartile for women
highest (45 8 g/day) vs
lowest (28 9 g/day)
quartile for men.
highest (36 6 g/day) vs
lowest (23 9 g/day)
quartile for women
highest (42 5 g/day) vs
lowest (28 2 g/day)
quartile for men.
highest (33 0 g/day) vs
lowest (22 4 g/day)
quartile for women
highest (291 g/day) vs
lowest (11 6 g/day)
quartile for men.
highest (22 5 g/day) vs
lowest (8 8 g/day)
quartile for women
highest (2 0 g/day) vs
lowest (0 8 g/day)
quartile for men,
highest ( 1 6 g/day) vs
lowest (0 6 g/day)
quartile for women
hghest (27 9 g/day) vs
lowest (100 g/day)
quartile for men,
highest (21 2 g/day) vs.
lowest (7 4 g/day)
quartile for women
Colon
wHd type K-ras/subcohort
mutated K-ns/subcohort
Recfum
wtH type K-/aa/subcohort
mutated K-ras/tubcohort
Coton
wild type K-rBS/subcohort
mutated K-ras/subcohort
Recfum
wild type K-ras/subconort
mutated K-rss/subcohort
Coton
wild type K-ras/subcohort
mutated K-ras/subcohort
Recfum
wild type K-ras/subcohort
mutated K-fas/subcohort
Coton
wild type K-fas/subcohort
mutated K-res/subcohort
Recfum
wild type K-ras/subcohort
mutated K-ras/subcohort
Coton
wild type K-ras/subcohort
mutated K-ras/subcohort
Recfum
wild type K-ras/subcohort
mutated K-ras/subcohort
Coton
wild type K-ras/subcohort
mutated K-ra$/suDCOhort
Rectum
wild type K-rss/subcohort
mutated K-ras/subconort
11(0 8-15
10 08-1.2
12(08-17)
11(08-15
0 8(0 7-1 1
1.3(0.9.1.9
11(0 8-14)
1.0 0 8-12
11(08-16)
1.1 (0.8-1.4
1.1 (0.9-1.4
1.0(0.7-1.4
0 99(0 70-138)
0 88(0 54-1,44)
063(0 33-120)
1 18(0 63-2 23)
106(0 74-1.54)
0 73(0 45-118)
064(0 34-121)
0.86(043-1.72)
1 18(060-1 26)
067(040-1 13)
0.69(0 38-1.24)
1.22(061-2.44)
091(063-131)
2 09 (1 25-3 49)
0.89 (0 49-1 62)
0.75(0.39-1.44)
105(0 74-149)
095(0 59-1.55)
066(0 37-1 17)
1.54(0 73-3.25)
1.01(0 70-1.45)
219(1.30-3.67)
112(0.61-2.07)
0 93(048-179)
" RR only «i itriy by Brir* «f af. in at otier Mudes «w OR « und
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Chapter 6
evaluate the influence of selection and information bias on misclassification. In addition,
implications of possible measurement errors in the assessments of dietary factors and K-ras
mutations, followed by confounding and multiple testing will be discussed.
Selection bias
Since the person-year follow-up was nearly 100% complete (98% for 7.3 years of
follow-up), selection bias in general is unlikely to be important in The Netherlands Cohort
Study on diet and cancer (NLCS). The cohort was recruited from samples drawn from a
large number of municipal population registries. Municipalities were selected according to
the degree of coverage of their inhabitants by the cancer registries (CR) and PALGA,
minimising loss to follow-up (7). The mean coverage appeared to increase from 98 5% at
the start of the study to 100% in 1988. Therefore, tumour tissue of CRC patients was
Table 3 Main findings of the molecular epidemiological studies on the associations between dietary
folate intake and K-ras mutations in sporadic CRC
Study
population Dietary factor Contfaat Comparison ORorRR'(95%CI)
Crojj-sectfona/ study
678 cotorectal dietary folate
adenoma
cases
Marine •eta/,
f 999(1) dietary* supple-
mental Mate
highest (>318ug/day)
vs. lowest (<226 ug/
day) fertile
highest (>571ug/day)
vs lowest (<279 ug/
day) fertile
mutated K-ras/wild type K-ras 0.91 (0 50-1.64)
mutated K-ras/wild type K-ras 0.52 (0.30-0.88)
Case-contro/ study
108 cotorectal folk; acid highest vs. lowest fertile mutated K-ras/wild type K-ras 2.03 (0.68-6.11)
and 295
controls
Sauhsfa et a/.
t997(5)
1428 colon
cancer cases
and 2406
controls
^efa/,
folate lowest (£125 meg
/1000 kcal) vs. highest
(>220 meg /1000 kcal)
fertile"
mutated K-ras/controls
wild type K-ras/controls
mutated K-ras/wild type K-ras
2 G>A/wik) type K-ras
Cohort study
increment of 100 ug
increase/day
wild type K-ras£ubcohort
Co/on
men
women
Rectum
men
women
mutated K-ras*ubcohort
Coton
men
women
Rectum
men
women
1.2(0.8-1.7)"
1.4(1.1-1.8)"
0.8(0.6-1.2)**
0.7(0.4-1.3)"
0.94(0.69-1.27)
0.89(0 52-1.52)
0 69(0.40-1 19)
1.94(1.03-3.66)
0.76 (0.47-1.22)
1.22(0.52-2.82)
0.40(0.17-0.89)
1.83(0.91-3.68)
608 incident
colon and
rectal cancer
cases and
2948
subcohort
members
Bnn/( el a/.
2004 (67
dietary folate
° RR only m study by Brink er al, in al other studies the OR is used
"the reference category is the highest level of intake of folate (instead of the lowest level of intake, as in footer studies in the total
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collected for the patients identified between 2 3 and 7 3 years after the start of the NLCS (in
1986), i.e. patients diagnosed with CRC between 1989 and 1994
Within this 5-year period, 929 incident CRC cases with histologically confirmed tumours
were identified of whom 819 cases could also be linked to a PALGA report of the lesion The
linkage to the PALGA database, and thus to the availability of the individual pathological
reports, was necessary in order to locate the tumour matenal at a specific laboratory.
Reasons for not finding PALGA reports for 12% of the eligible patients include 1) PALGA
alone reached national coverage from 1991 onwards, although the NCR and PALGA
combined reached a coverage of near 100% in the municipalities included in our study by
1988. 2) approximately 6% of histologically confirmed cases in the NCR are not reported by
PALGA due to administrative reasons (data Comprehensive Cancer Center Limburg 1990-
1996. personal communication L Schouten) and 3) mistakes in identifying information,
leading to incorrect linkage, i e name, date of birth and gender The pathology laboratories
that did, or did not deliver their reports to PALGA after 1991 were not different with respect
to location in an academic hospital or a cancer specialty centre Therefore, it is not expected
that differential selection bias occurred with respect to dietary intake or tumour
characteristics
In this study, tissue blocks were available for 83% of the cases (776 out of 929) since
the PALGA report of the lesion was unavailable for 12% of cases (110 out of 929 resulting in
819) and an additional 5% (43 out of 819. i.e. 776) of the tumour blocks could not be traced.
Reasons for this loss to foltow-up of tumour blocks (N=43) were 1) for 9 patients registered
in one pathology laboratory, tissue could not be retrieved due to administrative
inconsistencies and 2) for 34 patients the material could not be found (8) In addition, for 5%
of the patients {i.e. 39 out of 776) the K-ras mutation status could not be determined due to
either the presence of only normal colon mucosa (20 out of 39). a revision with a benign
adenoma instead of an adenocarcinoma (10 out of 39). an insufficient yield of DNA (6 out of
39) or the absence of malignant CRC tissue (3 out of 39) (6).
Nearly all tumour material of CRC patients was collected from the various pathology
laboratories by one person, usually by retrieval directly from the archives on location instead
of requesting the material by mail. This approach could have increased the invaluable
willingness of the pathologists to cooperate in the current study, since this way of collecting
the tumour material was both time and cost efficient for the pathology departments Both the
degree of participation and the yield of the samples are not expected to be related to either
characteristics of the tumour or dietary intake
Taken together, the recovery of the tumour tissue is considered as more than
satisfactory, and it is not anticipated that selection bias would lead to differential
misclassification of the K-ras mutation status of the tumour The series of samples that were
analysed consist of non-selected, incident CRC patients, representative for the NLCS.
Information bias
It is unlikely that systematic misclassification of exposure is of significant importance in
the current study, since all prevalent cases (i.e clinically diagnosed) were excluded at
baseline. All other participants completed a validated, semi-quantitative food frequency
questionnaire at baseline In addition, due to the exclusion of the first 2 3 years of follow-up,
influence of pre-clinical CRC on dietary intake was minimised.
Assessment of </«ete/y frcftvs
The intake data were validated against a nine-day record method (9) The observed
correlations were reasonable and were not different from the correlations observed in other
studies (chapters 3 through 5) Even though estimations of intake may not be as accurate as
we would wish them to be. possible misclassification is expected to be non-differential with
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respect to K-ras mutation status. Therefore, the associations observed are probably an
underestimation of the true association.
Asses*/nenf of Af-ra* /m/fcst/o/w
Mutation analysis of tumour samples, in particular when routinely-fixed, paraffin-
embedded tissue is used obtained within a multi-centred setting, is prone to false positive as
well as false negative results. The sensitivity and specificity of the methods used for K-ras
mutations in the current study are discussed in detail in chapter 2. Findings regarding the
reproducibility and validity of these techniques will be discussed briefly in this paragraph.
To establish the reproducibility of the technique in our study, a subset of DNA
Specimens was subjected twice to the complete procedure, from tissue sectioning to DNA
Mquencing (chapter 2). The reproducibility of the mutation analysis was found to be good
(88%), in view of the poor DNA template quality of a significant proportion of the archival
tissue samples Surprisingly little has been published on reproducibility of K-ras mutation
Identification in the other reported molecular epidemiological studies (1-5). In our study, the
reproducibility appeared to be strongly dependent on the quality of the DNA after tissue
processing The degree of fragmentation of the DNA templates, mainly due to effects of
tissue lysis and formalin fixation, is critical for amplification of the K-ras fragments, in
particular in the first cycles of the PCR The reproducibility is also dependent on the
heterogeneity of the tumour tissue, i.e. on the presence of a variety of clones with different
genetic make-up in the tumour. However, the effect of tissue heterogeneity has not been
tested experimentally
In the current study, routinely-fixed, paraffin-embedded colorectal tumour specimens
from 54 pathology departments were used for the determination of the K-ras mutation
status. Variation in procedures for post-operative storage, fixation, dehydration and paraffin-
embedding of the tissue between tumour samples as well as between pathology laboratories
affect the degree of DNA fragmentation and hence the quality of the DNA to be analysed.
Therefore, we took several precautions to warrant a reliable mutation analysis. The exon 1
fragment of the K-ras gene, including codons 12 and 13, is a small fragment (114 bp) that
can be amplified easily and reliably. Only purified, complete fragments were used for
sequencing, the accepted standard for determination of the K-ras mutation status. In the
end, the K-ras mutation status could be determined for all 737 colorectal tumour specimens
included in this study, the reproducibility is 88%, and the frequency of the K-ras mutations is
in line with the frequencies observed in the literature.
Several experiments were conducted to validate the assessment of the K-ras mutation
status of the archival samples (chapter 2). The mutation analysis was validated by
amplification and sequencing DNA fragments from CRC cell lines, and from adjacent blocks
with paraffin-embedded and fresh tissue from a series of CRC specimens. The validation of
the used techniques indicated that the observed point mutations of the CRC cell lines are
the same as those reported in the literature. Tissue processing under controlled conditions
was found not to affect the reliability of our K-ras mutation analysis of archival specimens.
Therefore, errors in the assessment of K-ras mutations may occur at low frequency, mainly
due to an intrinsic, poor quality of DNA from samples.
Most importantly, differential misclassification of the K-ras mutation status of tumours is
not very plausible, since molecular analysis and evaluation of data was done blinded with
respect to dietary intake, potential confounders or tumour characteristics such as
clinicopathological data of tumours. In addition, evaluation of sequence patterns and data
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entry were done by two different laboratory technicians, results were compared, and in case
of dissimilarities, data were reviewed together until consensus was obtained
In conclusion, potential misclassification of cases regarding the K-ras mutation status of
their tumour, due to minor faults in the reproducibility and validity of the used techniques, is
expected to be non-differential with respect to other aspects of the tumour as well as dietary
intake
Meat consumption, fat intake and dietary folate were evaluated for their relation with
overall colon and rectal cancer and with the K-ras mutation status in chapters 3. 4 and 5,
respectively The influence of possible confounders. based on the literature, was tasted In
the overall colon and rectal cancer models, i.e. without stratification on presence or absence
of a K-ras mutation Hence, the vanables, significant in either one or both of the models,
were included as covanates for all models to be tested, i.e models for specific molecular
endpoints as determined by the K-ras mutation status Possibly, confounders included in the
overall models are not important confounders for the associations studied with the K-ras
mutation status in colon or rectal cancer In addition, unknown confounders specific to the
diet-K-ras mutation status associations studied may have played a role. However, we would
rather not explore all potential confounders for the associations studied in our dataset
because of the increased chance of type-l errors Since little is known about potential
confounders. we restricted our evaluations to the known confounders for the specific diet-
CRC associations.
In total, sixteen food groups or nutrients were considered in this thesis. As differences in
the aetiology of colon and rectal cancer have been reported (10). statistical data-analyses
were performed separately for colon and rectal cancer as described in chapters 3, 4 and 5.
In addition, results were presented separately for men and women in chapter 5 Including
the K-ras mutation status of the tumours. 170 Cox proportional Hazard tests were
performed. A p-value 5 0.05 was considered statistically significant. In general, 5% of these
tests (9 out of 170 tests) may be found statistically significant, based on chance alone We
observed 18 statistically significant associations Therefore, caution is warranted in
interpreting our results. However, the choice of associations we investigated was primarily
based on prior hypotheses, generally generated from experimental studies.
IMPLICATIONS OF THE FINDINGS OF THIS STUDY AND FUTURE PERSPECTIVES
The relevance of the diet-gene associations with respect to the different aetiology of
colon and rectal cancer, the importance to the specific molecular alterations in the K-ras
gene versus the wild type gene, and other relevant mechanisms for the risk of CRC, will be
discussed.
Differences in aetiology between colon and rectal cancer
Many of the associations observed in this study were either confined to cancer in the
colon or cancer in the rectum, rarely both. Considering our hypotheses set out in chapter 1,
these differences were unexpected. However, in view of the finding that the K-ras mutation
status of tumours differed along the colorectal tract (chapter 2). and suggestions in literature
for differences in the aetiology of tumours in the colon versus the rectum (10,11), differences
according to localization in the colorectal tract are not surprising, after all Nevertheless, the
differences in associations of dietary factors with colon and rectal cancer with or without
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mutations in the K-ras gene cannot readily be explained with underlying biological
mechanisms that are known at present. Therefore, stratified analyses at different sites in the
colorectal tract are preferable if allowed by the power of the study. In our study, patients with
a rectosigmoid tumour (n=85) were excluded, since the tumours in this rather more clinically
than anatomically defined region could not be assigned to either the colon or the rectum.
Moreover, the number of patients with rectosigmoid tumours is too small for adequate
stratified analyses regarding the K-ras mutations status. Finally, replication of our findings
with regard to the K-ras gene for both colon and rectal cancer would be reassuring.
The importance of point mutations in the /r-ra$gene versus wild type /f-rasgene
Overall, some hypotheses suggested in chapter 1 were confirmed, some were not and,
surprisingly, some associations were observed for the wild type K-ras gene for which there
were no prior hypotheses.
In chapter 3, it was suggested that meat preparation is relevant for development of
CRC, i.e. broiled, fried, barbequed or smoked meats may increase the risk through the
generation of high concentrations of carcinogens, like PAA's and PAH's. Subsequently,
these carcinogens may induce specific point mutations Information on meat preparation
was not collected at baseline in the current study Since fresh meat generally needs further
preparation, this type of meat may be an important source of these carcinogens. Hence, it is
plausible that associations between fresh meat and colon or rectal cancer with specific point
mutations in the K-ras gene exist However, in this study no association was found between
any of the fresh meat variables and risk of colon or rectal cancer with specific point
mutations (chapter 3) This could be due to the expected low content of carcinogens in
prepared fresh meat consumed in this cohort, and also to the lack of correlation between
meat preparation and the amount of fresh meat consumed (12). Surprisingly, associations
were observed between certain fresh meat variables and cancer with a wild type K-ras gene
(chapter 3), i.e. a positive association between colon cancer risk and beef consumption and
inverse associations between both colon and rectal cancer risk and pork consumption.
Associations with the risk of colon tumours harbouring a wild type K-ras gene were also
observed with meat products consumption. Although associations were weak and of
opposite direction for different meat variables, and may be the result of type I errors, these
associations are intriguing and require replication and further study. More specifically, it is of
interest to focus on the K-ras independent pathway in relation to meat consumption in future
studies. For rectal tumours, our observations regarding the increased risk of tumours
harbouring G>A transitions support our initial hypothesis regarding the consumption of meat
products (chapter 3). However, the lack of this association for colon cancer remains
puzzling.
Regarding fat intake, an increased association was observed between PUFA, in
particular linoleic acid, and G>A transitions and G>T or G>C transversions in the K-ras gene
of colon cancer patients (chapter 4). These findings are in line with the observations in
previous experimental studies, but need replication in other observational epidemiological
studies. On the other hand, the hypotheses regarding MUFA and w-3 PUFA and K-ras
mutation status in CRC were not confirmed in the current study. One possible explanation is
that the intake of MUFA and co-3 PUFA in The Netherlands is too low to evoke its potentially
protective effect. Another explanation could be that MUFA and w-3 PUFA are not involved in
the development of CRC via a K-ras-dependent pathway. Indeed, for MUFA intake, Bautista
observed a significant inverse association with the risk of CRC with a wild type K-ras gene
(5) in a case-control study in Spain where the intake of MUFA is higher than in The
Netherlands. This underlines, once again, the potential importance the K-ras independent
route to colorectal carcinogenesis in relation to dietary intake. The uncertain role of MUFA
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and u>-3 PUFA in cotorectal caranogenesis with respect to the K-ras gene needs further
study
An inverse association was observed for dietary folate and the risk of rectal tumours
with a mutated K-ras gene in men. irrespective of the type of point mutation involved
(chapter 5) For women, however, a positive association was observed with the risk of rectal
tumours harbounng a wild type K-ras gene or a K-ras mutation. Moreover, the increased
association with K-ras mutations was confined to G>T or G>C transversions An inverse
association was also seen with rectal tumours harbounng a G>A transition and this finding is
in line with the hypothesis Possibly, the effect of dietary folate is differential for men and
women However, these findings also need replication in other prospective cohort studies.
Overall, our results suggest that meat, fat and folate appear to be of less importance for
the risk of colon and rectal tumours with specific point mutations in the K-ras gene than was
attributed to these factors at the start of the study However, these factors may be of
aetiologic importance for the nsk of colon or rectal tumours with a wild type K-ras gene
Several literature reports never focussed on the findings observed with wild type K-ras
tumours, partly because a definite conclusion on the risk of wild type K-ras tumours alone
was hampered by the case-case approach only (1.2). On the other hand, both Bautista and
Slattery observed significant associations between dietary factors, i.e. MUFA (5). folate (4)
and cruciferous vegetables (4) and the risk of tumours with the wild type K-ras gene It
would therefore be useful to study associations between dietary factors and the risk of colon
and rectal tumours with molecular characteristics compatible with wild type K-ras. such as
microsatellite instability of the tumour.
Importance of mechanisms other than the mutation status of the #•/»• gene
Although we focused on hypotheses related to specific point mutations in the K-ras
gene, it is interesting to consider other mechanisms relevant for the risk of CRC.
Other (epi)genetic mechanisms
As indicated above, other genes relevant for colorectal carcinogenesis (13,14) should
also be studied in this respect. The most important genes include the tumour suppressor
gene /\PC, the oncogene /*-cafen/n and the DNA repair enzymes (see fig 1 in chapter 1).
The focus should not only be on specific point mutations in these genes but could also be on
epigenetic aspects such as promotor methylation of the 4PC gene Methylation of the
promotor region of genes is important for the expression of genes, and therefore for normal
functioning of gene products (15,16) A number of dietary factors are thought to influence
methylation (16). Therefore, (epi)genetic factors involved in colorectal carcinogenesis may
be of importance, to be investigated in relation to dietary factors, in addition to the K-ras
gene alone.
Another aspect to be explored in the future may be the association between dietary
factors and types of mutations, not with respect to a specific gene, but genome-wide When
regarding the underlying biological mechanisms for associations between dietary factors and
specific point mutations, an association between for example the consumption of PUFA and
the increased risk of G>A transitions occurring throughout the genome in tumour cells from
CRC patients may be plausible However, caution is warranted, as the assessment of e.g.
G>A transitions will be performed in colorectal tumour tissue from patients already
diagnosed with the cancer Therefore, the assessment of G>A transitions will reflect the
genetic make-up of the tumour at the time of diagnosis and is the result of the effects of
many different factors responsible for the selective growth advantage of the tumour, and not
only dietary factors This also applies to the findings in this thesis, since the mutation status
of the K-ras gene is also the status of the tumour cells at the time of diagnosis.
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Dietary factors as indirect cancer promoting effectors
Dietary factors may act as promotor-stimulating compounds in the development of CRC
instead of as initiating factors by causing specific point mutations Cells may become more
or less susceptible to cell division, depending on dietary intake as well as on the molecular
make-up of the cells, for example, the K-ras mutation status of the cell. As a result,
associations between dietary factors and colon or rectal tumours with a mutated K-ras gene
may be observed Whether this may be an explanation for our findings is not clear and
needs further exploration in laboratory experiments
Finally, it would be interesting to consider the role of polymorphisms in metabolic
enzymes as effect-modifiers in the relationship between dietary factors and K-ras mutation
status in CRC patients Examples of polymorfic enzymes proposed to be involved in
colorectal carcinogenesis are the AM7 genes (17), involved in meat metabolism, the COX-2
gene (18), involved in fat metabolism, and the polymorphic genes involved in methyl
metabolism (19), and thus potentially important to consider when studying the effects of
folate.
CONCLUSION
Overall, our results suggest that meat, fat and folate appear to be of less importance for
the risk of colon and rectal tumours with specific point mutations in the K-ras gene than was
attributed to the factors at the start of the study, on the basis of biological mechanisms
However, these factors may be of aetiological importance for the risk of colon or rectal
tumours with a wild type K-ras gene, strongly suggesting the effects of dietary factors on
other pathways leading to CRC. This study shows that incorporating molecular endpoints in
classical epidemiological studies of diet and cancer is a relevant approach to unravel the
aetiology of colon and rectal cancer.
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Current eptdemtotogtcal evidence for associations between dietary factors with overall
colorectal cancer (CRC) risk is weak or inconsistent This could be due to methodological
factors such as study design, selection bias and information bias It could also be due to the
heterogeneity of the cancer endpoint that is studied Subtypes of colorectal cancer patients
could be distinguished by the absence or presence of alterations in genes involved in the
development of colorectal cancer Therefore, more insight in the aetiology of colorectal
cancer can be obtained by studying the associations between dietary factors and alterations
in genes involved in the early development of cancer The majority (95%) of colorectal
cancer is non-hereditary, i.e sporadic, and develops from small adenomatous polyps
through a well-defined sequence of cytological changes and this development is associated
with the accumulation of alterations in tumour suppressor genes and oncogenes regulating
cell division and growth Among the early alterations that occur in 40% of the colorectal
carcinomas are somatic mutations in the K-ras oncogens Approximately 90% of the
activating mutations in this gene is found in codons 12 and 13 of exon 1 and around 5% in
codon 61 located in exon 2 The most prevalent point mutations in exon 1 are the G>A
transitions, the G>T transversions and the G>C transversions The aim of this molecular
epidemiological study was to obtain more insight in the associations between dietary factors
and the risk of colorectal tumours with or without specific point mutations in exon 1 of the
K-ras oncogene.
The studies described in this thesis are embedded in The Netherlands Cohort Study on
diet and cancer (NLCS) The NLCS was initiated in 1986 and includes 58.279 men and
62,573 women (55-69 years of age) who onginated from 204 Dutch municipalities with
computerized population registries and who completed a self-administered questionnaire on
diet, family history of cancer and other risk factors for cancer The entire cohort is monitored
for cancer occurrence by annual linkage to The Netherlands Cancer Registry (NCR) and to
PALGA, a nationwide network and registry of histo- and cytopathology Accumulation of
person-time in the cohort has been estimated through biennial vital status follow-up of a
subcohort of 3,500 men and women who were randomly selected after baseline exposure
measurement. After 7 3 years of follow-up and with the exclusion of the first 2 3 years, 929
incident cases with histologically confirmed CRC were observed of whom 819 could also be
linked to a PALGA report of the lesion. The tumour tissue samples of these 819 cases were
distributed over 54 pathology laboratories throughout The Netherlands After approval of the
Medical Ethical committees, PALGA, the pathologists and the NCR the tissue blocks were
made available for this study Of the 819 tumour tissue samples that were identified, 775
(95%) could be traced and for 737 of these (95% of the available blocks), the K-ras mutation
status of exon 1 (including exons 12 and 13) could be determined.
In chapter 1 an overview is presented of the associations between dietary factors and
colorectal cancer, and of the (genetic) development of colorectal cancer with special
attention for the K-ras oncogene. Although much research is performed on diet and
colorectal cancer so far. there are still only few studies available on the associations
between dietary factors and K-ras oncogene mutations in colorectal cancer.
The frequency of K-ras oncogene mutations in tumours of incident colorectal cancer
patients from the NLCS is described in chapter 2. Moreover, the method of mutation
detection used in the current study, i.e. direct sequencing of amplified and purified K-ras
gene fragments, was validated by the confirmation of reported K-ras mutation status in CRC
cell lines and by a good correlation between fresh-frozen and routinely-fixed, paraffin-
embedded tissue The detection limit of mutated DNA was 5% The reported frequency of K-
ras mutations was observed to be 37% among 737 incident colorectal cancer patients, with
codons 12 and 13 as the most frequently affected codons (94%). The G>A transition and the
G>T and G>C transversions were the most frequently observed point mutations, with the
G>T transversion primarily confined to codon 12. Rectal tumours were found to have the
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highest frequency of G>T transversions. as compared to colon or rectosigmoid tumours.
Stratification by gender revealed that this difference was confined to the female patients. No
significant differences between tumours with or without specific K-ras mutations were
observed for Dukes' stage or tumour differentiation grade
Subsequently, associations between several dietary factors and the risk of colon or
rectal tumours with or without K-ras gene mutations were studied. The choice of dietary
factors evaluated in the current thesis was based on biological mechanisms underlying the
development of specific K-ras mutations in colorectal cancer Differences in the K-ras
mutation pattern at various subsites in the colorectal tract and in the aetiology of colon and
rectal cancer have been reported, and therefore, summarised results from the NLCS are
presented separately for colon and rectal cancer (chapters 3 through 5) Patients with a
rectosigmoid tumour (n=85) were excluded due to the criterion for classifying rectosigmoid
tumours and due to the small number of patients for adequate stratified analyses regarding
the K-ras mutation status
It was hypothesized that high levels of heterocyclic aromatic amines (HAA), generated
by high temperature cooking of meat proteins, and polycyclic aromatic amines (PAH)
originating from grilling and smoking of meat contribute to the occurrence of K-ras point
mutations. In chapter 3. associations between the intake of (several types of) meat, meat
products and fish, and the risk of colon or rectal tumours with or without a K-ras mutation.
Significant associations were mainly observed between meat and meat products and
tumours with a wild type K-ras gene A high consumption of beef and meat products was
associated with an increased risk of wild type K-ras tumours in the colon, but not in the
rectum. A high consumption of pork was inversely related with wild type K-ras tumours in
both colon and rectum. Based on these results, it was concluded that high consumption of
(several types of) meat and meat products may be relevant for the aetiology of colon and
rectal cancer.
Based on experimental results, it was hypothesized that w-6 polyunsaturated fat
(PUFA) peroxidation leads to the formation and accumulation of malondialdehyde and 4-
hydroxynonenal. These by-products could form DNA-adducts with guanine bases which
finally may result in G>A transitions or G>T transversions. Is a high to-6 PUFA intake
associated with an increased risk of G>A transitions or G>T transversions in the K-ras gene
of colon and rectal cancer patients? This was the aim of chapter 4. Null findings were
observed for the intakes of total fat, saturated fat, monounsaturated fat and co-3 PUFA, and
colon and rectal cancer, overall and also after the K-ras mutation status was taken into
account. Intake of dietary PUFA (total intake of u>-3 and to-6 fatty acids) and specifically
linoleic acid (as the main source of u>-6 fatty acids) was associated with an increased risk of
mutated K-ras colon tumours. Similar associations were observed for the specific K-ras point
mutations, i.e. the G>A transitions, G>T and G>C transversions, in colon tumours. For rectal
cancer, however, no associations were observed with overall risk or with K-ras mutation
status. Possibly, intake of PUFA, especially the u)-6 PUFA, is associated with an increased
risk of colon tumours with a K-ras gene mutation.
Folate plays an important role in one-carbon metabolism, in DNA synthesis and in
methylation of DNA and proteins. Deficient folate intake may generate genomic instability
through reduced availability of thymine for DNA synthesis and through increased
incorporation of uracil, which may lead to more DNA strand breaks In addition, global
genome hypomethylation and regional hypermethylation in gene promoters could occur as
another result of deficient folate intake In chapter 5 the relation between folate and K-ras
mutation status in colon or rectal cancer patients was studied For men, folate appears to be
inversely associated with the overall risk of rectal cancer, and this association was confined
to mutated K-ras tumours For women, however, an increased association was observed
between high folate intake and the risk of overall rectal cancer. With respect to the K-ras
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mutation status, the increased association remained for both wild type and mutated K-ras
tumours Moreover, this increased association was confined to rectal tumours harbouring
G>T and G>C trans versions, whereas a significant inverse association was observed with
rectal tumours harbounng a G>A transition Folate seems to play a role in the aetiology of
rectal cancer through the involvement of the K-ras oncogenes Results from this study
indicate that future molecular epidemiological research on folate intake need to account for
sex differences
In chapter 6. the most important findings of our study are summarized and compared
with the findings of other relevant molecular epidemiological studies. Overall, our results
suggest that meat, fat and folate appear to be of less importance for the nsk of colon and
rectal tumours with specific point mutations in the K-ras gene than was attributed to these
factors at the start of the study However, these factors may be of aetiological importance for
the risk of colon or rectal tumours with a wild type K-ras gene In addition, the possibilities
and pitfalls of molecular epidemiological studies are discussed in this chapter Moreover,
other genetic factors are pointed out which can be studied in future molecular
epidemiological research This study shows that incorporating molecular endpoints in
classical epidemiological studies of diet and cancer is a relevant approach the aetiology of
colon and rectal cancer
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Epidemiologische studies hebben tot nu toe zwakke of tegensthjdige relaties laten zien
tussen voedingsfactoren en net nsico op kanker van de dikke darm (colorectum: colon,
rectosigmoid en rectum) Dit kan te maken hebben met methodologische factoren zoals de
onderzoeksopzet. selectiebias en informatiebias Een andere verklanng kan zijn dat dikke
darmkanker te heterogeen is om beschouwd te kunnen worden als een ziektebeeld.
Mogelijk zijn er meerdere subgroepen van patienten te onderscheiden door ze in te delen op
basis van de af- of aanwezigheid van afwijkingen in genen die betrokken zijn bij de
ontwikkehng van dikke darmkanker Meer inzicht in het ontstaan van dikke darmkanker kan
worden verkregen door de relaties te onderzoeken tussen voedingsfactoren en afwijkingen
in genen die betrokken zijn bij de vroege ontwikkeling van kanker Het merendeel (ongeveer
95%) van dikke darmkanker behoort tot de sporadische vorm. dat wil zeggen dat ze niet zijn
ontstaan uit erfelijke genetische afwijkingen Volgens het gangbare model voor de
ontwikkeling van dikke darmkanker ontstaan de meeste tumoren uit adenomateuze poliepen
in een stapsgewijs proces Tijdens dit proces stapelen afwijkingen zich op in tumor-
suppressor-genen en oncogenen die de groei en differentiatie van dikke darmcellen
reguleren. Somatische mutaties in het K-ras gen behoren tot de vroege veranderingen die
plaatsvinden in een aanzienlijk deel (40%) van tumoren in de dikke darm. De meeste
mutaties in dit gen (90%) worden gevonden in codons 12 en 13 van exon 1 en een klein
deel (5%) wordt gevonden in codon 61 in exon 2 De puntmutaties in exon 1 zijn vooral G>A
transities, G>T transversies en G>C transversies Het doel van dit moleculair-
epidemiologisch onderzoek was om meer inzicht te knjgen in de relatie tussen verschillende
voedingsfactoren en het nsico op dikke darmkanker waarbij onderscheid is gemaakt tussen
tumoren met en tumoren zonder specifieke mutaties in exon 1 van het K-ras gen.
De studies die in dit proefschnft beschreven staan, zijn uitgevoerd binnen het kader van
de Nederiandse Cohort Studie naar voeding en kanker (NLCS) De NLCS is gestart in 1986
met ruim 120.000 mannen en vrouwen (55-69 jaar) in 204 Nederiandse gemeenten met een
geautomatiseerd bevolkingsregister, verspreid over het land. Bij de aanvang hebben de
deelnemers een lijst met vragen over voedingsgewoonten, kanker in de familie en andere
risicofactoren voor kanker ingevuld. Vervolgens is het optreden van kanker bij de
deelnemers nagegaan door middel van jaarlijkse koppelingen met de Nederiandse Kanker
Registratie (NKR) en met het Pathologisch Anatomisch Landelijk Geautomatiseerd Archief
(PALGA). Tevens is bij aanvang van de NLCS een aselect subcohort gekozen. bestaande
uit 3500 mannen en vrouwen, waarmee de persoonstijd voor het totale cohort wordt
geschat. Na 7,3 jaar follow-up, met uitzondering van de eerste 2,3 jaar, werden 929
patienten met dikke darmkanker geidentificeerd met behulp van koppeling met de NKR.
Voor 819 van de 929 patienten was ook een PALGA rapport beschikbaar De paraffine-
blokjes met het tumorweefsel van deze 819 patienten waren opgeslagen in 54 pathologie
laboratoria verspreid door heel Nederland Na toestemming door de betrokken medisch-
ethische commissies, PALGA, de pathologen en de NKR was het weefsel voor deze studie
beschikbaar. In totaal kon voor 775 van de 819 patienten (95%) het tumormatenaal worden
teruggevonden Voor 737 van hen (95% van de beschikbare weefselblokjes) kon de K-ras
mutatie status van exon 1 (waarin codons 12 en 13 zijn gelocaliseerd) worden bepaald
In hoofdstuk 1 wordt een literatuuroverzicht gegeven van de relaties tussen voeding en
dikke darmkanker, en van de (genetische) ontwikkeling van dikke darmkanker met daarbij
speciale aandacht voor het K-ras gen Alhoewel veel onderzoek is verricht naar voeding en
dikke darmkanker. zijn er maar weinig studies geweest naar de relatie tussen voeding en K-
ras mutaties
In hoofdstuk 2 is de frequentie van K-ras mutaties in tumoren van de incidente dikke
darmkanker patienten uit de NLCS beschreven Tevens werd de mutatiedetectie-techniek,
namelijk het op directe wijze bepalen van de basenvolgorde van geamplificeerde en
gezuiverde K-ras genfragmenten, op verschillende manieren gevalideerd De detectiehmiet
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werd bepaald op 5% gemuteerd DNA. Er werd een goede correlatie gevonden tussen de
bepaling van K-ras mutaties in gevroren tumorweefsel en in gefixeerd, paraffme-ingebed
tumorweefsel. Tevens konden de K-ras gen mutaties die beschreven zijn in cellijnen
afkomstig van dikke darmkanker met onze techniek worden bevestigd. Uiteindelijk werd bij
37% van de 737 patienten een mutatie in het K-ras gen gevonden. De meest voorkomende
types puntmutaties zijn G>A transities, en G>T en G>C transversies, waarbij G>T
transversies voornamelijk in codon 12 werden gedetecteerd. Tevens werden G>T
transversies vooral in rectum tumoren bij vrouwen gevonden. Er werden geen significants
verschillen aangetoond voor Dukes' stadiering of tumordifferentiatie tussen tumoren met of
zonder specifieke K-ras mutaties
Vervolgens werd onderzocht of bepaalde voedingsfactoren geassocieerd zijn met het
risico op colon of rectum tumoren met of zonder een K-ras mutatie. De keuze van de
bestudeerde voedingsfactoren in dit proefschrift is gebaseerd op de kennis van de
biologische mechanismen die ten grondslag liggen aan deze K-ras mutaties. De resultaten
in hoofdstukken 3 tot en met 5 zijn apart gepresenteerd voor colon en rectum kanker
aangezien gerapporteerd is dat er verschillen bestaan tussen K-ras mutatiepatronen in de
diverse sublokalisaties van de dikke darm, en dat colon- en rectumkanker mogelijk een
verschillende etiologie hebben Patienten met een rectosigmoid tumor werden uitgesloten
voor verdere analyses, omdat 1) het classificeren van een tumor in het rectosigmoid niet
gebeurt volgens een duidelijk critenum en 2) het aantal patienten met een rectosigmoid
tumor te klein was om adequate analyses te kunnen uitvoeren.
Er zijn vele studies die erop wijzen dat hoge concentraties van heterocyclische
aromatische amines, die ontstaan als vlees op zeer hoge temperatuur wordt verhit, en van
polycyclische aromatische amines, die gevormd worden door vlees te grillen of te roken,
K-ras puntmutaties kunnen veroorzaken. In hoofdstuk 3 worden associaties tussen de
inname van (verschillende soorten) vlees, vleeswaren en vis en het risico op colon- of
rectumtumoren met of zonder een K-ras mutatie beschreven. Een hoge consumptie van
rundvlees en vleeswaren bleek significant geassocieerd te zijn met een verhoogd risico op
tumoren met een wild type K-ras gen in het colon, maar niet in het rectum. Een hoge
consumptie van varkensvlees was geassocieerd met een verlaagd risico op tumoren met
een wild type K-ras gen in zowel het colon als het rectum. Op basis van de resultaten van
deze studie werd geconcludeerd dat een hoge inname van (verschillende soorten) vlees en
vleeswaren relevant kan zijn voor de etiologie van colon- en rectumkanker.
Een hoge inname van vetten lijkt ook een rol te spelen bij het ontstaan van colon- en
rectumkanker. Uit expenmentele studies blijkt dat peroxidatie van <»-6 poly-onverzadigd vet,
dat via de voeding wordt opgenomen, leidt tot vorming van malonaldehyde en 4-hydroxy-
nonenal. In dierexperimenteel onderzoek is aangetoond dat deze producten leiden tot DNA-
adducten aan guanine basen, welke uiteindelijk worden omgezet in G>A transities en G>T
transversies. Is een hoge inname van m-6 poly-onverzadigd vet geassocieerd met een
verhoogd risico op G>A transities dan wel G>T transversies in het K-ras gen in patienten
met colon of rectum kanker? Deze vraag komt aan de orde in hoofdstuk 4. Er zijn geen
significants associaties gevonden tussen de inname van totaal vet. verzadigd vet en mono-
onverzadigd vet enerzijds en het risico op colon en rectum kanker anderzijds, ook niet nadat
rekening is gehouden met de K-ras mutatiestatus. Een hoge inname van poly-onverzadigd
vet (de totale inname van <o-3 en <o-6 poly-onverzadigde vetzuren) en meer specifiek van
linolzuur (een hoofdbron van co-6 poly-onverzadigd vet) zijn wel geassocieerd met een
verhoogd risico op colontumoren met een K-ras mutatie en deze associatie blijkt
onafhankelijk van het type mutatie in de tumor. Voor rectumkanker werden deze relaties
echter niet gevonden. Dus, een hoge inname van poly-onverzadigd vet blijkt relevant voor
de ontstaanswijze van colon tumoren met een K-ras mutatie.
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Foliumzuur speett een belangnjke rol in het koolstofmetabohsme, in de synthese van
DNA en in de methylering van DNA en eiwitten Te weinig inname van foliumzuur kan
leiden tot instabiliteit van het genoom breuken in DNA-ketens kunnen ontstaan doordat
thymine onvoldoende voor de DNA-synthese beschikbaar is en doordat er een verhoogde
inbouw van uracil plaatsvindt Tevens kan globale hypomethylenng van het hele genoom en
regionale hypermethylenng in de promotorregio's van genen optreden door een deficiente
foliumzuunnname In hoofdstuk 5 wordt de relatie tussen foliumzuunnname en K-nss
mutaties in patienten met colon- of rectum kanker beschreven In deze studie werden
verschillen gevonden voor mannen en vrouwen Een hoge foliumzuunnname blijkt
geassocieerd te zijn met een vertaagd nsico op rectumtumoren bij mannen. ongeacht de
K-ras mutatiestatus. Echter, bij vrouwen werd een verhoogd risico op rectumtumoren
gevonden Dit verhoogd nsico werd gevonden voor tumoren met K-ras mutaties, maar ook
voor tumoren met een wild type K-ras gen Interessant is dat een hoge inname van
foliumzuur bij vrouwelijke patienten met een K-ras gemuteerde tumor een sterk
beschermend effect blijkt te hebben voor G>A transities Foliumzuur lijkt een duidelijke rol te
spelen in de ontwikkeling van rectumkanker, en het K-rps gen lijkt hierbij betrokken te zijn.
Deze studie toont ook aan dat in toekomstig moleculair epidemiologisch onderzoek naar
foliumzuur de man-vrouw verschillen moeten worden meegenomen
In hoofdstuk 6 wordt een slotbeschouwing gegeven waarin de belangrijkste
bevindingen van onze studie worden samengevat en vergeleken met andere moleculair
epidemiologische studies De resultaten suggereren dat een hoge inname van vlees en vet
en een lage inname van foliumzuur van minder groot belang zijn op het risico van die colon
of rectum tumoren met puntmutaties in het K-ras gen dan was verondersteld Echter, deza
factoren kunnen van etiologisch belang zijn voor het risico op colon of rectum tumoren met
een wild type K-ras gen. Tevens worden de mogelijkheden en beperkingen van moleculair
epidemiologische studies besproken Ook wordt in dit hoofdstuk aangegeven welke andere
genetische factoren in toekomstig moleculair epidemiologisch onderzoek kunnen worden
bestudeerd Deze studie laat zien dat het inbouwen van moleculaire eindpunten in de
klassieke epidemiologische onderzoeken naar voeding en kanker een relevante aanpak is
om de etiologie van colon- en rectumkanker gedeeltelijk op te helderen.
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Een multidisciplinair project als dit doe je NOOIT alleen... anders zou het niet
muttidisciplinair zijn.... Onmogelijk kan ik ledereen noemen. maar mocht lemand zichzelf
niet terugvinden . alsnog bedankt!
Allereerst wil ik mijn beide co-promotoren, Matty Weijenberg en Ton de Goeij, en
promotor, Piet van den Brandt, bedanken voor hun sturing en steun Matty, ook al was ik
jouw eerste AIO' moet ik zeggen dat ik het nooit heb kunnen merken Jouw niet-aflatende
enthousiasme en kntische blik heb ik als zeer motiverend ervaren! Ook mocht ik altijd bij jou
binnenvallen. hoe klein het punt ook was . jij kwam zelfs wel eens met drie kinderen mijn
kamer binnenvallen als de nood weer eens aan de vrouw was! Matty, ik heb ontzettend veel
van je geleerd! Hopelijk heb je wel jouw no-wornes-mood tijdens mijn verdediging
meegenomen. Ton, onze omgang heb ik altijd als plezierig en leerzaam ervaren (vooral wat
betreft mijn engels schrijven waann ik nogal eens eigenwijs was ) Jij Net altijd alles uit
handen vallen als ik met een vraag bij je kwam.. en je nam uitgebreid de tijd om mijn
vragen te beantwoorden Naast onderzoekszaken heb ik ook altijd ontzettend genoten van
jouw (reis)verhalen. Piet, jou wil ik in eerste instantie bedanken voor het aannemen van
deze nuchterling ut I Noord'n Tevens wil ik je bedanken voor het (mede) bewaken van mijn
voortgang, voor het beoordelen en het leveren van opbouwende kritieken op mijn stukken
waardoor deze 'tijdschhft-klaar' warden gestoomd.
De meer dan 120 000 participanten die deelnemen aan de Nederlandse Cohort Studle
naar voeding en kanker (NLCS) verdienen een grote dank, evenals alle Pathologie-
afdelingen in Nederland voor het beschikbaar stellen van het weefselmatenaall Zonder jullle
was dit project niet mogelijk geweest.
js SCREAM, get on top - "JS ! Naast een hit van Prince ook de naam van onze
projectgroep! Guido, jij hebt met heel veel enthousiasme orde en structuur weten te
scheppen in de 'chaos' van paraffineblokjes, coupes, epjes en pipetpuntjes! Daarnaast
stond je altijd open voor een goede discussie dan wel een prive-gesprek. Tot slot heb ik erg
veel bewondering gekregen voor jouw pogingen om salsa te leren dansen Marjolem,
halverwege CREAM kwam jij ons versterken Mede dankzij jouw enorme inzet is het gelukt
om de K-ras bepalingen tot een goed einde te brengen Manon, jouw enthousiasme
uberhaupt en voor het onderzoek is niet te evenaren (Jack bewonder ik des te meer als het
hem weer eens gelukt is om jou mee te slepen naar een of ander fantastisch vakantieoord)
Adriaan, in de vorm van 'onze afspraakjes' heb jij alle coupes beoordeeld. Dank je wel!
Margreet, na een jaar kwam jij me 'versterken' als mede-AlO op een gehjksoortig project.
Naast de discussies op het moleculair epidemiologisch vlak, ben ik veel te weten gekomen
over uitgaansgelegenheden inclusief drankjes en de mannen. en reizen Nog eventjes en
dan mag jij! Jan Willem Arends wil ik bedanken voor zijn betrokkenheid in de beginfase van
dit project.
Om de NLCS draaiende te houden. is/wordt veel energie en tijd gevraagd van de
volgende mensen: Linda van den Bosch. Henny Brants, Sacha van den Crommert, Willy van
Dijk, Margje Jansen, Arnold Kester, Ton van Moergastel, Marijke Moll, Harry van Montfort,
Jolanda Nelissen, Annemie Pisters, Ruud Schmeitz, Laura Voorrips en Conny de Zwart
Dank jullie wel! Tevens wil ik Sandra Bausch bedanken voor haar kritische en leerzame
bijdrage aan mijn artikelen.
Alle collega's van de cap groep Epidemiologie van de Universiteit Maastricht wil ik
bedanken voor de prettige sfeer Een aantal mensen wil ik speciaal noemen Caatje, ik
had me geen betere kamergenote kunnen wensen! Jij was het Brabantse absorberende
vermogen als ik weer eens een frustratie te verwerken had. Gerard "papa" Swaen, ook al
hebben we een haat-liefde verhouding, ik heb altijd van onze gesprekken, wandelingen en
gesprekken tijdens onze wandelingen genoten Leo. jou wil ik bedanken voor het
overnemen van een penode Minan-begeleiding en jouw onverdeelde interesse! Boukje, ik
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vond het leuk jou een beetje wegwijs (het grootste deel komt toch echt uit jezelf) te maken in
het verzamelen van alle blokjes. Anouk, Chhstel, Danielle, Marcus, Nicole. Raymond. Rik,
Rikkert, Saskia en Ute mede (ex) promovendi.de meesten zijn mij al voorgegaan.
Thamar, zal het ooit goed komen tussen ons? Kim en Femke, 'mijn' stagiaires...jullie
voorwerk heeft mede geleid tot een aantal artikelen in dit proefschnft Cobie, als mede
vroege vogel zetten we samen koffie Dit was mijn wek-service! Nathalie, you did it, girl! Het
boekie is prachtig gelay-out, dank je wel. En eeehhh als ik nog eens van die gigantische
tabellen heb, mag ik je dan bellen?
Annelies, Dianne, Jeanet, Marielle, Margreet en Marij, mijn KNAW-collegae, wil ik
bedanken voor hun interesse en begrip in mijn afronding van mijn promotie. De
verkenningscommissie wil ik hierbij ook noemen!
Werktljden zl]n van maandag tot en met vrijdag, 's ochtends vroeg tot s avonds laat! De
avonduren en weekenden zijn er om te "ontstressen".. .
Bianca (ligt het vliegveld van Parijs nog steeds in het centrum van Parijs?), Ischa (in
totale schuld de onschuld zelve...), Judith (mijn "nep'zus) en Natasja ("....00 leujkh")...
super dat jullie mij altijd het gevoel hebben gegeven dat ik alles bij jullie mocht droppen,
zowel letterlijk als figuurlijk! Judith, leuk dat je mijn paranimf wil zijn!
Ellen (mijn andere paranimf!) en Hans, dat een avondje oppassen heeft geleid tot 15
jaar vriendschap! Zullen we er nog minstens 15 bij doen? Harry, Ria, Lian en Heart, dank
jullie wel voor jullie gezelligheid Richard, als mede-noordeling wist jij als geen ander om
zaken op de juiste momenten te relativeren. Margriet en Jorge, ik ga eindelijk mee naar
Cuba... zucht Fleur, Sarah en Marco, ik ben blij dat we elkaar altijd weer opzoeken!
Annebe. een positieve instelling is zo belangrijk in het leven, dank je wel dat je me dat laat
zien!
Dansen (salsa) is een geweldige uitlaatklep, maar alleen als je uitgelaten' kan
worden...Marcel, Maurice (en zo ziet zo'n "scriptie" er dus uit...), Harold, Chris, Emiel ("prins
op het witte paard"). Ginny, Amel, Carine en Ischa (alweer...), ik mis jullie ontzettend!!
Ludovic, Edwin en Helen, dank jullie wel voor alle klimuurtjes en gezelligheid. Gaan we nog
eens buiten klimmen?
Leo, Mieke, Rinse, Marga, Imke en Erik...Vac (Hongarije), Hoensbroek, Maastricht,
Nijmegen, Heerenveen.zo komen we nog eens ergens! En altijd met veel gezelligheid!
Miek, dank voor het vormgeven van de prachtige omslag.
MIJURODIJA.mijn thuishaven! Lieve pap en mam, de basis voor het boekje dat hier
ligt, hebben jullie mij gegeven. Jullie zijn onmisbaar! Judith (mijn echte zus), Tony, Roland
en Ingrid, jullie maken MIJURODIJA compleet!
Jons, jou zing ik toe... ^  JS Moppie, moppie, moppie, ik vind jou helemaal toppie! JS -P
8a//amos deze vnydagavond, 79 november 2004/
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Mirian Bnnk werd op 3 oktober 1973 geboren te Gieten (Drenthe) In 1990 behaalde ze
het M.AV.O diploma aan de Esakker' te Gieten Vervolgens behaalde ze in 1992 het
H.A.V.O. diploma aan het D A G Hammarskjdld college/Dr Nassau college te Assen In
datzelfde jaar begon ze met de studie Voeding & Dietetiek aan de HanzeHogeschool te
Groningen waarvoor ze het propedeusecertificaat verkreeg Hiermee werd ze in 1993
toegelaten tot de studie Biologie aan de Rijksuniversiteit Groningen, waar ze in 1998
afstudeerde in de medisch-biologische richting. Tijdens deze studie heefl ze
onderzoekservanng opgedaan bij de vakgroepen Biologische Psychiatne en Pathologie van
het Groningen Universitair Medisch Centrum Na het afstuderen trad zij als assistant in
opleiding in dienst bi] de afdelingen Epidemiologie en Pathologie van de Universiteit
Maastricht Gedurende deze periode werd het door het Koningin Wilhelmina Fonds (KWF)
Kankerbestrijding gesubsidieerde en in dit proefschnft beschreven onderzoek uitgevoerd
onder begeleiding van Prof dr ir Piet A van den Brandt (Epidemiologie), Dr ir Matty P.
Weijenberg (Epidemiologie) en Dr Anton F.P.M de Goeij (Pathologie) Naast
werkzaamheden als het analyseren, schrijven en publiceren van gegevens, heefl ze veel
energie en tijd gestoken in het coordineren en uitvoeren van het verzamelen van het
tumormatenaal uit verschillende laboratona in Nederland en (deels) het coordineren van de
K-ras mutatiestatus-bepahng van het patientenmateriaal (het opzetten van de gebruikte
technieken en het vernchten van deze bepalingen is gedaan door twee analislen) Ook heeft
ze een coordinerende bijdrage geleverd in de opzet van twee databases waarin gegevens
over de voorraad van het tumormateriaal en de K-ras mutatiestatus van dikke darmkanker
patienten werden opgeslagen In deze periode behaalde zij haar registratie voor
Epidemiologie-A Sinds januari 2004 is ze werkzaam bij de Koninklijke Nederlandse
Akademie van Wetenschappen (KNAW) in Amsterdam als secretaris van de
wetenschapsverkenning 'Multifactonele aandoeningen in het Genomics-tijdperk' onder
begeleiding van Dr. Marij Stukart en uitgevoerd door een verkenningscommissie onder
voorzitterschap van Prof. dr. Dirkje S. Postma.
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